[Zurück]
 
Bitte auswählen
Jahr
Details
Sprache
Sortierung
Ausgabe
neu: RTF !
 Forschungsbericht für das Jahr

Klinik für Dermatologie und Venerologie

Hauptstrasse 7
79104 Freiburg
Tel: +49 - 761 - 270 - 67010 Fax: +49 - 761 - 270 - 68290
Email sabine.acker-heinig@uniklinik-freiburg.de
http://www.uniklinik-freiburg.de/hautklinik/live/index2.html?weiterleitung=ja


Einträge in der Rubrik "Who is Who"

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Abe K, Klaften M, Narita A, Imai K, Kimura M, Rubio-Aliaga I, Wagner S, Jakob T, Hrabé de Angelis M: Genome-wide search for genes which modulate inflammatory arthritis caused by ALI18 mutation in mice. Mamm Genome, 2009; 20: 152-161.
  • Abe K, Wechs S, Kalaydjiev S, Franz TJ, Busch DH, Fuchs H, Soewarto D, Behrendt H, Sibylle Wagner, Jakob T, Hrabé de Angelis M: Novel Lymphocyte-Independent Mechanisms to Initiate Inflammatory Arthritis via Bone Marrow Derived Cells of Ali18 Mutant Mice. Rheumatology, 2008; 47: 292-300.
  • Abeliovich H, Zarei M, Rigbolt KTG, Youle RJ, Dengjel J: Involvement of mitochondrial dynamics in the segregation of mitochondrial matrix proteins during stationary phase mitophagy. Nat Commun, 2013; 4: 2789.
  • Adam C, Wohlfarth J, Haußmann M, Sennefelder H, Maler M, Martin SF, Goebeler M, Schmidt M: Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation. J Invest Dermatol, 2017; 137: 367-376.
  • Agrawal P, George R, Thomas M, Has C, Pas H, Schmidt E, Leverkus M: A childhood subepidermal autoimmune bullous disease resembling mechanobullous epidermolysis bullosa acquisita. Brit J Dermatol, 2015; 173 (3): 871-874. : http://doi:10.1111/bjd.13833
  • Aguilar-Pimentel JA, Alessandrini F, Huster KM, Jakob T, Behrendt H, Ring J, Schulz H, Hrabe de Angelis M, Busch DH, Mempel M, Ollert M: Specific CD8 T cells in IgE-mediated allergy correlate with allergen dose and allergic phenotype. Am J Resp Crit Care, 2010; 181: 7-16.
  • Ahlgrim C, Gutermuth J, Önell A, Borres MP, Schäffler I, Darsow U, Pfab F, Brockow K, Behrendt H, Jakob T, Huss-Marp J: Comparison of Molecular Multiplex and Singleplex Analysis of IgE to Grass Pollen Allergens in Untreated German Grass Pollen-Allergic Patients. J Invest Allerg Clin, 2015; 25: 190-195. : http://www.jiaci.org/issues/vol25issue3/vol25issue03-4.htm
  • Al-Ahmad A, Kürschner A, Weckesser S, Wittmer A, Rauberger H, Jakob T, Hellwig E, Kist M, Waidner B: Is Helicobacter pylori resident or a transient germ in the human oral cavity? J Med Microbiol, 2012; 61: 1146-1152. : http://dx.doi.org/10.1099/jmm.0.043893-0
  • Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D: Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta. Am J Hum Genet, 2010; 86: 551-559.
  • Albani A., Villmann C., Pokorny T., D & Geyer M.: Alternative Cluster-Strukturen für die ZBKT-Methode (Zentrales Beziehungskonfliktthema). Psychother Psych Med, 2002; 52 (8): 363-367.
  • Albani C., Blaser G., Körner A., König S., Marschke F., Geißler I., Brenk K., Geyer M., Strauß B.: Zum Zusammenhang von Bindungsprototypen und zentralen Beziehungsmustern. Psychother Psych Med, 2002; 52 (12): 67-75.
  • Albani C., Blaser G., Körner A., König S., Marschke F., Geißler I., Geyer M., Pokorny D., Staats H., Benninghofen D., Dahlbender R., Cierpka M. & Kächele H.: Zum Zusammenhang zwischen der Valenz von Beziehungserfahrungen und der Schwere der psychischen Beeinträchtigung Psychother Psych Med, 2002; 52 (5): 226-235.
  • Albani C., Blaser G., Volkart R., Körner A., O´Connor L, Berry J., Geyer M., & Brähler E.: Der "Fragebogen zu interpersonellen Schuldgefühlen" (FIS) - Anwendung in einer repräsentativen Bevölkerungsstichprobe und bei PsychotherapiepatientInnen Psychother Psych Med, 2002; 52 (3/4): 189-197.
  • Albani C., Pokorny D., Blaser B., Grüninger S., König S., Marschke F., Geißler I., Körner A., Geyer M. & Kächele H.: Reformulation of the Core Conflictual Relationship Theme (CCRT) categories: The CCRT-LU Category System Psychother Res, 2002; 12 (3): 319-338.
  • Albani C., Reulecke M., Körner A., Villmann T., Blaser G., Geyer M., Pokorny D. & Kächele H.: Erinnertes elterliches Erziehungsverhalten und Zentrale Beziehungsmuster bei Psychotherapiepatientinnen Psychotherapie Forum, 2002; 9 (4): 162-171.
  • Albert A, Hein R, Ring J, Jakob T: Erythema anulare centrifugum-artige Psoriasis cum pustulatione Hautarzt, 2007; 58: 769-773.
  • Albrecht K, Droll H, Giesler JM, Nashan D, Meiss F, Reuter K: Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression. Psycho-oncology, 2013; 22 (9): 1972-1978. : http://dx.doi.org/10.1002/pon.3238
  • Albrecht KJ, Nashan D, Meiss F, Bengel J, Reuter K: Shared decision making in dermato-oncology: preference for involvement of melanoma patients. Melanoma Res, 2014; 24: 68-74.
  • Alessandrini F, Beck-Speier I, Krappmann D, Weichenmeier I, Takenaka S, Karg E, Kloo B, Schulz H, Jakob T, Mempel M, Behrendt H: Role of oxidative stress on ultrafine particles-induced exacerbation of allergic lung inflammation. Am J Resp Crit Care, 2009; 179: 984-991.
  • Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, Jakob T: Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung J Allergy Clin Immun, 2006; 117: 824-830.
  • Alessandrini F, Semmler-Behnke M, Jakob T, Schulz H, Behrendt H, Kreyling W: Total and Regional Deposition of Ultrafine Particles in a Mouse Model of Allergic Inflammation of the Lung. Inhal Toxicol, 2008; 20: 585-593.
  • Andrlová H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Rao Mittapalli V, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Römer W, Zeiser R: Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression. Oncotarget, 2017; 8: 42901-42916.
  • Antonioli M, Albiero F, Nazio F, Vescovo T, Perdomo AB, Corazzari M, Marsella C, Piselli P, Gretzmeier C, Dengjel J, Cecconi F, Piacentini M, Fimia GM: AMBRA1 Interplay with Cullin E3 Ubiquitin Ligases Regulates Autophagy Dynamics. Dev Cell, 2014; 31: 734-746.
  • Arin MJ, Grimberg G, Schumann H, De Almeida H Jr, Chang YR, Tadini G, Kohlhase J, Krieg T, Bruckner-Tuderman L, Has C: Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. Brit J Dermatol, 2010; 162: 1365-1369.
  • Arnold AW, Bruckner-Tuderman L, Has C, Happle R: Conradi-Hünermann-Happle syndrome in males vs. MEND syndrome (male EBP disorder with neurological defects. Brit J Dermatol, 2012; 166: 1309-1313.
  • Arnold AW, Bruckner-Tuderman L, Züger C, Itin PH: Cetuximab Therapy of Metastasizing Cutaneous Squamous Cell Carcinoma in a Patient with Severe Recessive Dystrophic Epidermolysis Bullosa. Dermatology, 2009; 219: 80-83.
  • Arnold AW, Happle R, Itin PH: Superimposed linear psoriasis unmasked by therapy with adalimumab. Eur J Dermatol, 2010; 20: 573-574.
  • Arnold AW, Itin PH, Pigors M, Kohlhase J, Bruckner-Tuderman L, Has C: Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria. Brit J Dermatol, 2010; 163 (4): 866-869.
  • Arnold AW, Kern JS, Itin PH, Pigors M, Happle R, Has C: Acromelanosis albo-punctata: a distinct inherited dermatosis with acral spotty dyspigmentation without systemic involvement. Dermatology, 2012; 224 (4): 331-339.
  • Arnold AW *, Kiritsi D *, Happle R, Kohlhase J, Hausser I, Bruckner-Tuderman L, Has C, Itin PH: Type 1 segmental Galli-Galli disease resulting from a previously unreported keratin 5 mutation. J Invest Dermatol, 2012; 132: 2100-2103.
  • Assaf Ch, Gellrich S, Steinhoff M, Nashan D, Weiße F, Dippel E, Coors E, Stein A, Gollin Ph, Henke U, Murati A, Koch A, Klemke CD, Stadler R, Sterry W: Kutane Lymphome in Deutschland. Einen Analyse des Zentralregisters Kutane Lymphome der Deutschen Dermatologischen Gesellschaft (DDG) Journal der Deutschen Dermatologischen Gesellschaft, 2007; 5: 662-668.
  • Athanassiadis GI, Pfab F, Braun-Falco M, v. Bubnoff N, Fend F, Ring J, Ollert M: Subcutaneous nodules revealing acute monoplastic leukemia (FAB type M5a) J Eur Acad Dermatol, 2007; 21: 1296-1297.
  • Athanassiadis GI, Pfab F, Klein A, Braun-Falco M, Ring J: Erythema multiforme due to contact with laurel oil Contact Dermatitis, 2007; 57: 116-118.
  • Augustin, M: Klinische Anwendungserfahrungen mit einer Hamamalis-Präparation (Deskin) bei atopischer Dermatitis. Therapiewoche, 2002; 18 (1): 3-4.
  • Augustin M: Mehr Lebensqualität bei chronischen Entzündungen und Ekzemen. Praxis Erfolg, 2003; 2 (3): 58-59.
  • Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I: Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system Eur J Dermatol, 2004; 14: 107-113.
  • Augustin M, Schloebe A, Hartmann A, Zschocke I: Nutzen und Wirtschaftlichkeit von Fumarsäureestern bei Psoriasis - Metaanalyse und ökonomische Modellierung Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 96.
  • Augustin M, Wenninger K, Gieler U, Schroth MJ, Chren M, Kupfer K, Amon U: German Adaption of the "Skindex-29" Questionnaire on Quality of Life in Dermatology: Validation and Clinical Results J Dermatol, 2004; 209: 14-20.
  • Augustin M., Ermuth T., Johnsen S., Zschocke I., Schöpf E., Vanscheidt W.: Kosteneffekte der autologen keratinozyten-Transplantation bei schweren therapieresistenten chronischen Wunden. Erste Ergebnisse einer monozentrischen Anwendungsbeobachtung. Ellipse, 2002; 18 (1): 1-10.
  • Augustin M., Heger M.: Mahonia aquafolium Der Kassenarzt, 2003; 4: 39-40.
  • Averbeck M, Braun T, Pfeifer G, Sleeman J, Dudda JC, Martin SF, Bremer B, Aktories K, Simon JC, Termeer C: Early cytoskeletal rearrangement during dendritic cell maturation enhances synapse formation and Ca²+-signaling in CD8+ T cells Eur J Immunol, 2004; 34: 2708-2719.
  • Babilas P, Liebsch G, Schacht V, Klimant I, Wolfbeis OS, Szeimies RM, Abels C: In Vivo Phosphorescence Imaging of pO2 Using Planar Oxygen Sensors. Microcirculation, 2005; 12: 477-487.
  • Babilas P, Shafirstein G, Baier J, Schacht V, Szeimies RM, Landthaler M, Bäumler W, Abels C: Photothermolysis of blood vessels using indocyanine green and pulsed diode laser irradiation in the dorsal skinfold chamber model Laser Surg Med, 2007; 39 (4): 341-352.
  • Baican A, Baican C, Chiriac G, Chiriac MT, Macovei V, Zillikens D, Ciuce D, Sitaru C: Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol, 2010; 49: 768-774.
  • Baican A *, Chiorean R *, Leucuta DC, Baican C, Danescu S, Ciuce D, Sitaru C: Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study. Orphanet J Rare Dis, 2015; 10 (online): 48. : http://dx.doi.org/10.1186/s13023-015-0263-4
  • Baldeschi C, Gache Y, Rattenholl A, Bouille P, Danos O, Ortonne JP, Bruckner-Tuderman L, Meneguzzi G: Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet, 2003; 12 (15): 1897-1905.
  • Bantleon F, Wolf S, Seismann H, Dam S, Lorentzen A, Miehe M, Jabs F, Jakob T, Plum M, Spillner E: Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells. Mol Immunol, 2016; 72: 42-56. : http://doi: 10.1016/j.molimm.2016.02.013
  • Barret JP, Podmelle F, Lipový B, Rennekampff HO, Schumann H, Schwieger-Briel A, Zahn TR, Metelmann HR: Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program. Burns, 2017; 43 (6): 1284-1294. : http://doi: 10.1016/j.burns.2017.03.005.
  • Basoglu Y, Metze D, Nashan D, Ständer S: Keratoackanthom mit perineuralem Wachstum: Indikator für ein aggressives Verhalten? Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6: 952-955.
  • Behrens D, Villone D, Koch M, Brunner G, Sorokin L, Robenek H, Bruckner-Tuderman L, Bruckner P, Hansen U: The epidermal basement membrane is a composite of separate laminin- and collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem, 2012; 287: 18700-18709.
  • Beikert FC, Le MT, Koeninger A, Technau K, Clad A: Recurrent vulvovaginal candidosis: focus on the vulva. Mycoses, 2011; 54 (6): E807-E810. : http://dx.doi.org/10.1111/j.1439-0507.2011.02030.x
  • Bertram L, Liß Y, Grözinger M: Neopterin and C-Reactive Protein in the Course of Stevens-Johnson Syndrome: Report of a Case. Acta Derm-venereol, 2009; 89: 285-287.
  • Betz RC, Planko L, Eigelshoven S, Hanneken S, Pasternack S, Büssow H, Van Den Bogaert K, Wenzel J, Braun-Falco M, Rütten A, Rogers MA, Ruzicka T, Nöthen MN, Magin TM, Kruse R: Loss-of function mutation in the Keratin 5 Gene Lead to Dowling-Degos disease Am J Hum Genet, 2006; 78: 510-519.
  • Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T, Bonadonna P, Fernandez J, Kosnik M, Helbling A, Mosbech H, Gawlik R, Niedoszytko M, Patella V, Pravettoni V, Rodrigues-Alves R, Sturm GJ, Rueff F: Self-medication of anaphylactic reactions due to Hymenoptera stings – An EAACI Task Force Consensus Statement. Allergy, 2016; 71: 931-943. : http://doi: 10.1111/all.12908
  • Blank S, Neu C, Hasche D, Bantleon FI, Jakob T, Spillner E: Polistes spp. venom is devoid of carbohydrate-based cross-reactivity and allows interference free diagnostics. J Allergy Clin Immun, 2013; 131: 1239-1242.
  • Boeckmann L, Schirmer M, Rosenberger A, Thoms KM, Gutzmer R, Has C, Kunz M, Kuschal C, Laspe P, Struever D, Schön MP, Brockmoeller J, Emmert S: Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in Caucasians. Pharmacogenet Genom, 2009; 19 (10): 760-769.
  • Boeckmann L, Thoms KM, Gutzmer R, Has C, Kunz M, Kuschal C, Laspe P, Struever D, Emmert S: Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro. Int J Clin Pharm Th, 2009; 47: 33-35.
  • Boerries M, Grahammer F, Eiselein S, Buck M, Meyer C, Goedel M, Bechtel W, Zschiedrich S, Pfeifer D, Laloe D, Arrondel C, Goncalves S, Krüger M, Harvey SJ, Busch H, Dengjel J, Huber TB: Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int, 2013; 83 (6): 1052-1064. : http://dx.doi.org/10.1038/ki.2012.487
  • Bohrer C, Pfurr S, Mammadzada K, Schildge S, Plappert L, Hils M, Pous L, Rauch KS, Dumit VI, Pfeifer D, Dengjel J, Kirsch M, Schachtrup K, Schachtrup C *: The balance of Id3 and E47 determines neural stem/precursor cell differentiation into astrocytes. Embo J, 2015; 34 (22): 2804-2819.
  • Booken N, Gratchev A, Utikal J, Weiß C, Yu X, Qadoumi M, Schmuth M, Sepp N, Nashan D, Rass K, Tüting T, Assaf C, Deppel E, Stadler R, Klemke CD, Goerdt S: Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia, 2008; 22: 393-399.
  • Bornert O, Kühl T, Bremer J, van den Akker PC, Pasmooij AMG, Nyström A: Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy. Mol Ther, 2016; 24: 1302-1311.
  • Bornholdt D, Atkinson TP, Bouadjar B, Catteau B, Cox H, De Silva D, Fischer J, Gunasekera CN, Hadj-Rabia S, Happle R, Holder-Espinasse M, Kaminski E, König A, Mégarbané A, Mégarbané H, Neidel U, Oeffner F, Oji V, Theos A, Traupe H, Vahlquist A, van Bon BW, Virtanen M, Grzeschik KH: Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2. Hum Mutat, 2013; 34: 587-594. : http://dx.doi.org/10.1002/humu.22275
  • Bornholdt D, Oeffner F, König A, Happle R, Alanay Y, Ascherman J, Benke PJ, Del Carmen Boente M, van der Burgt I, Chassaing N, Ellis I, Francisco CR, Giovanna PD, Hamel B, Has C, Heinelt K, Janecke A, Kastrup W, Loeys B, Lohrisch I, Marcelis C, Mehraein Y, Nicolas ME, Pagliarini D, Paradisi M, Patrizi A, Piccione M, Piza-Katzer H, Prager B, Prescott K, Strien J, Utine GE, Zeller MS, Grzeschik KH: PORCN mutations in focal dermal hypoplasia: coping with lethality. Hum Mutat, 2009; 30: E618-628.
  • Braun A, Bewersdorff M, Matuschek G, Jakob T, Buters JTM, Behrendt H, Mempel M: Differential impact of diesel composition on pro-allergic dendritic cell function. Toxicol Sci, 2010; 113: 85-94.
  • Braun A, Engel T, Aguilar-Pimentel JA, Zimmer A, Jakob T, Behrendt H, Mempel M: Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors. Immunobiology, 2011; 216: 466-476.
  • Braun-Falco M: Combined malignant melanoma and basal cell carcinoma tumor of the intermingled type J Cutan Pathol, 2007; 34: 731-735.
  • Braun-Falco M, Hofmann H: Nodular erythema elevatum diutinum in HIV-disease Clin Infect Dis, 2007; 44: 1009-1010.
  • Braun-Falco M, Kasche A, Ring J: Recurring localized scarlatiniform scaled erythema Féréol-Besnier Dermatology, 2006; 212: 253-257.
  • Braun-Falco M, Ring J: Nodular erythemata as early sign of systemic aspergillosis J Eur Acad Dermatol, 2006; 18: 610-612.
  • Braun-Falco M, Schempp W, Nevinny C, Köhn FM: Azoospermia due to a unique de novo balanced reciprocal translocation (Y;1) (q12;q25) J Androl, 2007; 28: 647-651.
  • Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, van Leeuwen FW, Kroemer G, Madeo F *: Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin. Cell Rep, 2015; 10 (9): 1557-1571. : http://dx.doi.org/10.1016/j.celrep.2015.02.009
  • Bremer J, Bornert O, Nyström A, Gostynski A, Jonkman MF, Aartsma-Rus A, van den Akker PC, Pasmooij AM: Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa. Mol Ther-nucl Acids, 2016; 5 (online): e379.
  • Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF: Guideline for the diagnosis of drug hypersensitivity reactions. S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Aller gologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group, the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergol Int, 2015; 24: 94-105.
  • Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Rietschel E, Schnadt S, Szczepanski R, Worm M, Kupfer J, Gieler U, Ring J: Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy, 2015; 70: 227-235.
  • Broekaert SM, Knauss-Scherwitz E, Biedermann T, Metzler G, Has C, Kohlhase J, Rocken M, Schaller M: Epidermolysis Bullosa Pruriginosa due to a Glycine Substitution Mutation in the COL7A1-gene Acta Derm-venereol, 2006; 86: 556-557.
  • Burger B, Spoerri I, Schubert M, Has C, Itin PH: Description of the natural course and clinical manifestations of ichthyosis with confetti caused by a novel KRT10 mutation. Brit J Dermatol, 2012; 166 (2): 434-439.
  • Buters JTM, Schober W, Gutermuth J, Jakob T, Aguilar-Pimentel A, Huss-Marp J, Traidl-Hofmann C, Mair S, Mayer F, Breuer K, Behrendt H: Toxicity of parked motor vehicle indoor air Environ Sci Technol, 2007; 41 (7): 2622-2629.
  • Büttner S, Habernig L, Broeskamp F, Ruli D, Vögtle FN, Vlachos M, Macchi F, Küttner V, Carmona-Gutierrez D, Eisenberg T, Ring J, Markaki M, Taskin AA, Benke S, Ruckenstuhl C, Braun R, Van den Tavernarakis N, Kovacs GG, Dengjel J, Meisinger C, Sigrist SJ, Madeo F: Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease. Embo J, 2013; 32 (23): 3041-3054.
  • Butzmann CM, Schempp CM: Exacerbation of atopic dermatitis upon alkaline skin care. J Dtsch Dermatol Ges, 2011; 9: 701-702.
  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H: Contact dermatitis due to use of Octenisept® in wound care. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7: 759-765.
  • Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T, Allen K, Asero R, Bohle B, Cox L, de Blay F, Ebisawa M, Maximiliano-Gomez R Gonzalez-Diaz S, Haahtela T, Holgate ST, Jakob T, Larche M, Matricardi PM, Oppenheimer J, Poulsen LK, Rosario N, Rothenberg M, Sanchez-Borges M, Scala E, Valenta R: A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J, 2013; 136 (online): 17-34.
  • Casetti F, Bartelke S, Biehler K, Augustin M, Schempp CM, Frank U: Antimicrobial activity against bacteria with dermatological relevance and skin tolerance of the essential oil from Coriandrum sativum L.fruits. Phytother Res, 2012; 26: 420-424. : http://onlinelibrary.wiley.com/doi/10.1002/ptr.3571/abstract
  • Casetti F, Ernst R, Hayler G, Jachens L, Kamentz U, Krause A, Müller M, Roesler B, Stetter C, Schempp CM: Anwendung von Oenothera Argento culta bei atopischer Haut von Kindern, Jugendlichen und jungen Erwachsenen. Der Merkurstab, 2013; 66: 32-35.
  • Casetti F, Jung W, Wölfle U, Reuter J, Neumann K, Gilb B, Wähling A, Wagner S, Merfort I, Schempp CM: Topical application of solubilized Reseda luteola extract reduces ultraviolet B-induced inflammation in vivo. Photochem Photobiol, 2009; 96: 260-265.
  • Casetti F, Miese A, Mueller ML, Simon JC, Schempp CM: Double trouble from sunburn: UVB-induced erythema is associated with a transient decrease of skin pigmentation. Skin Pharmacol Phys, 2011; 24: 160-165.
  • Casetti F, Wölfle U, Seelinger G, Schempp CM: Beinwellsalbe - klinischer Nutzen und Wirkmechanismus in der Haut. Zeitschrift für Phytotherapie, 2014; 35: 268-272.
  • Chiang LY, Poole K, Oliveira BE, Duarte N, Sierra YA, Bruckner-Tuderman L, Koch M, Hu J, Lewin GR: Laminin-332 coordinates mechanotransduction and growth cone bifurcation in sensory neurons. Nat Neurosci, 2011; 14: 993-1000.
  • Chiriac MT, Licarete E, Sas AG, Rados AM, Lupan I, Chiriac AM, Speth H, Pop-Vancia V, Domsa I, Sesarman A, Popescu O, Sitaru C: Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice. Orphanet J Rare Dis, 2013; 29 (8): 17. : http://10.1186/1750-1172-8-17
  • Chmel N, Danescu S, Gruler A, Kiritsi D, Bruckner-Tuderman L, Kreuter A, Kohlhase J, Has C *: A Deep-Intronic FERMT1 Mutation Causes Kindler Syndrome: An Explanation for Genetically Unsolved Cases. J Invest Dermatol, 2015; 135 (11): 2876-2879. : http://doi: 10.1038/jid.2015.227
  • Christopoulos PD, Dopfer EP, Malkovsky M, Esser PR, Eckart HE, Marx A, Kock S, Rupp N, Lorenz MR, Schwarz K, Harder J, Martin SF, Werner M, Bogdan C, Schamel WWA, Fisch P: A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression. J Immunol, 2015; 194: 3045-3053. : http://dx.doi.org/10.4049/jimmunol.1402805
  • Chylek LA *, Akimov V *, Dengjel J *, Rigbolt KT, Hu B, Hlavacek WS, Blagoev B: Phosphorylation site dynamics of early T-cell receptor signaling. Plos One, 2014; 9: e104240.
  • Cianfanelli V, Fuoco C, Lorente M, Salazar M, Quondamatteo F, Gherardini PF, De Zio D, Nazio F, Antonioli M, D'Orazio M, Skobo T, Bordi M, Rohde M, Dalla Valle L, Helmer-Citterich M, Gretzmeier C, Dengjel J, Fimia GM, Piacentini M, Di Bartolomeo S, Velasco G, Cecconi F *: AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat Cell Biol, 2015; 17 (1): 20-30.
  • Claudepierre T,, Manglapus MK,, Marengi N,, Radner S,, Champliaud MF,, Tasanen K,, Bruckner-Tuderman L,, Hunter DD,, Brunken WJ: Collagen XVII and BPAG1 expression in the retina: Evidence for an anchoring complex in the central nervous system J Comp Neurol, 2005; 487: 190-203.
  • Clorius S, Technau K, Watter T, Schwertfeger E, Fischer KG, Walz G, Gerke P: Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent. Clin Nephrol, 2007; 68 (4): 249-252.
  • Corsini E, Galbiati V, Esser PR, Pinto A, Racchi M, Marinovich M, Martin SF, Galli CL: Role of PKC-β in chemical allergen-induced CD86 expression and IL-8 release in THP-1 cells. Arch Toxicol, 2014; 88: 415-424. : http://doi: 10.1007/s00204-013-1144-z
  • Cribier B, Worret WI, Braun-Falco M, Peltre B, Langbein L, Schweizer J: Expression patterns of hair and epithelial keratins and transcription factors Hoxc13,LEF1, and ß-catenin in a malignant pilomatricoma: A histological and histochemical study J Cutan Pathol, 2006; 33: 1-9.
  • Csikos M, Orosz Z, Bottlik G, Szocs H, Szalai Z, Rozgonyi Z, Harsing J, Torok E, Bruckner-Tuderman L, Horvath A, Karpati S: Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis. Clin Exp Dermatol, 2003; 28 (2): 163-166.
  • Csikos M,, Szoscs M,, Laszik A,, Mecklenbeck S,, Horvath A,, Karpati S,, Bruckner-Tuderman L: High frequency of the 425A-->G splice-site mutation and novel mutations of COL7AI gene in Central-Europe: significance for future mutation-detection strategies in dystrophic epidermolysis bullosa Brit J Dermatol, 2005; 152: 879-886.
  • Csorba K, Chiriac MT, Florea F, Ghinia MG, Licarete E, Rados A, Sas A, Vuta V, Sitaru C: Blister-inducing antibodies target multiple epitopes on collagen VII in mice. J Cell Mol Med, 2014; 18 (9): 1727-1739. : http://doi: 10.1111/jcmm.12338
  • Csorba K, Schmidt S, Florea F, Ishii N, Hashimoto T, Hertl M, Kárpáti S, Bruckner-Tuderman L, Nishie W, Sitaru C: Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis, 2011; 28: 6-31.
  • Csorba K, Sesarman A, Oswald E, Feldrihan V, Fritsch A, Sitaru C: Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII. Cell Mol Life Sci, 2010; 67: 1343-1351.
  • Danescu S, Has C, Senila S, Ungureanu L, Cosgarea R: Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. J Eur Acad Dermatol, 2015; 29 (5): 899-903. : http://dx.doi.org/10.1111/jdv.12709
  • Darsow U, Brockow K, Pfab F, Jakob T, Petersson CJ, Borres MP, Ring J, Behrendt H, Huss-Marp J: Heterogeneity of molecular sensitization profiles in grass pollen allergy – implications for immunotherapy? Clin Exp Allergy, 2014; 44: 778-786.
  • De Araujo E, Dessirier V, Laprée G, Allanore L, Ortonne N, Stathopoulos EN, Bagot M, Bensussan A, Mockenhaupt M, Roujeau JC, Tsapis A: TRAIL and TWEAK in epidermal necrolysis. Exp Dermatol, 2011; 20 (2): 107-112. : http://10.1111/j.1600-0625.2010.01176.x
  • Dhami S, Nurmatov U, Varga EM, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Elberink JN, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Sheikh A: Allergen immunotherapy for insect venom allergy: protocol for a systematic review. Clin Transl Allergy, 2016; 6 (6) (online). : http://doi: 10.1186/s13601-016-0095-x
  • Dichmann S., Mrowitz U., Schöpf E., Norgauer J.: Chimeric monoclonal anti-CD25 antibody as a novel therapy option in HIV-associated psoriatic erythroderma. Am J Acad Dermol, 2002; 47: 635-636.
  • Diedrich B, Rigbolt KTG, Röring M, Herr R, Kaeser-Pebernard S, Gretzmeier C, Murphy RF, Brummer T, Dengjel J *: Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition. Embo J, 2017; 36 (5): 646-663.
  • Dietz L *, Esser PR *, Schmucker S, Goette I, Richter A, Schnoelzer M, Martin SF, Thierse HJ: Tracking human contact allergens: From mass spectrometric validated chemical-peptide interactions to chemical-specific naïve human T cell priming. Toxicol Sci, 2010; 17: 336-347.
  • Di Virgilio F, Ferrari D, Idzko M, Panther E, Norgauer J, La Sala A, Girolomoni G: Extracellular ATP, P2 receptors and inflammation. Drug Develop Res, 2003; 59: 171-174.
  • Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M: Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol, 2011; 131: 2271-2280.
  • Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann S, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M: Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol, 2008; 128: 415-426.
  • Doerken S, Mockenhaupt M, Naldi L, Schumacher M, Sekula P: The case-crossover design via penalized regression. Bmc Med Res Methodol, 2016; 16 (online): 103. : http://dx.doi.org/10.1186/s12874-016-0197-0
  • Doerken S, Mockenhaupt M, Schumacher M, Sekula P: Assessment of the "case-chaos" design as an adjunct to the case-control design. Am J Epidemiol, 2014; 179 (6): 775-780. : http://dx.doi.org/10.1093/aje/kwt310
  • Dolch A, Kunz S, Dorn B, Roers A, Martin SF, Jakob T: Contact allergens induce CD8+ T cell-derived interleukin 10 that appears dispensable for regulation of contact hypersensitivity. Letter to the Editor. Exp Dermatol, 2017; 26: 449-451. : http://doi: 10.1111/exd.13237
  • Dorn A, Zoellner A, Follo M, Martin SF, Weber F, Marks R, Zeiser R, Fisch P, Scheele JS: Rap1a deficiency modifies cytokine responses and MAPK-signalling in vitro and impairs the in vivo inflammatory response. Cell Immunol, 2012; 276: 187-195. : http://dx.doi.org/10.1016/j.cellimm.2012.05.008
  • Dudda J.C., Lembo A., Bachtanian E., Huehn J., Siewert C., Hamann A., Kremmer E., Förster R., Martin S.F.: Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor pattern of T cells: Important role for soluble factors and tissue microenvironment. Eur J Immunol, 2005; 35: 1056-1065.
  • Dudda JC, Denfeld RW, Simon JC, Martin SF: UVB-irradiated dendritic cells fail to tolerize murine CD8+ naive or effector T cells J Invest Dermatol, 2004; 122: 945-952.
  • Dudda JC, Simon JC, Martin SF: Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin. Role for tissue microenvironment and Dendritic cells in establishment of T cell homing subsets J Immunol, 2004; 172: 857-863.
  • Dumit VI, Küttner V, Käppler J, Piera-Velazquez S, Jimenez SA, Bruckner-Tuderman L, Uitto J, Dengjel J: Altered MCM Protein Levels and Autophagic Flux in Aged and Systemic Sclerosis Dermal Fibroblasts. J Invest Dermatol, 2014; 134: 2321-2330.
  • Dumit VI, Zerbes RM, Kaeser-Pebernard S, Rackiewicz M, Wall MT, Gretzmeier C, Küttner V, van der Laan M, Braun RJ, Dengjel J: Respiratory status determines the effect of emodin on cell viability. Oncotarget, 2017; 8 (23): 37476-37490.
  • Duteil D, Tosic M, Lausecker F, Nenseth HZ, Muller JM, Urban S, Willmann D, Petroll K, Messaddeq N, Arrigoni L, Manke T, Kornfeld JW, Bruning JC, Zagoriy V, Meret M, Dengjel J, Kanouni T, Schule R *: Lsd1 Ablation Triggers Metabolic Reprogramming of Brown Adipose Tissue. Cell Rep, 2016; 17: 1008-1021. : http://dx.doi.org/10.1016/j.celrep.2016.09.053
  • Easton JA, Donnelly S, Kamps MA, Steijlen PM, Martin PE, Tadini G, Janssens R, Happle R, van Geel M, van Steensel MA: Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations. J Invest Dermatol, 2012; 132: 2184-2191.
  • Eberlein-König B, Gulyas A, Schultz K, Lecheler J, Flögel S, Wolfmeyer C, Thiessen K, Jakob T, Hollweck R, Ring J, Behrendt H: Domestic allergens and endotoxin in three hospitals offering in-patient rehabilitation for allergic diseases in the alpine mountain climate of Bavaria – the AURA study. Int J Hyg Envir Heal, 2009; 212: 21-26.
  • Edele F, Dudda JC, Bachtanian E, Jakob T, Pircher H, Martin SF: Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route. Plos One, 2014; 9 (8) (online): e105266. : http://dx.doi.org/10.1371/journal.pone.0105266
  • Edele F, Molenaar R, Gütle D, Dudda JC, Jakob T, Homey B, Mebius R, Hornef M, Martin SF: Instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns. J Immunol, 2008; 181: 3745-3749.
  • Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C: Erfahrungen mit der neuen American Joint Committee on Cancer (AJCC) Klassifikation des kutanen malignen Melanoms - Eine kritische Analyse JDDG, 2005; 8: 592-598.
  • Eisenberg T, Schroeder S, Andryushkova A, Pendl T, Küttner V, Bhukel A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Moustafa T, Sprenger A, Jany E, Büttner S, Carmona-Gutierrez D Ruckenstuhl C, Ring J, Reichelt W, Schimmel K, Leeb T, Moser C, Schatz S, Kamolz LP, Magnes C, Sinner F, Sedej S, Fröhlich KU, Juhasz G, Pieber TR, Dengjel J, Sigrist SJ, Kroemer G, Madeo F: Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespan. Cell Metab, 2014; 19: 431-444.
  • Eisenhardt AE, Sprenger A, Roring M, Herr R, Weinberg F, Kohler M, Braun S, Orth J, Diedrich B, Lanner U, Tscherwinski N, Schuster S, Dumaz N, Schmidt E, Baumeister R, Schlosser A, Dengjel J, Brummer T *: Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. Oncotarget, 2016; 7: 26628-26652. : http://dx.doi.org/10.18632/oncotarget.8427
  • Eivazi B, Roessler M, Pfützner W, Teymoortash A, Werner JA, Happle R: Port-wine stains are more than skin-deep! Expanding the spectrum of extracutaneous manifestations of nevi flammei of the head and neck. Eur J Dermatol, 2012; 22: 246-251. : http://dx.doi.org/10.1684/ejd.2012.1653
  • Ekelund E, Bradley M, Weidinger S, Jovanovic D, Johansson C, Bruce S, Lindgren CM, Rummler L, Jakob T, Illig T, von Mutius E, Braun C, Brunekreef B, Riedler J, Holopainen P, Saarialho-Kere U MD, Scheynius A, Pershagen G, Nordenskjöld M, Kockum I, Kere J: Lack of association between Neuropeptide S Receptor 1 gene (NPSR1) and Eczema in five European populations. Acta Derm-venereol, 2009; 89: 115-121.
  • El Ali Z, Hamon P, Gerbeix C, Esser PR, Martin SF, Pallardy M, Kerdine-Römer S, , , : Allergic skin inflammation induced by chemicals is controlled by the transcription factor Nrf2. Toxicol Sci, 2013; 134: 39-48. : http://doi:10.1093/toxsci/kft084
  • El Beidaq A, Link CWM, Hofmann K, Frehse B, Hartmann K, Bieber K, Martin SF, Ludwig RJ, Manz RA: In vivo expansion of endogenous regulatory T cell populations induces long-term suppression of contact hypersensitivity. J Immunol, 2016; 197: 1567-1576. : http://dx.doi.org/10.4049/jimmunol.1600508
  • Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, Schuster V, Zillikens D, Goebeler M, Hertl M, Nast A, Orzechowski HD, Sárdy M, Schmidt E, Sitaru C, Sporbeck B, Worm M: S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges, 2015; 13 (8): 833-844.
  • Eming SA, Koch M, Krieger A, Bruckner-Tuderman L, Krieg T, Shannon JD, Fox JW: Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res, 2010; 9: 4758-4766.
  • Engel K, Reuter J, Seiler C, Schulte Mönting J, Jakob T, Schempp CM: Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test. J Eur Acad Dermatol, 2008; 22: 447-450.
  • Engel K, Schmidt U, Simon-Haarhaus U, Schempp C: Usnea barbata extract prevents ultraviolet-B induced prostaglandin E2 synthesis and COX-2 activation in HaCaT keratinocytes J Photoch Photobio B, 2007; 89: 9-14.
  • Engel K, Bruckner-Tuderman L,, Schempp CM: Generalisiertes noduläres Exanthem mit Augenentzündung bei einer 34-Jährigen. Hautarzt, 2005; 56: 1160-1164.
  • Engelke R, Riede J, Hegermann J, Wuerch A, Eimer S, Dengjel J, Mittler G: The quantitative nuclear matrix proteome as a biochemical snapshot of nuclear organization. J Proteome Res, 2014; 13: 3940-3956.
  • Erbil S, Oral O, Mitou G, Kig C, Durmaz-Timucin E, Guven-Maiorov E, Gulacti F, Gokce G, Dengjel J, Sezerman OU, Gozuacik D *: RACK1 Is an Interaction Partner of ATG5 and a Novel Regulator of Autophagy. J Biol Chem, 2016; 291: 16753-16765. : http://dx.doi.org/10.1074/jbc.M115.708081
  • Ermuth T: Kutane Manifestation innerer Erkrankungen. Was der gründliche Blick auf die Haut verraten kann. Hautarzt, 2004; 7: 55-58.
  • Ermuth T., Johnsen S., Vanscheidt W., Tanczos E., Augustin M., Peschen M.: Therapieefraktäres Ulcus cruris leukozytoklastisch-Vaskulitischer Genese im Rahmen eines hereditären Thrombophilie-Syndroms Aktuelle Dermatologie, 2002; 28: 170-172.
  • Ermuth T., Johnsen S., Vanscheidt W., Tanczos E., Augustin M., Peschen M.: Therapierefrakträres Ulcus cruris leukozytoklastisch-vaskulitischer Genese im Rahmen eines hereditären Thrombophilie-Syndroms. Akt Dermatol, 2002; 28: 170-172.
  • Esser PR, Wölfle U, Dürr C, von Loewenich FD, Schempp C, Freudenberg MA, Jakob T, Martin SF: Contact sensitizers induce skin inflammation via ROS and hyaluronic acid degradation in humans and mice. Plos One, 2012; 7 (online): e41340. : http://dx.doi.org/10.1371/journal.pone.0041340
  • Eyerich K, Traidl-Hoffmann C, Albert A, Kerzl R, Rombold S, Darsow U, Eberlein B, Jakob T, Ring J, Hein R: Lipomatous metaplasia after severe and chronic cutaneous inflammation. Dermatology, 2008; 217: 52-55.
  • Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, Nashan D, Sachse MM, Nicolay JP, Booken N, Goerdt S, Klemke CD: Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells. Brit J Dermatol, 2012; 167 (2): 348-358.
  • Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT: IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice. Hum Immunol, 2014; 75 (4): 354-363. : http://doi: 10.1016/j.humimm.2014.01.005
  • Fiala GJ, Janowska I, Prutek F, Hobeika E, Satapathy A, Sprenger A, Plum T, Seidl M, Dengjel J, Reth M, Cesca F, Brummer T, Minguet S, Schamel WW *: Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation. J Exp Med, 2015; 212 (10): 1693-1708. : http://dx.doi.org/10.1084/jem.20141271
  • Finegold DN, Schacht V, Kimak MA, Lawrence EM, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE: HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol, 2008; 6 (2): 65-68.
  • Fischer M, Horn S, Belkacemi A, Kojer K, Petrungaro C, Habich M, Ali M, Küttner V, Bien M, Kauff F, Dengjel J, Herrmann JM, Riemer J: Protein import and oxidative folding in the mitochondrial intermembrane space of intact mammalian cells. Mol Biol Cell, 2013; 24 (14): 2160-2170. : http://dx.doi.org/10.1091/mbc.E12-12-0862
  • Florea F, Bernards C, Caproni M, Kleindienst J, Hashimoto T, Koch M, Sitaru C: Ex vivo pathogenicity of anti-laminin γ1 autoantibodies. Am J Pathol, 2014; 184 (2): 494-506. : http://doi: 10.1016/j.ajpath.2013.10.019
  • Florea F, Torio-Padron N, Hashimoto T, Sitaru C: Nonscarring skin blistering disease and mucosal lesions with IgA autoantibodies reactive with collagen VII and IgG reactivity with laminin γ2. Brit J Dermatol, 2012; 167 (4): 938-941. : http://dx.doi.org/10.1111/j.1365-2133.2012.10946.x
  • Fontao L, Tasanen K, Huber M, Hohl D, Bruckner-Tuderman L, Sonnenberg A, Borradori L: Characterization of the molecular mechanisms underlying features of mainly epidermolysis bullosa simplex in a patient with deletion of the cytoplasmatic domain of BP180 J Invest Dermatol, 2004; 122: 65-72.
  • Frank DO, Dengjel J, Wilfling F, Kozjak-Pavlovic V, Hacker G, Weber A: The pro-apoptotic BH3-only protein Bim interacts with components of the translocase of the outer mitochondrial membrane (TOM). Plos One, 2015; 10 (4) (online): e0123341. : http://dx.doi.org/10.1371/journal.pone.0123341
  • Franzke CW, Bruckner-Tuderman L, Blobel C: Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. J Biol Chem, 2009; 284: 23386-23396.
  • Franzke CW, Cobzaru C, Triantafyllopoulou A, Löffek S, Horiuchi K, Threadgill DW, Kurz T, van Rooijen N, Bruckner-Tuderman L, Blobel CP: Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med, 2012; 209: 1105-1119.
  • Franzke CW, Has C, Schulte C, Huilaja L, Tasanen K, Aumailley M, Bruckner-Tuderman L: C-terminal truncation impairs glycosylation of transmembrane collagen XVII and leads to intracellular accumulation J Biol Chem, 2006; 281: 30260-30268.
  • Franzke CW, Tasanen K, Borradori L, Huotari V, Bruckner-Tuderman L: Shedding of collagen XVII/BP180: structural motifs influence cleavage from cell surface J Biol Chem, 2004; 279: 24521-24529.
  • Frick M, Fischer J, Helbling A, Rueff F, Wieczorek D, Ollert M, Pfützner W, Müller S, Huss-Marp J, Dorn B, Biedermann T, Lidholm J, Ruecker G, Bantleon F, Mühe M, Spillner E, Jakob T: Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. J Allergy Clin Immun, 2016; 138: 1663-1671. : http://doi: 10.1016/j.jaci.2016.04.024
  • Frick M, Müller S, Bantleon F, Huss-Marp J, Lidholm J, Spillner E, Jakob T: rApi m 3 and rApi m 10 improve detection of honey bee sensitization in Hymenoptera venom allergic patients with double sensitization to honey bee and yellow jacket venom. Allergy, 2015; 70 (12): 1665-1668. : http://dx.doi.org/10.1111/all.12725
  • Fritsch A, Löckermann S, Kern JS, Braun A, Bösl MR, Bley TA, Schumann H, von Elverfeldt R, Bruckner-Tuderman L: A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest, 2008; 118 (5): 1669-1679.
  • Fritsch A, Spassov S, Elfert S, Schlosser A, Gache Y, Meneguzzi G, Bruckner-Tuderman L: Dominant negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII. J Biol Chem, 2009; 284: 30248-30256.
  • Fukumoto T, Umekawa T, Higuchi M, Hashimoto T, Schumann H, Bruckner-Tudermann L, Asada H, Miyagawa S: Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen J Am Acad Dermatol, 2004; 50: 480-482.
  • Funk MC, Bera AN, Menchen T, Kuales G, Thriene K, Lienkamp SS, Dengjel J, Omran H, Frank M, Arnold SJ *: Cyclin O (Ccno) functions during deuterosome-mediated centriole amplification of multiciliated cells. Embo J, 2015; 34 (8): 1078-1089.
  • Gahr N, Technau K, Ghanem N: Intraductal papillary mucinous adenoma of the pancreas presenting with lobular panniculitis Eur Radiol, 2006; 16 (6): 1397-1398.
  • Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, Tsai SH, Wu TL, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC: HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J, 2014; 14 (3): 281-288.
  • Genin E, Schumacher M, Roujeau J, Naldi L, Liß Y, Kazma R, Sekula P, Hovnanian A, Mockenhaupt M: Genome-Wide Association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis, 2011; 6 (online): 52. : http://dx.doi.org/10.1186/1750-1172-6-52
  • Gibson A, Faulkner L, Lichtenfels M, Al-Attar Z, Esser PR, Martin SF, Pirmohamed M, Park BK, Naisbitt DJ: The effect of inhibitory signals on the priming of drug-hapten-specific T-cells that express distinct Vβ receptors. J Immunol, 2017; 199: 1223-1234. : http://doi: 10.4049/jimmunol.1602029
  • Giese S, Ciminski K, Bolte H, Moreira ÉA, Lakdawala S, Hu Z, David Q, Kolesnikova L, Götz V, Zhao Y, Dengjel J, Chin YE, Xu K, Schwemmle M: Role of influenza A virus NP acetylation on viral growth and replication. Nat Commun, 2017; 8 (1): 1259.
  • Gilles S, Jacoby D, Blume C, Müller MJ, Jakob T, Behrendt H, Schäkel K, Traidl-Hoffmann C: Pollen derived low molecular weight factors inhibit slanDCs capacity to induce Th1 responses. Clin Exp Allergy, 2010; 40: 269-278.
  • Gilles S, Mariani V, Thiel M, Mueller Martin J, Ring J, Jakob T, Pastore S, Behrendt H, Traidl-Hoffmann C: Pollen derived phytoprostanes signal via NF-kappa B dependent mechanisms. J Immunol, 2009; 182: 6653-6658.
  • Göbel K, Gruschke OG, Leupold J, Kern JS, Has C, Bruckner-Tuderman L, Hennig J, von Elverfeldt D, Baxan N, Korvink JG: Phased-array of microcoils allows MR microscopy of ex vivo human skin samples at 9.4 T. Skin Res Technol, 2015; 21 (1): 61-68. : http://dx.doi.org/10.1111/srt.12157
  • Gonzalez JM, Franzke CW, Yang F, Romero R, Girardi G: Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am J Pathol, 2011; 179 (2): 838-849.
  • Gretzmeier C, Eiselein S, Johnson GR, Engelke R, Nowag H, Zarei M, Küttner V, Becker AC, Rigbolt KTG, Høyer-Hansen M, Andersen JS, Münz C, Murphy RF, Dengjel J *: Degradation of protein translation machinery by amino acid starvation-induced macroautophagy. Autophagy, 2017; 13 (6): 1064-1075.
  • Groesser L, Vogt T, Happle R, Herschberger E, Mickler M, Landthaler M, Hafner C: Naevus marginatus revisited: a combined organoid and nonorganoid epidermal naevus caused by HRAS mutation. Brit J Dermatol, 2013; 168: 892-894.
  • Groll N, Petrikat T, Vetter S, Wenz C, Dengjel J, Gretzmeier C, Weiss F, Poetz O, Joos TO, Schwarz M, Braeuning A *: Inhibition of beta-catenin signaling by phenobarbital in hepatoma cells in vitro. Toxicology, 2016; 370: 94-105.
  • Gruber C, Gratz IK, Murauer EM, Mayr E, Koller U, Bruckner-Tuderman L, Meneguzzi G, Hintner H, Bauer JW: Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells. Mol Cancer Ther, 2011; 10: 233-241.
  • Gupta VK, Pech U, Bhukel A, Fulterer A, Ender A, Mauermann SF, Andlauer TF, Antwi-Adjei E, Beuschel C, Thriene K, Maglione M, Quentin C, Bushow R, Schwärzel M, Mielke T, Madeo F, Dengjel J, Fiala A, Sigrist SJ: Spermidine Suppresses Age-Associated Memory Impairment by Preventing Adverse Increase of Presynaptic Active Zone Size and Release. Plos Biol, 2016; 14 (9) (online): e1002563. : http://dx.doi.org/10.1371/journal.pbio.1002563
  • Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, Ring J, Mueller MJ, Behrendt H, Jakob T: Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo J Allergy Clin Immun, 2007; 120: 293-299.
  • Gutermuth J, Hein R, Fend F, Ring J, Jakob T: Cutaneous pseudolymphoma arising after tattoo placement J Eur Acad Dermatol, 2007; 21: 566-567.
  • Haddad C, Sidoroff A, Kardaun SH, Mockenhaupt M, Creamer D, Dunant A, Roujeau JC: Stevens-Johnson syndrome / toxic epidermal necrolysis: are drug dictionaries correctly informing physicians on the risk? Drug Safety, 2013; 36 (8): 681-686.
  • Halbach S, Hu Z, Gretzmeier C, Ellermann J, Wöhrle FU, Dengjel J, Brummer T: Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Cell Commun Signal, 2016; 14 (online): 6. : http://dx.doi.org/10.1186/s12964-016-0129-y
  • Halbach S, Rigbolt KT, Wöhrle FU, Diedrich B, Gretzmeier C, Brummer T, Dengjel J: Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal, 2013; 11 (1) (online): 30. : http://dx.doi.org/10.1186/1478-811X-11-30
  • Halevy S, Ghislain PD, Mockenhaupt M, Fagot JB, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC: Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol, 2008; 58 (1): 25-32.
  • Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, Tardieu M, Metzler M, Bruckner-Tuderman L, Schneider H: Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa. J Invest Dermatol, 2016; 136 (11): 2150-2157.
  • Happle R: Giant melanocytic nevus may be explained as a superimposed patchy manifestation of a polygenic trait. Dermatology, 2010; 221: 30-33.
  • Happle R: Type 2 segmental manifestation of "blue rubber bleb nevus syndrome": a reappraisal of 5 case reports. Eur J Dermatol, 2010; 20: 266-268.
  • Happle R: A novel X-linked phenotype caused by hypomorphic EBP mutations. Am J Med Genet A, 2011; 155 (A): 1770-1771.
  • Happle R: Hornstein-Birt-Hogg-Dubé syndrome: a renaming and reconsideration. Am J Med Genet A, 2012; 158: 1247-1251.
  • Happle R, König A: Smoker's boils. Dermatology, 2011; 222: 282-284.
  • Happle R, Nuñez-Giralda AI: Superimposed lateralized exanthema of childhood: a proposed explanation for an enigmatic disorder. Eur J Dermatol, 2012; 22: 542-544.
  • Has C, Bruckner-Tuderman L: A novel nonsense mutation in Kindler syndrome J Invest Dermatol, 2004; 122: 84-86.
  • Has C, Bruckner-Tuderman L: Molecular and clinical aspects of genetic skin fragility J Dermatol Sci, 2006; 44: 129-144.
  • Has C, Bruckner-Tuderman L: Genetische Ursachen für epidermale Fragilität. Med Genetik, 2009; 21: 471-478.
  • Has C, Burger B, Volz A, Kohlhase J, Bruckner-Tuderman L, Itin P: Mild Clinical Phenotype of Kindler Syndrome Associated with Late Diagnosis and Skin Cancer. Dermatology, 2010; 221 (4) (online): 309-312.
  • Has C, Castiglia D, del Rio M, Diez MG, Piccinni E, Kiritsi D, Kohlhase J, Itin P, Martin L, Fischer J, Zambruno G, Bruckner-Tuderman L: Kindler syndrome: extension of mutational spectrum and natural history. Hum Mutat, 2011; 32: 1204-1212.
  • Has C, Chang YR, Volz A, Hoeping D, Kohlhase J, Bruckner-Tuderman L: Novel Keratin 14 Mutations in Patients with Severe Recessive Epidermolysis Bullosa Simplex J Invest Dermatol, 2006; 126 (8): 1912-1914.
  • Has C, Herz C, Zimina E, Qu HY, He Y, Zhang ZG, Wen TT, Gache Y, Aumailley M, Bruckner-Tuderman L: Kindlin-1 is required for RhoGTPase-mediated lamellipodia formation in keratinocytes. Am J Pathol, 2009; 175 (4): 1442-1452.
  • Has C, Jakob T, He Y, Kiritsi D, Hausser I, Bruckner-Tuderman: Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergies. Brit J Dermatol, 2015; 172 (1): 257-261.
  • Has C, Jakob T, He Y, Kiritsi D, Hausser I, Bruckner-Tuderman L: Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergies. Brit J Dermatol, 2014; 172 (1): 257-261.
  • Has C, Kiritsi D, Mellerio JE, Franzke CW, Wedgeworth E, Tantcheva-Poor I Kernland-Lang K, Itin P, Simpson MA, Dopping-Hepenstal PJ, Fujimoto W, McGrath JA, Bruckner-Tuderman L: The Missense Mutation p.R1303Q in Type XVII Collagen Underlies Junctional Epidermolysis Bullosa Resembling Kindler Syndrome. J Invest Dermatol, 2014; 134: 845-849.
  • Has C, Ludwig RJ, Herz C, Kern JS, Ussar S, Ochsendorf FR, Kaufmann R, Schumann H, Kohlhase J, Bruckner-Tuderman L: C-terminally truncated kindlin-1 leads to abnormal adhesion and migration of keratinocytes. Brit J Dermatol, 2008; 159 (5): 1192-1196.
  • Has C, Schumann H, Leppert J, He Y, Hartmann B, Hausser I, Kohlhase J: Monoallelic Large Intragenic KRT5 Deletions Account for Genetically Unsolved Cases of Epidermolysis Bullosa Simplex. J Invest Dermatol, 2017; 137 (10): 2231-2234. : http://doi: 10.1016/j.jid.2017.05.016.
  • Has C, Wessagovit V, Pascucci M, Baer C, Biagio D, Wilhelm C, Pedicelli C, Locatelli A, Kohlhase J, Ashton G, Tadini G, Zambruno G, Bruckner-Tuderman L, McGrath J, Castiglia D: Molecular basis of Kindler syndrome: splice site, frameshift and Alu/Alu recombination mutations in the KIND1 gene J Invest Dermatol, 2006; 126: 1776-1783.
  • Has C, Wessagowit V, Pascucci M, Baer C, Didona B, Wilhelm C, Pedicelli C, Locatelli A, Kohlhase J, Ashton GH, Tadini G, Zambruno G, Bruckner-Tuderman L, McGrath JA, Castiglia D: Molecular basis of Kindler syndrome in Italy: novel and recurrent Alu/Alu recombination, splice site, nonsense, and frameshift mutations in the KIND1 gene J Invest Dermatol, 2006; 126: 1776-1783.
  • Has C, Yordanova I, Balabanova M, Kazandjieva J, Herz C, Kohlhase J, Bruckner-Tuderman L: A novel large FERMT1 (KIND1) gene deletion in Kindler syndrome. J Dermatol Sci, 2008; 52 (3): 209-212.
  • Has C *, Chmel N, Levati L, Neri I, Sonnenwald T, Pigors M, Godbole K, Dudhbhate A, Bruckner-Tuderman L, Zambruno G, Castiglia D: FERMT1 promoter mutations in patients with Kindler syndrome. Clin Genet, 2015; 88 (3): 248-254. : http://doi: 10.1111/cge.12490
  • Has C *, Spartà G *, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, Waters A, He Y, Anikster Y, Esser P, Straub BK, Hausser I, Bockenhauer D, Dekel B, Hildebrandt F, Bruckner-Tuderman L, Laube GF: Integrin α3 mutations with kidney, lung, and skin disease. New Engl J Med, 2012; 366 (16): 1508-1514.
  • Hashimoto T, Tsuruta D, Yasukochi A, Imanishi H, Sekine H, Fujita T, Wanibuch H, Gi M, Kárpáti S, Sitaru C, Zone JJ, Endo D, Abe S, Nishino T, Koji T, Ishii N: Granular C3 Dermatosis. Acta Derm-venereol, 2016; 96 (6): 748-753. : http://doi: 10.2340/00015555-2379
  • Hassel JC, Lee SB, Meiss F, Meier F, Dimitrakopoulou-Strauss A, Jäger D, Enk AH: Vemurafenib and ipilimumab: A promising combination? Results of a case series. Oncoimmunology, 2016; 29 (5) (online): e1101207.
  • Haug S, Braun-Falco M: Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome Gene Ther, 2006; 13: 1021-1026.
  • Haug S, Schnerch D, Halbach S, Mastroianni J, Dumit VI, Follo M, Hasenburg A, Kohler M, Dierbach H, Herzog S, Proske A, Werner M, Dengjel J, Brummer T, Lassmann S, Wasch R, Zeiser R *: Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer. International journal of cancer. Int J Cancer, 2015; 136 (10): 2328-2340.
  • Hecker J, Schulz D, Diethers A, Sabri A, Plum M, Michel Y, Mempel M, Ollert M, Jakob T, Blank S, Braren I, Spillner E: An IgE epitope of Bet v 1 and fagales PR10 proteins as defined by a human monoclonal IgE. Allergy, 2012; 67 (12): 1530-1537. : http://dx.doi.org/10.1111/all.12045
  • Heinemann A, He Y, Zimina E, Boerries M, Busch H, Chmel N, Kurz T, Bruckner-Tuderman L, Has C: Induction of phenotype modifying cytokines by FERMT1 mutations. Hum Mutat, 2011; 32: 397-406.
  • Hensen P, Beissert S, Bruckner-Tuderman L, Luger TA, Roeder N, Müller ML: Introduction of Diagnosis-Related Groups in Germany: Evaluation of impact on inpatient care in a dermatological setting. Eur J Public Health, 2008; 18: 85-91.
  • Hensen P, Müller ML, Haschemi R, Ständer H, Luger TA, Sunderkötter C, Schiller M: Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol, 2009; 19 (4): 345-354.
  • Hensen P, Müller ML, Stadler R, Luger TA: Dermatologic subspecialties in German inpatient dermatology:a national survey. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6 (9): 735-740.
  • Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C: Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer, 2017; 81: 36-44.
  • Herouy Y, Idzko M, Hildenbrand T, Ail M, Ferrari D, Di Virgilio F, Norgauer J: Venous leg ulcers and apoptosis: A TIMP-3 mediated pathway? J Invest Dermatol, 2003. (in Druck)
  • Herouy Y, Kahle B, Idzko M, Eberth I, Norgauer J, Fischer P, Rabe E, Jünger M, Bruckner-Tuderman L: Tight junctions and compression therapy in chronic venous insufficiency Int J Mol Med, 2006; 18: 215-219.
  • Herouy Y, Kahle B, Idzko M, Hildenbrand T, Yli MY, Clement J, Ferrari D, Di Virgilio F, Bruckner-Tuderman L, Norgauer J: Venous leg ulcers and apoptosis: a TIMP-3 mediated pathway? J Invest Dermatol, 2004; 123: 1210-1212.
  • Herouy Y, Kreis S, Mueller T, Duerk T, Martiny-Baron G, Reusch P, May F, Idzko M, Norgauer J: Inhibition of angiogenesis in lipodermatosclerosis: Implication for venous ulcer formation. Int J Mol Med, 2009; 24: 645-651.
  • Herouy Y, Krutmann J, Norgauer J, Schöpf E: Xeroderma pigmentosum Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 191-198.
  • Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S: Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6: 366-374.
  • Herz C, Aumailley M, Schulte C, Schlötzer-Schrehardt U, Bruckner-Tuderman L, Has C: Kindlin-1 is a phosphoprotein involved in regulation of polarity, proliferation and motility of epidermal keratinocytes J Biol Chem, 2006; 281 (47): 36082-36090.
  • Herzog C, Has C, Franzke CW, Echtermeyer FG, Kröger S, Gustafsson E, Fässler R, Bruckner-Tuderman L: Dystroglycan in skin and cutaneous cells: ß-subunit is shed from the cell surface J Invest Dermatol, 2004; 122: 1372-1380.
  • He Y, Balasubramanian M, Humphreys N, Waruiru C, Brauner M, Kohlhase J, O'Reilly R, Has C: Intronic ITGA3 mutation impacts splicing regulation and causes interstitial lung disease, nephrotic syndrome and epidermolysis bullosa. J Invest Dermatol, 2016; 136 (5): 1056-1059. : http://doi: 10.1016/j.jid.2015.11.031
  • He Y, Esser P, Heinemann A, Bruckner-Tuderman L, Has C: Kindlin-1 and -2 have overlapping functions in epithelial cells implications for phenotype modification. Am J Pathol, 2011; 178: 975-982.
  • He Y, Esser P, Schacht V, Bruckner-Tuderman L, Has C: Role of kindlin-2 in fibroblast functions: implications for wound healing. J Invest Dermatol, 2011; 131: 245-256.
  • He Y, Maier K, Leppert J, Hausser I, Schwieger-Briel A, Weibel L, Theiler M, Kiritsi D, Busch H, Boerries M, Hannula-Jouppi K, Heikkilä H, Tasanen K, Castiglia D, Zambruno G, Has C: Monoallelic Mutations in the Translation Initiation Codon of KLHL24 Cause Skin Fragility. Am J Hum Genet, 2016; 99 (6): 1395-1404.
  • He Y, Sonnenwald T, Sprenger A, Hansen U, Dengjel J, Bruckner-Tuderman L, Schmidt G, Has C: RhoA activation by CNFy restores cell-cell adhesion in kindlin-2 deficient keratinocytes. J Pathol, 2014; 233: 269-280.
  • Hieke N, Loffler AS, Kaizuka T, Berleth N, Bohler P, Driessen S, Stuhldreier F, Friesen O, Assani K, Schmitz K, Peter C, Diedrich B, Dengjel J, Holland P, Simonsen A, Wesselborg S, Mizushima N, Stork B *: Expression of a ULK1/2 binding-deficient ATG13 variant can partially restore autophagic activity in ATG13-deficient cells. Autophagy, 2015; 11 (9): 1471-1483.
  • Hildenbrand T., Idzko M., Panther E., Norgauer J., Herouy Y.: Treatment of non-healing leg ulcers with the fibrin-stabilazing factor XIII. Dermatol Surg, 2002; 28 (11): 1098-1099.
  • Hoffmann J, Casetti F, Bullerkotte U, Haarhaus B, Vagedes J, Schempp CM, Wölfle U: Anti-Inflammatory Effects of Agrimoniin-Enriched Fractions of Potentilla erecta. Molecules, 2016; 21 (online): 792. : http://dx.doi.org/10.3390/molecules21060792
  • Hoffmann J, Tasiopoulou G: Update Heilpflanzen, Phytotherapie in der Dermatologie. Hautarzt, 2017; 33 (3): 38-43.
  • Hoffmann J, Wölfle U, Schempp CM, Casetti F: Gerbstoffe aus Potentilla officinalis wirken entzündungshemmend im UV‐Erythem‐Test und bei Anwendung auf atopischer Haut. [Tannins from Potentilla officinalis display antiinflammatory effects in the UV erythema test and on atopic skin]. J Dtsch Dermatol Ges, 2016; 14 (9): 917-922. : http://dx.doi.org/10.1111/ddg.12792
  • Hoffmann K, Casetti F, Venzke T, Löckermann S, Schempp CM: Collagenous colitis during treatment with fumaric acid esters. J Dtsch Dermatol Ges, 2014; 12: 1138-1140.
  • Hofmann S, Bruckner-Tuderman L: Bullöses Pemphigoid: Diagnose und neue therapeutische Strategien Deut Med Wochenschr, 2006; 131: 389-392.
  • Hofmann S, Kopp G, Gall C, Bruckner-Tuderman L, Bertz H: Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft-versus-host disease. J Eur Acad Dermatol, 2010; 24: 587-594.
  • Hofmann S, Voith U, Sasaki T, Trüeb RM, Nischt R, Bruckner-Tuderman L: The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2. J Invest Dermatol, 2008; 128: 87-95.
  • Hofmann SC, Bosma A, Bruckner-Tuderman L, Vukmanovic-Stejic M, Jury EC, Isenberg DA, Mauri C: Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus. J Dermatol Sci, 2013; 71: 22-28.
  • Hofmann SC, Kautz O, Hertl M, Sticherling M, Zillikens D, Bruckner-Tuderman L: Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7: 227-233.
  • Hofmann SC, Nashan D, Bruckner-Tuderman L: Petechiae on the fingertips as presenting symptom of dermatitis herpetiformis Duhring. J Eur Acad Dermatol, 2009; 23: 732-733.
  • Hofmann SC, Otto C, Bruckner-Tuderman L, Borradori L: Isolated NC16a-ELISA testing in elderly patients with chronic pruritus to identify bullous pemphigoid is of little value in clinical practice. Eur J Dermatol, 2009; 19: 634-635.
  • Hofmann SC, Saborowski V, Lange S, Kern WV, Bruckner-Tuderman L, Rieg S: Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. J Am Acad Dermatol, 2012; 66: 966-974. : http://dx.doi.org/10.1016/j.jaad.2011.07.020
  • Hofmann SC, Schubert M, Bruckner-Tuderman L: Serological diagnosis of pemphigoids: comparison of immunoblotting to ELISA with recombinant NC 16a Arch Dermatol Res, 2004; 295: 353.
  • Hofmann SC, Voith U, Schönau V, Sorokin L, Bruckner-Tuderman L, Franzke CW: Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LABD97. J Invest Dermatol, 2009; 129: 1730-1739.
  • Hrenn A, Steinbrecher T, Labahn A, Schwager J, Schempp C, Merfort I: Plant phenolics inhibit neutrophil elastase and proliferation of keratinocytes Planta Med, 2006; 72 (12): 1127-1131.
  • Huilaja L, Hurskainen T, Autio-Harmainen H, Hofmann S, Sormunen R, Räsänen J, Ilves M, Franzke CW, Bruckner-Tuderman L, Tasanen K: Pemphigoid gestationis autoantigen, transmembrane collagen XVII, promotes the migration of cytotrophoblastic cells of placenta and is a structural component of fetal membranes. Matrix Biol, 2008; 27: 190-200.
  • Huilaja L, Hurskainen T, Autio-Harmainen H, Sormunen R, Tu H, Hofmann SC, Pihlajaniemi T Bruckner-Tuderman L, Tasanen K: Glycine substitution mutations cause intracellular ccumulation of collagen XVII and affect its post-translational modifications. J Invest Dermatol, 2009; 129: 2302-2306.
  • Hurskainen T, Kokkonen N, Sormunen R, Jackow J, Löffek S, Soininen R, Franzke CW, Bruckner-Tuderman L, Tasanen K: Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice. J Invest Dermatol, 2015; 135: 1303-1310.
  • Hurskainen T, Moilanen J, Sormunen R, Franzke CW, Soininen R, Loeffek S, Huilaja L, Nuutinen M, Bruckner-Tuderman L, Autio-Harmainen H, Tasanen K: Transmembrane collagen XVII is a novel component of the glomerular filtration barrier. Cell Tissue Res, 2012; 348: 579-588.
  • Hüsken AC, Tsianakas A, Hensen P, Nashan D, Loquai C, Beissert S, Luger TA, Sunderkötter C, Schiller M: Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma. J Eur Acad Dermatol, 2012; 26 (1): 71-78. : http://10.1111/j.1468-3083.2011.04011.x
  • Huss-Marp J, Gutermuth J, Schäffner I, Darsow U, Pfab F, Brockow K, Ring J, Behrendt H, Jakob T, Ahlgrim C: Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis. Allergo J Int, 2015; 24: 46-53.
  • Huyke C, Laszczyk M, Scheffler A, Ernst R, Schempp C: Treatment of actinic keratoses with birch bark extract - a pilot study J Deutsch Dermatol Ges, 2006; 4: 132-137.
  • Huyke C, Reuter J, Maunz H, Müller ML, Schempp CM: Betulin-basierte Creme für die topische Behandlung exsudativer Hauterkrankungen. Der Merkurstab, 2008; 61: 370-376.
  • Huyke C, Reuter J, Rödig M, Kersten A, Laszczyk M, Scheffler A, Nashan D, Schempp CM: Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7: 128-134.
  • Huyke C, Simon-Haarhaus B, Quirin KW, Schempp C: Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis Planta Med, 2007; 73: 1116-1126.
  • Idzko M, Laut M, Panther E, Sorichter S, Curk T, Fluhr JW, Herouy Y, Mockenhaupt M, Myrtek D, Elsner P, Norgauer J: Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation, Ca(2+) mobilization, and actin reorganization in human eosinphils via pertussis toxin-sensitive G proteins J Immunol, 2004; 172: 4480-4485.
  • Idzko M, Panther E, Bremer H.C, Windisch W, Sorichter S, Herouy Y, Elsner P, Girolomoni G, Norgauer J: Inosine stimulates chemotaxis, Ca²+ -transients and actin polymerization in immature human dentritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors. J Cell Physiol, 2003. (in Druck)
  • Idzko M, Panther E, Bremer HC, Sorichter S, Luttmann W, Virchow CJ Jr, Di Virgilio F, Herouy Y, Norgauer J, Ferrari D: Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils. Brit J Pharmacol, 2003; 138 (7): 1244-1250.
  • Idzko M, Panther E, Bremer HC, Windisch W, Sorichter S, Herouy Y, Elsner P, Mockenhaupt M, Girolomoni G, Norgauer J: Inosine stimulates chemotaxis, Ca2+ -transients and actin polymerization in immature human dendritic cells via pertussis toxin-sensitive mechanism independent of adenosine receptors J Cell Physiol, 2004; 199: 149-156.
  • Idzko M., Dichmann S., Ferrari M., diVirgilio F., laSala Girolomoni G., Panther E., Norgauer J.: Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dentritic cell via activation of pertussuis toxin-sensitive P2Y receptors. Blood, 2002; 100: 925-932.
  • Idzko M., LaSala A., Ferrari D., Panther E., Herouy Y., Dichmann S., DiVergilio F., Girolomoni G., Norgauer J.: Expression and function of histamine receptors in human dentritc cells. J Allergy Clin Immun, 2002; 109: 839-847.
  • Idzko M., LaSala A., Ferrari D., Panther E., Herouy Y., Dichmann S., Di Vergilio F., Giromoloni G., Norgauer J.: Expression an function of histamine receptors in human dentritic cells. J Allergy Clin Immun, 2002; 109: 839-846.
  • Idzko M., Panther E., Corinti S., Morelli A., Ferrari D., Herouy Y., Dichmann S., Mockenhaupt M., Gebicke-Haerter P., Di Virgilio F., Girolomoni G., Norgauer J.: Sphingosine 1-phophate induces chemotaxis of immature dentritic cells and modulates cytokine-release in mature human dentritic cells for emergence of Th2 immune responses. Faseb J, 2002; 12: 1433-1438.
  • Ishii N, Yoshida M, Ishida-Yamamoto A, Fritsch A, Elfert S, Bruckner-Tuderman L, Hashimoto T: Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Brit J Dermatol, 2009; 160: 1090-1093.
  • Jacków J, Löffek S, Nyström A, Bruckner-Tuderman L, Franzke CW: Collagen XVII shedding suppresses re-epithelialization by directing keratinocyte migration and dampening mTOR signaling. J Invest Dermatol, 2016; 136: 1031-1041.
  • Jacków J, Schlosser A, Sormunen R, Nyström A, Sitaru C, Tasanen K, Bruckner-Tuderman L, Franzke CW: Generation of a functional non-shedding collagen XVII mouse model: Relevance of collagen XVII shedding in wound healing. J Invest Dermatol, 2016; 136: 516-525. : http://dx.doi.org/10.1016/j.jid.2015.10.060
  • Jakob T, Köhler J, Blank S, Huss-Marp J, Spillner E, Lidholm J: Comparable IgE reactivity to nApi m 1 and rApi m 1 in CCD negative bee venom allergic patients. J Allergy Clin Immun, 2012; 130: 276-278.
  • Jakob T, Köllisch G, Bewersdorff M, Howaldt M, Rathkolb B, Mueller M, Sandholzer N, Nitschke L, Schiemann M, Mempel M, Ollert M, Soewarto D, Kremmer E, Ring J, Behrendt H, Flaswinkel H: Novel mouse mutants with primary cellular immunodeficienicies generated by genome wide mutagenesis. J Allergy Clin Immun, 2008; 121: 179-184.
  • Jakob T, Mariani V, Gutermuth J, Gilles S, Bewersdorff M, Müller MJ, Ring J, Behrendt H, Traidl-Hoffmann C: Th2 micromilieu generated by pollen associated lipid mediators (PALMs) Allergy From the Nose to the Lung (Japanese), 2007; 5: 9-12.
  • Jankovic D, Ganesan J, Bscheider M, Stickel N, Weber FC, Guarda G, Follo M, Pfeifer D, Tardivel A, Ludigs K, Bouazzaoui A, Kerl K, Fischer J, Haas T, Schmitt-Gräff A, Manoharan A, Müller L, Finke J, Martin SF, Gorka O, Peschel C, Ruland J, Idzko M, Duyster J, Holler E, French LE, Poeck H, Contassot E, Zeiser R: The Nlrp3-inflammasome regulates graft-versus-host disease. J Exp Med, 2013; 210: 1899-1910.
  • Jank T, Belyi Y, Wirth C, Rospert S, Hu Z, Dengjel J, Tzivelekidis T, Andersen GR, Hunte C, Schlosser A, Aktories K: Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A. J Biol Chem, 2017; 292 (39): 16014-16023.
  • Jantke M, Has C, Haenssle HA, Schön MP, Emmert S: Epidermolysis bullosa simplex: greater penetrance due to a keratin 5 gene variant. Clin Exp Dermatol, 2014; 39: 80-81.
  • Jensen RJ, Plum M, Tjerrild L, Jakob T, Spillner E, Andersen GR: Structure of the Omalizumab Fab. Acta Crystallogr F, 2015; 71: 419-426.
  • Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, Matsuda F, Weissenbach J, Lathrop M, Prud'homme JF, Fischer J.: Related Identification of mutations in a new gene encording a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet, 2003; 15 (12): 925-935.
  • Jocher A, Nist G, Weiss JM, Wetzel D, Merfort I, Jakob T, Schempp CM: Allergenic potential of Arnica containing formulations in Arnica-allergic patients. Contact Dermatitis, 2009; 61: 304-306.
  • Joeckel LT, Wallich R, Pardo J, Martin P, Weber FC, Martin SF, Borner C, Froelich C, Simon MM: Mouse granzyme K has pro-inflammatory potential. Cell Death Differ, 2011; 18: 1112-1119. : http://dx.doi.org/10.1038/cdd.2011.5
  • Johnsen S, Ermuth T, Tanczos E, Bannasch H, Horch RE, Zschocke I, Peschen M, Schöpf E, Vanscheidt W, Augustin M: Treatment of therapy-refractive ulcera cruris of various origins with autologous keratinocytes in fibrin sealant Vasa-j Vascular Dis, 2005; 34 (1): 25-29.
  • Kahle B, Idzko M, Norgauer J, Rabe E, Herouy Y: Tightening tight junctions with compression therapy. J Invest Dermatol, 2003; 121 (5): 1228-1229.
  • Kahofer P, Bruckner-Tuderman L, Metze D, Lemmink H, Scheffer H, Smolle J: Dystrophic epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/3 protein. Pediatr Dermatol, 2003; 20 (3): 243-248.
  • Kaiser P, Mockenhaupt M: Erythema exsudativum multiforme majus bei Kindern. Pädiat Prax, 2013; 81: 453-454.
  • Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, Veith J, Kamath N, Staubach P, Jakob T, Stirling RG, Kuna P, Berger W, Maurer M, Rosén K: Omalizumab in chronic idiopathic urticaria/chronic spontaneous urticaria patients symptomatic despite standard combination therapy. J Allergy Clin Immun, 2013; 132: 101-109.
  • Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Brit J Dermatol, 2013; 169: 1071-1080.
  • Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Brit J Dermatol, 2007; 156: 609-611.
  • Kassem A, Technau K, Kurz AK, Pantulu D, Löning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, zur Hausen A: Merkel cell polyomavirus sequences are frequently detected in nonmelaloma skin cancer of immunosuppressed patients. Int J Cancer, 2009; 125 (2): 356-361.
  • Kassner A, Hansen U, Miosge N, Reinhardt DP, Aigner T, Bruckner-Tuderman L, Bruckner P, Grassel S: Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils Matrix Biol, 2003; 22 (2): 131-143.
  • Kautz O, Bruckner-Tuderman L, Müller ML, Schempp CM: Trigeminal trophic syndrome with extensive ulceration following herpes zoster. Eur J Dermatol, 2009; 19: 61-63.
  • Kautz O, Müller S, Braun-Falco M, Nashan D: Milia en plaque in a linear pattern. J Eur Acad Dermatol, 2009; 23 (11): 1335-1336.
  • Kautz O, Schumann H, Degerbeck F, Venemalm L, Jakob T: Severe anaphylaxis to the antiseptic polyhexanide. Allergy, 2010; 65: 1068-1070.
  • Keller A, Müller ML, Calow T, Kern IK, Schumann H: Bandage pressure measurement and training: simple interventions to improve efficacy in compression bandaging. Int Wound J, 2009; 6 (5): 324-330.
  • Kern J, Herz C, Haan E, Moore D, Nottelmann S, von Lilien T, Greiner P, Schmitt-Graeff A, Opitz OG, Bruckner-Tuderman L, Has C: Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoforms J Pathol, 2007; 213 (4): 462-470.
  • Kern JS, Grüninger G, Imsak R, Müller ML, Schumann H, Kiritsi D, Emmert S, Borozdin W, Kohlhase J, Bruckner-Tuderman L, Has C: Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort. Brit J Dermatol, 2009; 161 (5): 1089-1097.
  • Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C: Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa J Invest Dermatol, 2006; 126: 1006-1012.
  • Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C: The molecular basis of dystrophic epidermolysis bullosa: mutation detection and study of clinical, biochemical and molecular findings in 41 patients J Invest Dermatol, 2006; 126: 1006-1012.
  • Kern JS, Loeckermann S, Fritsch A, Hausser I, Roth W, Magin TM, Mack C, Müller ML, Paul O, Ruther P, Bruckner-Tuderman L: Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther, 2009; 17 (9): 1605-1615.
  • Kern JS, Technau-Hafsi K, Schwacha H, Kuhlmann J, Hirsch G, Brass V, Deibert P, Schmitt-Graeff A, Kreisel W: Esophageal involvement is frequent in lichen planus: study in 32 patients with suggestion of clinicopathologic diagnostic criteria and therapeutic implications. Eur J Gastroen Hepat, 2016; 28 (12): 1374-1382. : http://dx.doi.org/10.1097/MEG.0000000000000732
  • Kespohl S, Maryska S, Bünger J, Hagemeyer O, Jakob T, Joest M, Knecht R, Koschel D, Kotschy-Lang N, Merget R, Mülleneisen NK, Rabe U, Röseler S, Sander I, Stollewerk D, Straube H, Ulmer HM, van Kampen V, Walusiak-Skorupa J Wiszniewska M, Wurpts G, Brüning T, Raulf M: How to diagnose mould allergy? Comparison of skin prick tests with specific IgE results. Clin Exp Allergy, 2016; 46: 981-991. : http://doi: 10.1111/cea.12733
  • Kiritsi D, Chmel N, Arnold AW, Jakob T, Bruckner-Tuderman L, Has C: Novel and recurrent AAGAB mutations in patients with punctate palmoplantar keratoderma. J Invest Dermatol, 2013; 133: 2483-2486.
  • Kiritsi D, Cosgarea I, Franzke C, Schumann H, Oji V, Kohlhase J, Bruckner-Tuderman L, Has C: Acral peeling skin syndrome with TGM5 mutations may resemble epidermolysis bullosa simplex in young individuals. J Invest Dermatol, 2010; 130 (6): 1741-1746.
  • Kiritsi D, Garcia M, Brander R, Has C, Meijer R, Jose Escámez M, Kohlhase J, van den Akker PC, Scheffer H, Jonkman MF, Del Rio M, Bruckner-Tuderman L, Pasmooij AM: Mechanisms of Natural Gene Therapy in Dystrophic Epidermolysis Bullosa. J Invest Dermatol, 2014; 134: 2097-2104.
  • Kiritsi D, He Y, Pasmooij AM, Onder M, Happle R, Jonkman MF, Bruckner-Tuderman L, Has C: Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest, 2012; 122 (5): 1742-1746.
  • Kiritsi D, Huilaja L, Franzke CW, Kokkonen N, Pazzagli C, Schwieger-Briel A, Larmas M, Bruckner-Tuderman L, Has C*, Tasanen K: Junctional Epidermolysis Bullosa with LAMB3 Splice-site Mutations. Acta Derm-venereol, 2015; 95 (7): 849-851. : http://doi: 10.2340/00015555-2073
  • Kiritsi D, Kern JS, Schumann H, Kohlhase J, Has C, Bruckner-Tuderman L: Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa. J Med Genet, 2011; 48 (7): 450-457.
  • Kiritsi D, Lorente AI, Happle R, Bernabeu Wittel J, Has C *: Blaschko line acne on pre-existent hypomelanosis reflecting a mosaic FGFR2 mutation. Brit J Dermatol, 2015; 172: 1125-1127.
  • Kiritsi D, Nanda A, Kohlhase J, Bernhard C, Bruckner-Tuderman L, Happle R, Has C: Extensive postzygotic mosaicism for a novel keratin 10 mutation in epidermolytic ichthyosis. Acta Derm-venereol, 2014; 94: 346-348.
  • Kiritsi D, Pigors M, Tantcheva-Poor I, Wessel C, Arin MJ, Kohlhase J, Bruckner-Tuderman L, Has C: Epidermolysis bullosa simplex Ogna revisited. J Invest Dermatol, 2013; 133: 270-273.
  • Kiritsi D, Schauer F, Wölfle U, Valari M, Bruckner-Tuderman L, Has C *, Happle R: Targeting epidermal lipids for treatment of Mendelian disorders of cornification. Orphanet J Rare Dis, 2014; 9: 33.
  • Kiritsi D, Valari M, Michos A, Karakosta V, Has C: The mysteries of mosaicism: phenotypic variability in a family with incontinentia pigmenti. Eur J Dermatol, 2016; 26 (5): 504-506.
  • Kiritsi D, Valari M, Mileounis K, Bruckner-Tuderman L, Has C *: 'Double trouble': diagnostic challenges in genetic skin disorders. Brit J Dermatol, 2015; 172 (1): 276-278. : http://doi: 10.1111/bjd.13159
  • Kiritsi D, Valari M, Paola Fortugno P, Hausser I, Zambruno G, Fischer J, Bruckner-Tuderman L, Jakob T, Has C: Whole-exome sequencing reveals genetic modifiers associated with elevated IgE and allergic sensitizations in ichthyosis. J Allergy Clin Immun, 2015; 135: 280-283.
  • Klein A, Prokosch HU, Müller M, Ganslandt T: Experiences with an interoperable data acquisition platform for multi-centric research networks based on HL7 CDA Method Inform Med, 2007; 46 (5): 580-585.
  • Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC: The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers. Brit J Dermatol, 2008; 159 (4): 871-880.
  • Klemm S, Gutermuth J, Hültner L, Sparwasser T, Behrendt H, Peschel C, Mak TW, Jakob T, Ruland J: The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation J Exp Med, 2006; 203: 334-347.
  • Klöcker M, Jakob T: Adrenalin-Autoinjektor - Lebensretter mit Tücken? Allergo J, 2009; 18: 71-73.
  • Knobler R, Berlin G, Calzavara-Pinton P, Greinix H, Jaksch P, Laroche L, Ludvigsson J, Quaglino P, Reinisch W, Scarisbrick J, Schwarz T, Wolf P, Arenberger P, Assaf C, Bagot M, Barr M, Bohbot A, Bruckner-Tuderman L, Dreno B, Enk A, French L, Gniadecki R, Gollnick H, Hertl M, Jantschitsch C, Jung A, Just U, Klemke CD, Lippert U, Luger T, Papadavid E, Pehamberger H, Ranki A, Stadler R, Sterry W, Wolf IH, Worm M, Zic J, Zouboulis CC, Hillen U: Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol, 2014; 28 Suppl. 1: 1-37.
  • Koch M, Schulze J, Hansen U, Ashwodt T, Keene DR, Brunken WJ, Burgeson RE, Bruckner P, Bruckner-Tuderman L: A novel marker of tissue junctions: collagen XXII J Biol Chem, 2004; 279: 22514-22521.
  • Köhler J, Blank S, Müller S, Frick M, Bantleon F, Huss-Marp J, Lidholm J, Spillner E, Jakob T: Component resolution reveals additional major allergens in bee venom allergic patients. J Allergy Clin Immun, 2014; 133: 1383-1389.
  • Komorowski L, Mockenhaupt M, Sekula P, Roujeau JC, Probst C, Teegen B, Li W, Stöcker W, Zillikens D: Lack of a Specific Humoral Autoreactivity in Sera from Patients with Early Erythema Exsudativum Multiforme Majus. J Invest Dermatol, 2013; 133 (12): 2799-2802.
  • Kopecki Z, Arkell RM, Strudwick XL, Hirose M, Ludwig RJ, Kern JS, Bruckner-Tuderman L, Zillikens D, Murrell DF, Cowin AJ: Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol, 2011; 225 (3): 401-413.
  • Körner A., Geyer M. & Brähler E.: Das NEO-Fünf-Faktoren Inventar (NEO-FFI)-Ergebnisse der ersten bundesweiten Repräsentativerhebung. Diagnostica, 2002; 48 (1): 19-27.
  • Kovács M, Németh T, Jakus Z, Sitaru C, Simon E, Futosi K, Botz B, Helyes Z, Lowell CA, Mócsai A: The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J Exp Med, 2014; 211 (10): 1993-2011. : http://doi: 10.1084/jem.20132496
  • Krishna CV, Parmar NV, Has C: Kindler syndrome with severe mucosal involvement in childhood. Clin Exp Dermatol, 2014; 39: 340-343.
  • Kroeger JK, Hofmann SC, Leppert J, Has C, Franzke CW: Amino acid duplication in the coiled-coil structure of collagen XVII alters its maturation and trimerization causing mild junctional epidermolysis bullosa. Hum Mol Genet, 2017; 26 (3): 479-488.
  • Kühl T, Mezger M, Hausser I, Guey L, Handgretinger R, Bruckner-Tuderman L, Nyström A: Collagen VII half-life at the dermal-epidermal junction zone: Implications for mechanisms and therapy of genodermatoses. J Invest Dermatol, 2016; 136: 1116-1123.
  • Kühl T, Mezger M, Hausser I, Handgretinger R, Bruckner-Tuderman L, Nyström A: High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa. Mol Ther, 2015; 23: 1368-1379.
  • Kulkarni S, Sitaru C, Jakus Z, Anderson KE, Davidson D, Hirose M, Oxley D, Chessa TAM, Ramadani F, Guillou H, Segonds-Pichon A, Fritsch A, Jarvis GE, Okkenhaug K, Ludwig RJ, Zillikens D, Mocsai A, van Haesebroeck B, Stephens LR, Hawkins PT: PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes. Sci Signal, 2011; 4 (168) (online): ra23. : http://dx.doi.org/10.1126/scisignal.2001617
  • Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, Lin Cs, Fiebiger E, Wu Ya, Hicklin D, Bohlen P, Detmar M: Induction of cutaneous delayed-type hypersensitivity reaction in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood, 2004; 104: 1048-1057.
  • Kunz S, Dolch A, Dorn B, Bewersdorff M, Alessandrini F, Surianarayanan S, Behrendt R, Karp CL, Mueller W, Martin SF, Roers A, Jakob T: T cell derived interleukin 10 is dispensable for tolerance induction in a murine model of specific immunotherapy. Eur J Immunol, 2016; 46: 2018-2027. : http://doi: 10.1002/eji.201646319
  • Kurschat P, Nashan D, Krieg T, Mauch C: Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression. Brit J Dermatol, 2007; 156: 653-658.
  • Kurth R.A., Pokorny D., Körner A. & Geyer M.: Der Beziehungs-Muster Fragebogen (BeMus): Validierung anhand einer repräsentativen Bevölkerungsstichprobe Psychother Psych Med, 2002; 52 (3/4): 179-188.
  • Kuttner V, Mack C, Rigbolt KT, Kern JS, Schilling O, Busch H, Bruckner-Tuderman L, Dengjel J: Global remodelling of cellular microenvironment due to loss of collagen VII. Mol Syst Biol, 2013; 9 (online): 657. : http://dx.doi.org/10.1038/msb.2013.17
  • Küttner V, Mack C, Gretzmeier C, Bruckner-Tuderman L, Dengjel J: Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity. J Invest Dermatol, 2014; 134: 2381-2389.
  • Kvainickas A, Orgaz AJ, Nägele H, Diedrich B, Heesom KJ, Dengjel J, Cullen PJ, Steinberg F: Retromer/WASH dependent sorting of nutrient transporters requires a multivalent interaction network with ANKRD50. Retromer- and WASH-dependent sorting of nutrient transporters requires a multivalent interaction network with ANKRD50. J Cell Sci, 2017; 130: 382-395. : http://dx.doi.org/10.1242/jcs.196758
  • Lapp T, Auw-Haedrich C, Reinhard T, Evans R, Rodríguez E, Weidinger S, Jakob T: Analysis of Filaggrin Mutations and Expression in Corneal Specimens from patients with or without Atopic Dermatitis. International Archives of Allergy and Immunology. Int Arch Allergy Imm, 2014; 163: 20-24. : http://dx.doi.org/10.1159/000355965
  • LaSala A., Sebastiani S., Ferrari D., DiVergilio F., Idzko M., Norgauer J., Girolomo G.: Dendritic cells exposed to extracellular ATP acquire the migratory properties of mature cells and show a reduced capacity to attract type 1T-lymphocytes. Blood, 2002; 99: 1715-1722.
  • Lass C, Merfort I, Martin SF: In vitro and in vivo analysis of pro-and anti-inflammatory effects of weak and strong contact allergens. Exp Dermatol, 2010; 19: 1007-1013.
  • Lass C, Vocanson M, Wagner S, Schempp CM, Nicolas JF, Merfort I, Martin SF: Anti-inflammatory and immune regulatory mechanisms prevent contact hypersensitivity to Arnica montana L. Exp Dermatol, 2008; 17: 849-857.
  • Laszczyk M, Jäger S, Simon-Haarhaus B, Scheffler A, Schempp C: Physical, chemical and pharmacological characterization of a new oleogel forming triterpene extract from the outer bark of birch Planta Med, 2006; 72: 1389-1395.
  • Lee HY, Dunant A, Sekula P, Mockenhaupt M, Wolkenstein P, Valeyrie-Allanore L, Naldi L, Halevy S, Roujeau JC: The role of prior corticosteroids on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control analysis of patients selected from the multi-national EuroSCAR and RegiSCAR studies. Brit J Dermatol, 2012; 167 (3): 555-562. : http://dx.doi.org/10.1111/j.1365-2133.2012.11074.x
  • Lennerz JK *, Hoffmann K *, Bubolz AM, Lessel D, Welke C, Rüther N, Viardot A, Möller P: Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma. Oncotarget, 2015; 6 (30): 29097-29110. : http://dx.doi.org/10.18632/oncotarget.4829
  • Lesueur F, Lefevre C, Has C, Guilloud-Bataille M, Oudot T, Mahe E, Lahfa M, Mansouri S, Mosharraf-Olmolk H, Sobel E, Heath S, Lathrop M, Dizier MH, Prud'Homme JF, Fischer J: Confirmation of psoriasis susceptibility loci on chromosome 6p21 and 20p13 in French families J Invest Dermatol, 2007; 127: 1403-1409.
  • Leuner K, Kraus M, Woelfle U, Beschmann H, Harteneck C, Boehncke WH, Schempp CM, Müller WE: Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. Plos One, 2011; 6 (2): e14716. : http://10.1371/journal.pone.0014716
  • Leverkus M, Ambach A, Hoefeld-Fegeler M, Kohlhase J, Schmidt E, Schumann H, Has C, Gollnick H: Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII. Brit J Dermatol, 2011; 164 (5): 1104-1106.
  • Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P: Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics, 2009; 123 (2): 297-304.
  • Leyendeckers H, Tasanen K, Bruckner-Tuderman L, Zillikens D, Sitaru C, Schmitz J, Hunzelmann N: Memory B cells specific for the NC 16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies. J Invest Dermatol, 2003; 120: 372-378.
  • Licarete E, Ganz S, Recknagel MJ, Di Zenzo G, Hashimoto T, Hertl M, Zambruno G, Hundorfean G, Mudter J, Neurath MF, Bruckner-Tuderman L, Sitaru C: Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. Bmc Immunol, 2012; 4: 13-16.
  • Licarete E, Sitaru C, Chiriac MT: Inhibition of myeloperoxidase, but not superoxide dismutase activity show protective function in the ex vivo model of bullous pemphigoid. Studia Universitatis Babes-bolyai Biologica, 2011; 2: 59-69.
  • Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, Roujeau JC, Mockenhaupt M: Prognosis of Generalized bullous fixed drug eruption: a case control study. Brit J Dermatol, 2013; 168 (4): 726-732.
  • Livingstone E, Krajewski C, Eigentler TK, Windemuth-Kieselbach C, Benson S, Elsenbruch S, Hauschild A, Rompel R, Meiss F, Mauerer A, Kähler KC, Dippel E, Möllenhoff K, Kilian K, Mohr P, Utikal J, Schadendorf D: Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study. Eur J Cancer, 2015; 51 (5): 653-667.
  • Livingstone E, Windemuth-Kieselbach C Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D: A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up Eur J Cancer, 2011; 47 (13): 1977-1989.
  • Löckermann S, Braun-Falco M: Eruptive xanthomas in association with metabolic syndrome. Clin Exp Dermatol, 2010; 35 (5): 565-566.
  • Löckermann S, Braun-Falco M: Lichen nitidus and molluscum contagiosum: a pure coincidence? J Dermatol, 2011; 38 (4): 412-413.
  • Löffek S, Bruckner-Tuderman L, Magin TM: Involvement of the ubiquitin-proteasome system in the stabilization of cell-cell contacts in human keratinocytes. Exp Dermatol, 2012; 21 (10): 791-793. : http://10.1111/j.1600-0625.2012.01564.x
  • Löffek S, Hurskainen T, Jackow J, Sigloch FC, Schilling O, Tasanen K, Bruckner-Tuderman L, Franzke CW: Transmembrane collagen XVII modulates integrin dependent keratinocyte migration via PI3K/Rac1 signaling. Plos One, 2014; 9 (2) (online): e87263. : http://dx.doi.org/10.1371/journal.pone.0087263
  • Löffek S, Wöll S, Höhfeld J, Leube RE, Has C, Bruckner-Tuderman L, Magin TM: The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation. Hum Mutat, 2010; 31 (4): 466-476.
  • Loi M, Müller A, Steinbach K, Niven J, Barreira da Silva R, Paul P, Ligeon LA, Caruso A, Albrecht RA, Becker AC, Annaheim N, Nowag H, Dengjel J, García-Sastre A, Merkler D, Münz C, Gannagé M: Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses. Cell Rep, 2016; 15 (5): 1076-1087.
  • Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes Bavnick JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M: A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genom, 2008; 18 (2): 99-107.
  • Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC: A marker for Stevens-Johnson-syndrome and toxic epidermal necrolysis: ethnicity matters Pharmacogenomics J, 2006; 6 (4): 265-268.
  • Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, Meiss F, Stein A, Nashan D, Micke O, Muecke R, Muenstedt K, Stoll C, Schmidtmann I, Huebner J: Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol, 2016; 33 (5) (online): 52. : http://dx.doi.org/10.1007/s12032-016-0764-6
  • Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, Stein A, Nashan D, Stoll C, Schmidtmann I, Huebner J: Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer, 2017; 71: 70-79.
  • Loquai C, Nashan D, Hensen P, Sunderkötter C, Luger TA, Grabbe ST, Schiller M: Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas. Eur J Dermatol, 2008; 18: 29-35.
  • Loquai C, Schmidtmann I, Beutel M, Sunderkötter C, Grabbe S, Schiller M, Nashan D: Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients’ and doctors’ views. Eur J Dermatol, 2011; 21 (6): 976-984.
  • Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kähler KC, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, Nashan D, Stein A, Stoll C, Dechent D, Huebner J: Interactions from complementary and alternative medicine in patients with melanoma. Melanoma Res, 2017; 27: 238-242.
  • Luckey U, Schmidt T, Pfender N, Romer M, Lorenz N, Schmidt T, Martin SF, Bopp T, Schmitt E, Nikolaev A, Yogev N, Waisman A, Jakob T *, Steinbrink K *: Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance. J Allergy Clin Immun, 2012; 130: 781-797.e11.
  • Lütke Volksbeck S, Nashan D, Bruckner-Tuderman L, Braun-Falco M: Localized sclerosis of the scalp (alopecia porphyrinica) as predominant presentation of porphyria cutanea tarda. J Eur Acad Dermatol, 2007; 21: 1125-1127.
  • Määttä M, Liakka A, Salo S, Tasanen K, Bruckner-Tuderman L, Autio-Harmainen H: Differential expression of basement membrane components in lymphatic tissues J Histochem Cytochem, 2004; 52: 1073-1081.
  • Määttä M, Salo S, Tasanen K, Soini Y, Liakka A, Bruckner-Tuderman L, Autio-Harmainen: Distribution of basement membrane anchoring molecules in normal and transformed endometrium: Altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas Journal of Molecular Histology, 2004; 35: 715-722.
  • Maertens B, Hopkins D, Franzke C, Keene DR, Bruckner-Tuderman L, Greenspan DS, Koch M: Shedding and processing of gliomedin, a collagenous- and Olfactomedin-domain containing protein required for sodium channel clustering at the nodes of Ranvier J Biol Chem, 2007; 282: 10647-10659.
  • Mahoney MG, Sadowski S, Brennan D, Pikander P, Saukko P, Wahl J, Aho H, Heikinheimo K, Bruckner-Tuderman L, Fertala A, Uitto J, Peltonen S: Compound heterozygous desmoplakin mutations result in a phenotype with a novel combination of skin, hair, heart and dental abnormalities. J Invest Dermatol, 2010; 130: 968-978.
  • Maier K, He Y, Esser PR, Thriene K, Sarca D, Kohlhase J, Dengjel J, Martin L, Has C: Single Amino Acid Deletion in Kindlin-1 Results in Partial Protein Degradation Which Can Be Rescued by Chaperone Treatment. J Invest Dermatol, 2016; 136 (5): 920-929.
  • Maier KL, Alessandrini F, Beck-Speier I, Hofer TPJ, Diabaté S, Bitterle E, Stöger T, Jakob T, Behrendt H, Horch M, Beckers J, Ziesenis A, Hültner L, Frankenberger M Krauss-Etschmann S, Schulz H: Health effects of ambient particulate matter – biological mechanisms and inflammatory responses to in vitro and in vivoparticle exposures. Inhal Toxicol, 2008; 20: 319-337.
  • Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, Suomalainen M, Gyory I, Huber M, Müller-Quernheim J, Schamel WWA, Gordon S, Jakob T, Martin SF, Jahnen-Dechent W, Greber UF, Freudenberg MA, Fejer G: Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages. Mbio, 2017; 8: e00670-e006717.
  • Mansur TA, Elcioglu NH, Aydingöz IE, Akkaya D, Arman A, Herz C, Bruckner-Tuderman L, Has C: Novel and recurrent KIND1 mutations in two patients with Kindler syndrome and severe mucosal involvement. Acta Derm-venereol, 2007; 87: 563-565.
  • Mariani V, Gilles S, Jakob T, Thiel M, Mueller MJ, Ring J, Behrendt H, Traidl-Hoffmann C: Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and licence them for Th2 attraction J Immunol, 2007; 178: 7623-7631.
  • Marrakchi S, Audebert S, Boudjar B, Has C, Lefevre C, Munro C, Cure S, Jobard F, Morlot S, Hohl D, Prud'homme JF, Zahaf A, Turki H, Fischer J.: Novel mutations in the gene encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) and description of five ancestral haplotypes in patients with Mal de Meleda. J Invest Dermatol, 2003; 120 (3): 351-355.
  • Martin S, Delattre V, Leicht C, Weltzien H.U, Simon J.C: A high frequency of allergen-specific CD8+ Tcl cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp Dermatol, 2003; 12: 78.
  • Martin S, Delattre V, Leicht C, Weltzien HU, Simon JC: A high frequency of allergen-specific CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp Dermatol, 2003; 12 (1): 78-85.
  • Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Dürr C, Heimesaat MM, Bereswill S, Fejer G, Vassileva R, Jakob T, Freudenberg N, Termeer CC, Johner C, Galanos C, Freudenberg MA: Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med, 2008; 205: 2151-2162.
  • Martin SF, Dudda JC, Delattre V, Bachtanian E, Leicht C, Burger B, Weltzien HU, Simon JC: Fas-mediated inhibition of CD4+ T cell priming results in dominance of CD8+ Tc1 cells in the immune response to the contact sensitizer trinitrophenyl J Immunol, 2004; 173: 3178-3185.
  • Maurer M, Schütz A, Weller K, Schoepke N, Peveling-Oberhag A, Staubach P, Müller S, Jakob T, Metz M: Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial. J Allergy Clin Immun, 2017; 140 (3): 870-873.
  • Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P: Efficacy and Safety of Omalizumab in Patients with Chronic Urticaria who Exhibit IgE against Thyreoperoxidase. J Allergy Clin Immun, 2011; 128: 202-209.
  • May A.E., Kälsch T., Herouy Y., Massberg S., Müller I., Gawaz M.: Engagement of GPIIb-IIIa on Platelets Triggers CD40L-Dependent Matrix Degradation by Endothelial Cells. Implications for Destabilization of the Atherosclerotic Plaque.. Circulation, 2002; 106: 2111-2117.
  • Mayer B, Silló P, Mazán M, Pintér D, Medvecz M, Has C, Castiglia D, Petit F, Charlesworth A, Hatvani Z, Pamjav H, Kárpáti S: A unique LAMB3 splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries. Brit J Dermatol, 2016; 175 (4): 721-727. : http://doi: 10.1111/bjd.14646
  • McMillan JR, Matsumura T, Hashimoto T, Schumann H, Bruckner-Tuderman L, Shimizu H: Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa. Exp Dermatol, 2003; 12: 261-267.
  • Meinke MC, Richter H, Kleemann A, Lademann J, Tscherch K, Rohn S, Schempp CM: Characterization of atopic skin and the effect of a hyperforin-rich cream by laser scanning microscopy. J Biomed Opt, 2015; 20 (5) (online). : http://doi: 10.1117/1.JBO.20.5.051013
  • Meinke MC, Schanzer S, Haag SF, Casetti F, Müller ML, Wölfle U, Kleemann A, Lademann J, Schempp CM: In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. Eur J Pharm Biopharm, 2012; 81: 346-350. : http://dx.doi.org/10.1016/j.ejpb.2012.03.002
  • Meiss F, Technau K, Nashan D: A rapidly changing scar 18 months after melanoma excision. J Eur Acad Dermatol, 2009; 23: 969-971.
  • Meiß F, Kautz O, Braun-Falco M, Nashan D: Bandförmige symmetrische horizontale Einsenkungen beider Oberschenkel Journal der Deutschen Dermatologischen Gesellschaft, 2007; 5: 1141-1142.
  • Meiß F, Kautz O, Nashan D, Braun-Falco M: Erythematöse Papeln an Hals, Axillae und Thoraxwand. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6: 1089-1090.
  • Meiß F, Nashan D, Braun-Falco M: An infant with pustules an both soles. Hautarzt, 2008; 59: 323-324.
  • Metelmann HR, Brandner J, Schumann H, Bross F, Hoffmann M, Podmelle F: Accelerating the aesthetic benefit of wound healing by triterpene. J Cranio Maxill Surg, 2012; 40 (5): e150-154.
  • Metelmann HR, Brandner JM, Schumann H, Bross F, Fimmers R, Böttger K, Scheffler A, Podmelle F: Accelerated Reepithelialization by Triterpenes: Proof of Concept in the Healing of Surgical Skin Lesions. Skin Pharmacol Phys, 2014; 15 (28): 1-11.
  • Metelmann HR, Brandner JM, Schumann H, Bross F, Fimmers R, Böttger K, Scheffler A, Podmelle F: Accelerated reepithelialization by triterpenes: proof of concept in the healing of surgical skin lesions. Skin Pharmacol Phys, 2015; 28 (1): 1-11.
  • Metzger E, Willmann D, McMillan J, Forne I, Metzger P, Gerhardt S, Petroll K, von Maessenhausen A, Urban S, Schott AK, Espejo A, Eberlin A, Wohlwend D, Schüle KM, Schleicher M, Perner S, Bedford MT, Jung M, Dengjel J, Flaig R, Imhof A, Einsle O, Schüle R: Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation. Nat Struct Mol Biol, 2016; 23 (2): 132-139. : http://dx.doi.org/10.1038/nsmb.3153
  • Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L: Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression. Cancer Res, 2016; 76 (4): 940-951. : http://dx.doi.org/10.1158/0008-5472.CAN-15-1348
  • Moali C,, Font B,, Ruggiero F,, Eichenberger D,, Rousselle P,, Francois V,, Oldberg A,, Bruckner-Tuderman L,, Hulmes DJ: Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J Biol Chem, 2005; 280: 24188-24194.
  • Möbs C, Müller J, Rudzio A, Pickert J, Blank S, Jakob T, Spillner E, Pfützner W: Decline of Ves v 5-specific blocking capacity in wasp venom allergic patients after stopping allergen immunotherapy. Allergy, 2015; 70: 715-719.
  • Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W: Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation. J Immunol, 2010; 184: 2194-2203.
  • Mockenhaupt M, Grosber M, Norgauer J, Daclizumab A: A novel therapeutic option in severe bullous pemphigoid Acta Derm-venereol, 2004; 84: 1-2.
  • Mockenhaupt M, Idzko M, Grosber M, Schöpf E, Norgauer J: Epidemilogy of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol, 2005; 124: 700-703.
  • Mockenhaupt M, Peters F, Schwenk-Davoine I, Herouy Y, Schraufstatter I, Elsner P, Norgauer J: Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes. Int J Mol Med, 2003; 12 (4): 597-601.
  • Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A: Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol, 2008; 128 (1): 35-44.
  • Mockenhaupt M,, Messenheimer J,, Tennis P,, Schlingmann J: Risk for Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs in Germany. Neurology, 2005; 64: 1134-1138.
  • Moillanen JM, Kokkonen N, Löffek S, Väyynen JP, Syväniemi E, Hurskainen T, Mäkinen M, Klintrup K, Mäkelä J, Sormunen R, Bruckner-Tuderman L, Autio-Harmainen H, Tasanen K: Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. Hum Pathol, 2015; 46 (3): 434-442.
  • Molenaar R, Greuter MJ, van der Marel APJ, Rozendaal R, Martin SF, Edele F, Huehn J, Förster R, O’Toole T, Jansen W, Eestermans IL, Kraal G, Mebius RE: Lymph node stromal cells support dendritic cell-induced gut-homing of T cells. J Immunol, 2009; 183: 6395-6402.
  • Mühle C, Jiang Q-J, Charlesworth A, Bruckner-Tuderman L, Meneguzzi G, Schneider H: Novel and recurrent mutations in the laminin-5 gene causing lethal junctional epidermolysis bullosa: Molecular basis and clinical course of Herlitz disease Hum Genet, 2004; 116: 33-42.
  • Müller AM, Martens UM, Hofmann S, Bruckner-Tuderman L, Mertelsmann R, Lübbert M: Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature. Ann Hematol, 2006; 85: 1-16.
  • Müller FB, Küster W, Wodecki K, Almeida H Jr, Bruckner-Tuderman L, Korge BP, Arin MJ: Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly Hum Mutat, 2006; 27: 719-720.
  • Muller-Horvat C, Radny P, Eigentler TK, Schafer J, Pfannenberg C, Horger M, Khorchidi S, Nagele T, Garbe C, Claussen CD, Schlemmer HP: Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma Eur J Cancer, 2006; 42 (3): 342-350.
  • Müller M, Forschner A, Luger TA, Rompel R, Roeder N, Hensen P: [G-DRG version 2007: a short overview] Journal der Deutschen Dermatologischen Gesellschaft, 2007; 5 (9): 778-787.
  • Müller M, Hill K, Beschmann K, Rubant S, Boehncke WH, Harteneck C, Schempp C, Müller WE, Leuner K: Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem, 2008; 283: 33942-33954.
  • Müller M, Markó K, Daumke P, Paetzold J, Roesner A, Klar R: Biomedical data mining in clinical routine: expanding the impact of hospital information systems Medinfo, 2007; 12: 340-344.
  • Muller T, Durk T, Blumenthal B, Herouy Y, Sorichter S, Grimm M, Panther E, Cicko S, Norgauer J, Idzko M: Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells. Clin Exp Allergy, 2010; 40 (8): 1214-1221. : http://dx.doi.org/10.1111/j.1365-2222.2010.03558.x
  • Müller T, Dürk T, Blumenthal B, Grimm M, Cicko S, Panther E, Sorichter S, Herouy Y, Di Virgilio F, Ferrari D, Norgauer J, Idzko M: 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. Plos One, 2009; 4 (7): e6453.
  • Müller T, Paula Vieira R, Grimm M, Dürk T, Cicko S, Zeiser R, Jakob T, Martin SF, Blumenthal B, Sorichter S, Ferrari D, di Virgilio F, Idzko M: A Potential Role for P2X7R in Allergic Airway Inflammation in Mice and Humans. Am J Resp Cell Mol, 2011; 44: 456-464.
  • Müller T, Robaye B, Vieira RP, Ferrari D, Grimm M, Jakob T, Martin SF, Di Virgilio F, Boeynaems J-M, Virchow JC, Idzko M: The purinergic receptor P2Y_2 mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy, 2010; 65: 1545-1553.
  • Nancey S, Holvoet S, Graber I, Philippe D, Martin S, Nicolas JF, Desreumaux P, Flourie B, Kaiserlian D: CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology, 2006; 131: 485-496.
  • Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R: Mycosis fungoides: a dermatological masquerader Brit J Dermatol, 2006; 156 (1): 1-10.
  • Nashan D, Haufs MG, Kleinheinz J, Al-Dandashi C, Bruckner-Tuderman L: Prolonged untreated and treated course of a malignant melanoma Dermatology, 2006; 212: 93-95.
  • Nashan D, Meiss F, Gralow I: Basics and relevance in dermatology. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7: 704-717.
  • Nashan D, Meiss F, Müller M: Therapeutic strategies for actinic keratoses - a systematic review. Eur J Dermatol, 2013; 23 (1): 14-32. : http://dx.doi.org/10.1684/ejd.2013.1923
  • Nashan D, Meiß F, Braun-Falco M, Hofbauer M, Hofmann S: Multiple target-like pigmented nevi: an inverse halo-nevus phenomenon. J Eur Acad Dermatol, 2010; 24 (1): 104-105.
  • Nashan D, Meiß F, Braun-Falco M, Reichenberger S: Cutaneous metastases from internal malignancies. Dermatol Ther, 2010; 23: 567-580.
  • Nashan D, Reuter K, Mohr P, Agarwala SS: Understanding and managing interferon-α-related fatigue in patients with melanoma. Melanoma Res, 2012; 22 (6): 415-423. : http://10.1097/CMR.0b013e328358d98c
  • Natsuga K, Nishie W, Akiyama M, Nakamura H, Shinkuma S, McMillan JR, Nagasaki A, Has C, Ouchi T, Ishiko A, Hirako Y, Owaribe K, Sawamura D, Bruckner-Tuderman L, Shimizu H: Plectin expression patterns determine two distinct subtypes of epidermolysis bullosa simplex. Hum Mutat, 2010; 31 (3): 308-316.
  • Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D, Roujeau JC, Sekula P, Simpson MA, Trembath RC, Mockenhaupt M, Smith CH: Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Invest Dermatol, 2013; 133 (7): 1904-1907.
  • Nazio F, Strappazzon F, Antonioli M, Bielli P, Cianfanelli V, Bordi M, Gretzmeier C, Dengjel J, Piacentini M, Fimia GM, Cecconi F: mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol, 2013; 15 (4): 406-416. : http://dx.doi.org/10.1038/ncb2708
  • Németh T, Futosi K, Sitaru C, Ruland J, Mócsai A: Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat Commun, 2016; 7: 11004. : http://doi: 10.1038/ncomms11004
  • Neumann E, Amtage D, Bruckner-Tuderman L, Mockenhaupt M: Eine monozentrische, offene Langzeitbeobachtung von Tacrolimus Salbe und topischen Steroiden zur Behandlung der Atopischen Dermatitis. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6 (7): 548-554.
  • Nishie W, Jackow J, Hofmann SC, Franzke CW, Bruckner-Tuderman L: Coiled coils ensure the physiological ectodomain shedding of collagen XVII. J Biol Chem, 2012; 287: 29940-29948.
  • Nishie W, Kiritsi D, Nyström A, Hofmann SC, Bruckner-Tuderman L: Dynamic interactions of epidermal collagen XVII with the extracellular matrix: Laminin 332 as a major binding partner. Am J Pathol, 2011; 179: 829-837.
  • Nishie W, Lamer S, Schlosser A, Licarete E, Franzke CW, Hofmann SC, Jackow J, Sitaru C, Bruckner-Tuderman L: Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. J Immunol, 2010; 185 (8): 4938-4947.
  • Nittka S, Günther J, Ebisch C, Erbersdobler A, Neumaier M: The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis Oncogene, 2004; 23: 9306-9313.
  • Norgauer J, Dichmann S, Peters F, Mockenhaupt M, Schraufst tter I, Herouy Y: Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type II expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes. Eur J Dermatol, 2003; 13 (2): 124-129.
  • Norgauer J, Ibig Y, Gmeiner D, Herouy Y, Fiebich BL: Prostaglandin E2 synthesis in human monocyte-derived dendritic cells. Int J Mol Med, 2003; 12 (1): 83-86.
  • Norgauer J.: Chemotaxis of immature and modulates cytokine-release in mature dentritic cells for emergence of Th2 immune response. Faseb J, 2002; 16: 625-627.
  • Norgauer J., Hildenbrand T., Idzko M., May A.E., Panter E., Bandemir E., Hartmann M., Herouy Y.: Elevated expression of EMMPRIN (CD147) and membrane-type matrix metallproteinases in venous leg ulcers. Brit J Dermatol, 2002; 147: 1180-1186.
  • Nyström A, Buttgereit J, Bader M, Shmidt T, Ozcelik C, Hausser I, Bruckner-Tuderman L, Kern JS: Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect. Plos One, 2013; 8 (5) (online): e64243. : http://doi: 10.1371/journal.pone.0064243
  • Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L: Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. Embo Mol Med, 2015; 7: 1211-1228.
  • Nyström A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L: Collagen VII plays a dual role in wound healing. J Clin Invest, 2013; 123 (8): 3498-3509. : http://doi: 10.1172/JCI68127
  • Oswald E, Sesarman A, Franzke CW, Wölfle U, Bruckner-Tuderman L, Jakob T, Martin SF, Sitaru C: The flavonoid luteolin inhibits Fcy-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice. Plos One, 2012; 7 (2) (online): e31066. : http://10.1371/journal.pone.0031066
  • Pacho F, Zambruno G, Calabresi V, Kiritsi D, Schneider H: Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon. J Med Genet, 2011; 48 (9): 640-644.
  • Palová-Jelínková L, Dáňová K, Drašarová H, Dvořák M, Funda DP, Fundová P, Kotrbová-Kozak A, Černá M, Kamanová J, Martin SF, Freudenberg M, Tučková L, : Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB Signaling Pathway and an NLRP3 Inflammasome Activation. Plos One, 2013; 8 (4) (online): e62426. : http://doi:10.1371/journal.pone.0062426
  • Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J: Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood, 2003; 101 (10): 3985-3990.
  • Panther E, Durk T, Ferrari D, Di Virgilio F, Grimm M, Sorichter S, Cicko S, Herouy Y, Norgauer J, Idzko M, Muller T: AMP affects intracellular Ca2+ signaling, migration, cytokine secretion and T cell priming capacity of dendritic cells. Plos One, 2012; 7 (5) (online): e37560-e37560. : http://dx.doi.org/10.1371/journal.pone.0037560
  • Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T: Spontaneous Adverse Event Reports of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN): Detecting Associations with Medications. Pharmacoepidem Dr S, 2012; 21 (3): 289-296. : http://dx.doi.org/10.1002/pds.2276
  • Parikka M, Kainulainen T, Tasanen K, Vaananen A, Bruckner-Tuderman L, Salo T: Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma. J Histochem Cytochem, 2003; 51 (7): 921-929.
  • Parikka M, Nissinen L, Kainulainen T, Bruckner-Tuderman L, Salo T, Heino J, Tasanen K: Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration - a novel role for aIIb integrin and tirofiban Exp Cell Res, 2006; 312: 1431-1438.
  • Paulmann M, Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen: Klinik, Diagnostik, Ätiologie und Therapie. J Dtsch Dermatol Ges, 2015; 13 (7): 625-645. : http://doi: 10.1111/ddg.130_12747
  • Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E, Nyström A, Lener T, Reichelt J, Bauer J, Murauer E: A gene gun-mediated non-viral RNA trans-splicing strategy for Col7a1 repair. Mol Ther-nucl Acids, 2016; 5 (online): e287.
  • Petrungaro C, Zimmermann KM, Kuttner V, Fischer M, Dengjel J, Bogeski I, Riemer J *: The Ca(2+)-Dependent Release of the Mia40-Induced MICU1-MICU2 Dimer from MCU Regulates Mitochondrial Ca(2+) Uptake. Cell Metab, 2015; 22 (4): 721-733.
  • Pettenkoffer M, Wilson C, Ebner W, Norgauer J, Ruden H, Daschner F: Surveillance of nosocomial infections in an german dermatology hospital Brit J Dermatol, 2003; 149: 620-623.
  • Pfab F, Willi R, Albert A, Huss-Marp J, Athanasiadis I, Jakob T, Ollert M, Ring J, Darsow U: Anaphylactic reaction to folic acid verified by provocational testing Allergy, 2007; 62: 823-824.
  • Pfender N, Lucassen R, Offermann N, Schulte-Pelkum J, Fooke M, Jakob T: Evaluation of a novel rapid test system for the detection of specific IgE to hymenoptera venoms. Journal of Allergy, 2012 (online). : http://10.1155/2012/862023
  • Pflugfelder A, Andonov E, Weide B, Dirschka T, Schempp CM, Stockfleth E, Stratigos A, Krüger-Krasagakis S, Bauer J, Garbe C, Eigentler TK: Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial. Brit J Dermatol, 2015; 172 (4): 926-932.
  • Pflugfelder A, Welter AK, Leiter U, Weide B, Held L, Eigentler TK, Dirschka T, Stockfleth E, Nashan D, Garbe C: Open label randomized study comparing three months versus six months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel. A trial of the German Dermatologic Cooperative Oncology Group (DeCOG) J Eur Acad Dermatol, 2011; 18: 1468-3083.
  • Pföhler C, Müller CSL, Dorn B, Jakob T, Vogt T: Contact anaphylaxis after application of an herbal ointment containing phenonip. Allergol Int, 2016; 25: 64-66.
  • Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA: Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immun, 2011; 127 Suppl. 3: 60-66.
  • Piccinni E, Di Zenzo G, Maurelli R, Dellambra E, Teson M, Has C, Zambruno G, Castiglia D: Induction of senescence pathways in Kindler syndrome primary keratinocytes. Brit J Dermatol, 2013; 168: 1019-1026.
  • Pigors M, Kiritsi D, Cobzaru C, Schwieger-Briel A, Suárez J, Faletra F, Aho H, Mäkelä L, Kern JS, Bruckner-Tuderman L, Has C: TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome. J Invest Dermatol, 2012; 132 (10): 2422-2429. : http://10.1038/jid.2012.166
  • Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, Kohlhase J, Hausser I, Bruckner-Tuderman L, Has C: Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet, 2011; 20: 1811-1819.
  • Pigors M, Schwieger-Briel A, Cosgarea R, Diaconeasa A, Bruckner-Tuderman L, Fleck T, Has C *: Desmoplakin mutations with palmoplantar keratoderma, woolly hair and cardiomyopathy. Acta Derm-venereol, 2015; 95 (3): 337-340. : http://doi: 10.2340/00015555-1974
  • Pourreyron C, Jones C, Mao X, Cox G, Volz A, Baksh N, Wong T, Fassihi H, Arita K, O'Toole EA, Chen M, Hart IR, Bruckner-Tuderman L, Salas-Alanis JC, McGrath JA, Leigh IM, South AP: Patients with recessive dystrophic epidermolysis bullosa develop squamous cell carcinoma regardless of type VII collagen expression J Invest Dermatol, 2007; 127 (10): 2438-2444.
  • Prasse A, Zissel G, Lützen N, Schupp J, Schmiedlin R, Gonzalez-Rey E, Rensing-Ehl A, Bacher G, Cavalli V, Bevec D, Delgado M, Müller-Quernheim J: Inhaled Vasoactive Intestinal Peptide exerts immunoregulatory effects in sarcoidosis. Am J Resp Crit Care, 2010; 182: 540-548.
  • Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF: Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6 (3): 240-243.
  • Przybilla B, Ruëff F, Walker A, Räwer HC, Aberer W, Bauer CP, Berdel D, Biedermann T, Brockow K, Forster J, Fuchs T, Hamelmann E, Jakob T, Jarisch R, Merk HF, Müller U, Ott H, Sitter W, Urbanek R, Wedi B: S2 Leitlinie (AWMF 061-020) Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergologie, 2012; 35: 563-589.
  • Przybilla B, Ruëff F, Walker A, Helen-Caroline Räwer HC, Aberer W, Bauer CP, Berdel D, Biedermann T, Brockow K, Forster J, Fuchs T, Hamelmann E, Jakob T, Jarisch R, Merk HF, Müller U, Ott H, Sitter W, Urbanek R, Wedi B: S2 Leitlinie (AWMF 061-020) Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo J, 2011; 20: 318-339.
  • Purdie KJ, Pourreyron C, Fassihi H, Cepeda-Valdes R, Frew JW, Volz A, Weissenborn SJ, Pfister H, Proby CM, Bruckner-Tuderman L, Murrell DF, Salas-Alanis JC, McGrath JA, Leigh IM, Harwood CA, South AP: No Evidence That Human Papillomavirus Is Responsible for the Aggressive Nature of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. J Invest Dermatol, 2010; 130 (12): 2853-2855.
  • Rackiewicz M, Große-Hovest L, Alpert AJ, Zarei M, Dengjel J: Hydrophobic Interaction Chromatography for Bottom-Up Proteomics Analysis of Single Proteins and Protein Complexes. J Proteome Res, 2017; 16 (6): 2318-2323.
  • Radny P, Eigentler TK, Soennichsen K, Overkamp D, Raab HR, Viebahn R, Müller-Horvat C, Sotlar K, Rassner G: Metastatic Glucagonoma-successful treatment with liver transplantation. A case report and review of treatment options J Am Acad Dermatol, 2006; 54 (2): 344-347.
  • Raghavan B, Martin SF, Esser PR, Goebeler M, Schmidt M: Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. Embo Rep, 2012; 13: 1109-1115. : http://10.1038/embor.2012.155
  • Ramachandran H, Engel C, Muller B, Dengjel J, Walz G, Yakulov TA *: Anks3 alters the sub-cellular localization of the Nek7 kinase. Biochem Bioph Res Co, 2015; 464 (3): 901-907.
  • Ramao S, Glaser N, Becker AC, Guhl B, Bajagic M, Vanoaica D, Ziegler U, Roesler J, Dengjel J, Reichenbach J, Münz C: Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. J Cell Biol, 2013; 203 (5): 757-766. : http://dx.doi.org/10.1083/jcb.201308173
  • Recke A, Sitaru C, Vidarsson G, Evensen M, Chiriac MT, Ludwig RJ, Zillikens D: Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J Autoimmun, 2010; 34: 435-444. : http://dx.doi.org/10.1016/j.jaut.2009.11.003
  • Rehor G, Braun-Falco M, Nashan D, Meiß F: Cheilitis granulomatosa as initial manifestation of Crohn's disease. Hautarzt, 2010; 61 (8): 691-693.
  • Renkl A, Berod L, Mockenhaupt M, Idzko M, Panther E, Termeer C, Elsner P, Huber M, Norgauer J: Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dentritic cells. Int J Mol Med, 2003; 13: 203-210.
  • Renkl A, Berod L, Mockenhaupt M, Idzko M, Panther E, Termeer C, Elsner P, Huber M, Norgauer J: Distinct effects of spingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells Int J Mol Med, 2004; 13: 203-209.
  • Renkl A, Mockenhaupt M, Herouy Y, Technau K, Norgauer J: A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody. Brit J Dermatol, 2003. (in Druck)
  • Renkl A, Mockenhaupt M, Technau K, Herouy Y, Norgauer J: A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody Brit J Dermatol, 2004; 150: 1220-1222.
  • Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S.F., Simon J.C., Weiss J.M.: Osteopontin functionally activates dendritic cells and induces their differentiation towards a Th1 polarizing phenotype. Blood, 2005; 106: 946-955.
  • Rennekampff HO, Fimmers R, Metelmann HR, Schumann H, Tenenhaus M: Reliability of photographic analysis of wound epithelialization assessed in human skin graft donor sites and epidermolysis bullosa wounds. Trials, 2015; 28 (16) (online): 235. : http://dx.doi.org/10.1186/s13063-015-0742-x
  • Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin S: Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in Bullous Pemphigoid Exp Dermatol, 2007; 16: 13-21.
  • Reuter J, Braun-Falco M: Pseudovesikel an Handflächen und Fußsohlen Hautarzt, 2007; 58: 698-700.
  • Reuter J, Braun-Falco M, Termeer C, Bruckner-Tuderman L: Erythema annulare centrifugum Darier: Successful therapy with topical calcitriol and 311 nm-ultraviolet B narrow band phototherapy Hautarzt, 2007; 58: 146-148.
  • Reuter J, Bruckner-Tuderman L, Braun-Falco M: Epidermotropic scrotal metastasis of colorectal cancer Int J Colorectal Dis, 2007; 22 (9): 1133-1134.
  • Reuter J, Huyke C, Casetti F, Theek C, Frank U, Augustin M, Schempp CM: Anti-inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6: 847-851.
  • Reuter J, Huyke C, Scheuvens H, Ploch M, Neumann K, Jakob T, Schempp CM: Skin tolerance of a new bath oil containing St. John`s wort extract. Skin Pharmacol Phys, 2008; 21: 306-311.
  • Reuter J, Jocher A, Hornstein S, Schulte Mönting J, Schempp C: Sage extract rich in phenolic diterpenes inhibits ultraviolet-induced erythema in vivo Planta Med, 2007; 73: 1190-1191.
  • Reuter J, Jocher A, Stump J, Franke G, Grossjohann B, Schempp CM: Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test. Skin Pharmacol Phys, 2008; 21: 106-110.
  • Reuter J, Termeer C, Bruckner-Tuderman L: Tacrolimus - Neue Therapieoption beim Morbus Hailey-Hailey? JDDG, 2005; 3: 278-279.
  • Reuter K, Albrecht K, Seelig H, Meiss F, Mauch C, Kreuzberg N, Nashan D: Health-related Quality of Life, Fatigue, and Depression Under Low-Dose IFN-α Therapy in Melanoma Patients. J Immunother, 2014; 37: 461-467. : http://dx.doi.org/10.1097/CJI.0000000000000057
  • Richert L, Augustin M, Weber R, Doelfs P, Tscheulin D: Diagnose-bezogene Kostenträgerrechnung einer Universitäts-Hautklinik in Bezug zum DRG-Entgelt-System Hautarzt, 2004; 55: 1047-1051.
  • Richter A, Schmucker SS, Esser PR, Traska V, Weber V, Dietz L, Thierse HJ, Pennino D, Cavani A, Martin SF: Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC – IFN-g and TNF-a readout. Toxicol in Vitro, 2013; 27: 1180-1185. : http://doi:10.1016/j.tiv.2012.08.007
  • Rieg S, Kaasch AJ, Wehrle J, Hofmann SC, Szymaniak-Vits M, Saborowski V, Jonas D, Kalbacher H, Seifert H, Kern WV: Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides. Microbes Infect, 2011; 13: 761-765. : http://dx.doi.org/10.1016/j.micinf.2011.03.010
  • Rieg S, Saborowski V, Kern WV, Jonas D, Bruckner-Tuderman L, Hofmann S: Expression of the sweat-derived innate defence antimicrobial peptide dermcidin is not impaired in Staphylococcus aureus colonization or recurrent skin infections. Clin Exp Dermatol, 2014; 39: 209-212. : http://dx.doi.org/10.1111/ced.12189
  • Rigbolt KTG, Zarei M, Sprenger A, Becker AC, Diedrich B, Huang X, Eiselein S, Kristensen AR, Gretzmeier C, Andersen JS, Zi Z, Dengjel J: Characterization of early autophagy signaling by quantitative phosphoproteomics. Autophagy, 2014; 10: 356-371.
  • Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, Friedrichs F, Fuchs T, Gieler U, Jakob T, Klimek L, Lange L, Merk H, Niggemann B, Pfaar O, Przybilla B, Ruëff F, Rietschel E, Schnadt S, Seifert R, Sitter H, Varga E, Worm W, Brockow K: Akuttherapie und Management der Anaphylaxie. Allergo Journal International, 2014; 23: 96-112.
  • Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F, Gebert N, Gieler U, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Reese I, Rietschel E, Schallmayer S, Schnadt S, Szczepanski R, Worm M, Brockow K: Anaphylaxieschulung – ein neues Behandlungsprogramm zur tertiären Krankheitsprävention nach Anaphylaxie. Allergo J, 2012; 21: 96-102.
  • Rothley M, Thiele W, Schacht V, Plaumann D, Gartner M, Giannis A, Sleeman JP: Hyperforin inhibits lymphatic endothelial cell proliferation in vitro and suppresses tumor-induced lymphangiogenesis in vivo. Int J Cancer, 2009; 125: 34-42.
  • Roth W, Reuter U, Wohlenberg C, Bruckner-Tuderman L, Magin T: Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex. Hum Mutat, 2009; 30: 832-841.
  • Roujeau JC, Mockenhaupt M, Tahan SR, Henshaw J, Martin EC, Harding M, van Baelen B, Bengtsson L, Singhal P, Kauffman RS, Stern RS: Telaprevir-Related Dermatitis. JAMA Dermatology, 2013. : http://dx.doi.org/10.1001/jamadermatol.2013.938 (in Druck)
  • Sammain A, Jocher A, Bruckner-Tuderman L, Schempp C: Lupus vulgaris – ein Verlauf über mehr als 20 Jahre bis zur Diagnosestellung J. Deutsch Dermatol Ges., 2006; 4: 958-960.
  • Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, Unal E, Ozdemir MA, Jouhadi Z, Khadir K, Ben-Khemis L, Ben-Ali M, Ben-Mustapha I, Borchani L, Pfeifer D, Jakob T, Khemiri M, Asplund AC, Gustafsson MO, Lundin KE, Falk-Sorqvist E, Moens LN, Gungor HE, Engelhardt KR, Dziadzio M, Stauss H, Fleckenstein B, Meier R, Prayitno K, Maul-Pavicic A, Schaffer S, Rakhmanov M, Henneke P, Kraus H, Eibel H, Kolsch U, Nadifi S, Nilsson M, Bejaoui M, Schaffer AA, Smith CI, Dell A, Barbouche MR, Grimbacher B: Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immun, 2014; 133 (5): 1410-1419.e13. : http://dx.doi.org/10.1016/j.jaci.2014.02.025
  • Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liß Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, LeLouet H: ALDEN an algorithm for assessment of drug causality in Stevens-Johnson-syndrome and Toxic epidermal necrolysis. Comparison with case-control analysis. Clin Pharmacol Ther, 2010; 88 (1): 60-68.
  • Schacht V, Berens von Rautenfeld D, Abels C: The lymphatic system in the dorsal skinfold chamber of the Syrian Golden Hamster Arch Dermatol Res, 2004; 295: 542-548.
  • Schacht V, Luedemann W, Abels C, Berens von Rautenfeld D: Anatomy of the subcutaneous lymphvascular network of the human leg in relation to the great saphenous vein. Anat Rec, 2009; 292: 87-93.
  • Schacht V, Szeimies RM, Abels C: Photodynamic therapy with 5-aminolevulinic acids inducesdifferent microcirculatory effects following systemic or topical application Photoch Photobio Sci, 2006; 5: 452-458.
  • Schara U, Tücke J, Mortier W, Nüßlein Th, Rouan F, Pfendner E, Zillikens D, Bruckner-Tuderman L, Uitto J, Wiche G, Schröder R: Clinical and genetic findings in a novel case of plectin-related epidermolysis bullosa simplex with muscular dystrophy Eur J Pediatr, 2004; 163: 218-222.
  • Schauer F, Poppert S, Technau-Hafsi K, Mockenhaupt M, Muntau B, Häcker G, Tappe D, Jakob T: Travel-acquired subcutaneous Sparganum Proliferum infection diagnosed by molecular methods. Brit J Dermatol, 2014; 170 (3): 741-743. : http://doi: 10.1111/bjd.12679
  • Scheer S, Krempl C, Kallfass C, Frey S, Jakob T, Mouahid G, Mone H, Schmitt-Gräff A, Staeheli P, Lamers MC: S. mansoni bolsters anti-viral immunity in the murine respiratory tract. Plos One, 2014; 9 (11) (online): e112469. : http://dx.doi.org/10.1371/journal.pone.0112469
  • Schell C, Rogg M, Suhm M, Helmstädter M, Sellung D, Yasuda-Yamahara M, Kretz O, Küttner V, Suleiman H, Kollipara L, Zahedi RP, Sickmann A, Eimer S, Shaw AS, Kramer-Zucker A, Hirano-Kobayashi M, Abe T, Aizawa S, Grahammer F, Hartleben B, Dengjel J, Huber TB: The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier. Proc Natl Acad Sci USA, 2017; 114 (23): E4621-E4630.
  • Schempp C: Herpes simplex: Welche Therapieansätze sind zu empfehlen? NaturaMed, 2007; 22: 37-38.
  • Schempp C, Simon-Haarhaus B, Krieger R, Simon JC: Solar simulator induced phototoxicity of the furoquinoline alkaloid dictamnine compared to 8-methoxypsoralen and 5-methoxypsoralen Planta Med, 2006; 72: 941-943.
  • Schempp CM: Nutraceuticals - new beneficial products or old shoes on new feet again? Biovalley Journal, 2004; 4: 11-12.
  • Schempp CM, Hezel S, Simon JC: Behandlung der subakuten Atopischen Dermatitis mit Johanniskraut-Creme. Eine randomisierte, plazebokontrollierte Doppelblindstudie im Halbseitendesign Hautarzt, 2003; 54 (3): 248-253.
  • Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC, Gilb B, Kaufmann T, Borner C, Sleeman JP, Simon JC: Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene, 2002; 21 (8): 1242-1250.
  • Schempp CM, Meinke M, Lademann J, Ferrari Y, Brecht T, Gehring W: Topical antioxidants protect the skin from chemical-induced irritation in the repetitive washing test: a placebo-controlled, double-blind study. Contact Dermatitis, 2012; 67: 234-237. : http://dx.doi.org/10.1111/j.1600-0536.2012.02114.x
  • Schempp CM, Simon-Haarhaus B, Simon JC: Phototoxic and apoptosis-inducing capacity of pseudohypericin. Planta Med, 2002; 68 (2): 171-173.
  • Schempp CM, Winghofer B, Muller K, Schulte-Monting J, Mannel M, Schopf E, Simon JC: Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation. Phytother Res, 2003; 17 (2): 141-146.
  • Schempp CM, Kiss J, Averbeck M, Simon-Haarhaus B, Kremer B, Termeer C, Sleeman JP, Simon JC: Hyperforin acts as an angiogenesis inhibitor in vitro and in vivo. Planta Med, 2005; 71: 999-1004.
  • Schempp CM., Winghofer B., Müller K., Schulte-Mönting J., Mannel M., Schöpf E., Simon JC.: Effect of oral administration of Hypericum perforatum extract (St. John's wort) on skin erythema and pigmentation induced by UVB, UVA, visible ligt and solar simulated radiation. Phytother Res, 2002. (in Druck)
  • Schiller M, Böhm M, Luger TA, Nashan D: Dermatomyositis associated with malignant melanoma – a poor prognosis? J Am Acad Dermatol, 2006; 54: 221-226.
  • Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U: SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. Embo Rep, 2016; 17 (10): 1485-1497.
  • Schloebe A, Daun T, Augustin M: Off-label use in der Dermatologie - Häufigkeit und Stellenwert Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 92.
  • Schmidt E, Goebeler M, Hertl M, Sárdy M, Sitaru C, Eming R, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A: S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges, 2015; 13 (7): 713-727. : http://doi: 10.1111/ddg.12612
  • Schmidt M, Raghavan B, Müller V, Vogl T, Fejer G, Tchaptchet S, Keck S, Kalis C, Nielsen P, Galanos C, Roth J, Skerra A, Martin SF, Freudenberg MA, Goebeler M: A crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol, 2010; 11: 814-819.
  • Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I, Kreis S: Interferon-gamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Commun Signal, 2012; 10 (1) (online): 41. : http://dx.doi.org/10.1186/1478-811X-10-41
  • Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M: Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol, 2008; 58 (1): 33-40.
  • Schuler T, Boeker M, Klar R, Müller M: A generic, web-based clinical information system architecture using HL7 CDA: successful implementation in dermatological routine care Medinfo, 2007; 12: 439-443.
  • Schulz S, Daumke P, Fischer P, Müller ML: Evaluation of a document search engine in a clinical department system. AMIA Annu Symp Proc, 2008; 6: 647-651.
  • Schumann H, Calow T, Weckesser S, Müller ML, Hoffmann G: Walter-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. Brit J Dermatol, 2011; 165 (3): 541-551.
  • Schumann H, Has C, Kohlhase J, Bruckner-Tuderman L: Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations. Brit J Dermatol, 2008; 159 (2): 464-469.
  • Schumann H, Kiritsi D, Pigors M, Hausser I, Kohlhase J, Peters J, Ott H, Hyla-Klekot I, Gacka F, Sieron AL, Valari M, Bruckner-Tuderman L, Has C: Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations. Brit J Dermatol, 2013; 169 (1): 115-124.
  • Schumann H, Roth W, Has C, Volz A, Erfurt-Berge C, Magin TM, Bruckner-Tuderman L: Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene. Brit J Dermatol, 2012; 167 (4): 929-936.
  • Schuster D, Pfister-Wartha A, Bruckner-Tuderman L, Schempp CM: Successful treatment of refractory pityriasis rubra pilaris with secukinumab. Jama Dermatol, 2016; 152: 1278-1280.
  • Schwab L, Goroncy L, Palaniyandi S, Gautam S, Triantafyllopoulou A, Mocsai A, Reichardt W, Karlsson FJ, Radhakrishnan SV, Hanke K, Schmitt-Graeff A, Freudenberg M, von Loewenich FD, Wolf P, Leonhardt F, Baxan N, Pfeifer D, Schmah O, Schönle A, Martin SF, Mertelsmann R, Duyster J, Finke J, Prinz M, Henneke P, Häcker H, Hildebrandt GC, Häcker G, Zeiser R: Neutrophil granulocytes recruited upon translocation of intestinal commensal bacteria enhance Graft versus Host Disease via local tissue damage. Nat Med, 2014; 20: 648-654. : http://doi: 10.1038/nm.3517
  • Schwarz JJ, Wiese H, Tolle RC, Zarei M, Dengjel J, Warscheid B, Thedieck K: Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate. Mol Cell Proteomics, 2015; 14 (8): 2042-2055.
  • Schwieger-Briel A, Kiritsi D, Schempp CM, Has K, Schumann H: Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study. Dermatol Res Pract, 2017 (online). : http://doi:10.1155/2017/5068969
  • Schwieger-Briel A *, Moellmann C, Mattulat B, Schauer F, Kiritsi D, Schmidt E, Sitaru C, Ott H, Kern JS *: Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis, 2014; 9: 185. (download: http://www.ojrd.com/content/9/1/185)
  • Sekula P, Caputo A, Dunant A, Roujeau JC, Mockenhaupt M, Sidoroff A, Schumacher M: An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactions. Pharmacoepidem Dr S, 2010; 19 (1): 10-18.
  • Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau J: Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol, 2013; 133 (5): 1197-1204.
  • Sekula P, Liß Y, Davidovici B, Dunant A, Roujeau JC, Kardaun S, Naldi L, Schumacher M, Mockenhaupt M: Evaluation of SCORTEN, a predictive score for the mortality of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Burn Care Res, 2011; 32 (2): 237-245.
  • Seppänen A, Autio-Harmainen H, Alafuzoff I, Särkioja T, Veijola J, Hurskainen T, Bruckner-Tuderman L, Tasanen K, Majamaa K: Collagen XVII is expressed in human CNS neurons Matrix Biol, 2006; 25 (3): 185-188.
  • Seppänen A, Pikkarainen M, Hartikainen P, Hofmann SC, Majamaa K, Alafuzoff I: Expression of collagen XVII and ubiquitin-binding protein p62 in motor neuron disease. Brain Res, 2009; 1247: 171-177.
  • Seppänen A, Suuronen T, Hofmann S, Majamaa K, Alafuzoff I: Distribution of collagen XVII in the human brain Brain Res, 2007; 1158: 50-56.
  • Sesarman A, Mihai S, Chiriac MT, Zillikens D, Solbach W, Hultman P, Sitaru C: T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita. J Immunol, 2010; 184: 1596-1603.
  • Sesarman A, Oswald E, Chiriac MT, Csorba K, Vuta V, Feldrihan V, Baican A, Bruckner-Tuderman L, Sitaru C: Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice? Immunol Lett, 2012; 143 (1): 92-100.
  • Shigeta M, Saiki M, Tsuruta D, Ohata C, Ishii N, Ono F, Hamada T, Dainichi T, Furumura M, Zone JJ, Karpati S, Sitaru C, Hashimoto T: Two Japanese cases of dermatitis herpetiformis associated each with lung cancer and autoimmune pancreatitis but showing no intestinal symptom or circulating immunoglobulin A antibodies to any known antigens. J Dermatol, 2012; 39 (12): 1002-1005. : http://10.1111/j.1346-8138.2012.01663.x
  • Sidoroff A, Dunant A, Viboud C, Halevy S, Bouwes-Bavinck JN, Naldi L, Mockenhaupt M, Fagot JP, Roujeau JC: Risk factors for acute generalized exanthematous pustulosis (AGEP) – results of a multinational case-control study (EuroSCAR) Brit J Dermatol, 2007; 157: 989-996.
  • Simon JC, Hara H, Denfeld RW, Martin S: UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol Appl, 2002; 15 (5): 330-334.
  • Sommer B, Zschocke I, Bergfeld D, Sattler G, Augustin M: Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg, 2003; 39 (5): 456-460.
  • Sonderegger S, Haslinger P, Sabri A, Leisser C, Otten JV, Fiala C, Knöfler M: Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology, 2010; 151 (1): 211-220.
  • Soubeiran E, Müller S, Jakob T: Soforttypallergie auf Omeprazol mit systemischer Reaktion nach Hauttestung. Allergo J, 2012; 21: 238-242.
  • Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, Rohr J, Jakob T, Oswald E, Sanal O, Litzman J, Plebani A, Pietrogrande C, Franco JL, Espanol T, Huzly D, Grimbacher B, Ehl S: Reduced memory B cells in patients with Hyper IgE syndrome. Clin Immunol, 2008; 129: 448-454.
  • Sprenger A, Küttner V, Biniossek ML, Gretzmeier C, Boerries M, Mack C, Has C, Bruckner-Tuderman L, Dengjel J: Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol Biosyst, 2010; 6 (9): 1579-1582.
  • Sprenger A, Weber S, Zarai M, Engelke R, Nascimento JM, Gretzmeier C, Hilpert M, Boerries M, Has C, Busch H, Bruckner-Tuderman L, Dengjel J: Consistency of the proteome in primary human keratinocytes with respect to gender, age, and skin localization. Mol Cell Proteomics, 2013; 12: 2509-2521.
  • Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W: Short German guidelines: cutaneous lymphomas. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6 Suppl. 1: 25-31.
  • Stadler R, Luger T, Bieber T, Köhler U, Linse R, Technau K, Schubert R, Schruth K, Vakilzadeh F, Volkenandt M, Gollnick H, VonEick H, Thoren F, Strannegard Ö: Long-term survival benefit after dajuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trail Acta Oncol, 2006; 45 (4): 389-399.
  • Stancu E: Akne: Schönen sie Ihre Haut Naturarzt, 2004; 9: 19-21.
  • Stancu E, Braun-Falco M, Bruckner-Tuderman L, Schempp C: Umbilicated blisters on sun-exposed skin Hautarzt, 2007; 58: 343-346.
  • Stancu Ella: Heilplfanzen gegen Neurodermitis-Ekzembehandlung ohne Kortison Naturarzt, 2003; 2 (144): 21-23.
  • Stefanova M,, Zemke K,, Dimitrov B,, Has C, Kern JS, Bruckner-Tuderman L,, Kutsche K: Disruption of ERBB2IP ist not associated with dystrophic epidermolysis bullosa in both father and son carrying a balanced 5; 13 translocation J Invest Dermatol, 2005; 125: 700-704.
  • Strüh CM, Jäger S, Schempp C, Scheffler A, Martin SF: A Novel Triterpene Extract from Mistletoe Induces Rapid Apoptosis in Murine B16.F10 Melanoma Cells Phytother Res, 2012; 26: 1507-1512. : http://10.1002/ptr.4604
  • Strüh CM, Kersten A, Jäger S, Scheffler A, Schempp CM, Martin SF: Triterpenoids Amplify Anti-Tumoral Effects of Mistletoe Extracts on Murine B16.F10 Melanoma In Vivo. Plos One, 2013; 8 (4) (online): e62168. : http://dx.doi.org/10.1371/journal.pone.0062168
  • Süß A, Sticherling M, Volz A, Frank R, Rudolph KD, Simon JC: Large metastasizing squamous cell carcinoma in epidermolysis bullosa dystrophica Hallopeau-Siemens J Eur Acad Dermatol, 2007; 21 (4): 539-541.
  • Szczecinska W, Nesteruk D, Wertheim-Tysarowska K Greenblatt DT, Baty D, Browne F, Liu L, Ozoemena L, Terron-Kwiatkowski A, McGrath JA, Mellerio JE, Morton J, Woźniak K, Kowalewski C, Has C, Moss C: Under-recognition of acral peeling skin syndrome: 59 new cases with 15 novel mutations. Brit J Dermatol, 2014; 171: 1206-1210.
  • Tadini G, Restano L, Happle R, Itin P: PENS syndrome: a new neurocutaneous phenotype. Dermatology, 2012; 224: 24-30.
  • Tanaka N, Dainichi T, Ohyama B, Yasumoto S, Ono T, Iwatsuki K, Elfert S, Bruckner-Tuderman L, Hashimoto T: A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol, 2009; 61: 715-719.
  • Tang MM, Leong KF, Has C, Bruckner-Tuderman: Dystrophic epidermolysis bullosa pruriginosa: the first report of a family in Malaysia. Med J Malaysia, 2013; 68: 81-85.
  • Tang Y, Mockenhaupt M, Henry A, Bounoua M, Naldi L, Le-Gouvello S, Bensussan A, Roujeau JC: Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Exp Allergy, 2012; 42 (2): 248-254. : http://dx.doi.org/10.1111/j.1365-2222.2011.03875.x
  • Tasanen K, Tunggal L, Chometon G, Bruckner-Tuderman L, Aumailley M: Keratinocytes from patients lacking collagen XVII display a migratory phenotype Am J Pathol, 2004; 164: 2027-2038.
  • Technau K, Renkl A, Norgauer J, Ziemer M: Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma. Eur J Dermatol, 2005; 15 (2): 110-112.
  • Termeer C, Averbeck M, Hara H, Eibel H, Herrlich P, Sleeman J, Simon JC: Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis. Immunology, 2003; 109 (1): 32-40.
  • Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med, 2002; 195 (1): 99-111.
  • Termeer C, Schöpf E, Simon JC: Selektive Cyclooxygenase II Hemmer bei Patienten mit pseudoallergischen Reaktionen auf nichtsteroidale Antiphlogistika Aktuelle Dermatologie, 2002; 28: 153-155.
  • Termeer CC, Technau K, Augustin M, Simon JC: Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus J Eur Acad Dermatol, 2004; 18: 636-637.
  • Tholen S, Wolf C, Mayer B, Knopf JD, Löffek S, Qian Y, Kizhakkedathu JN, Biniossek ML, Franzke CW *, Schilling O *: Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations. J Proteome Res, 2016; 15: 1402-1417.
  • Thomas AC, Zeng Z, Rivière JB, O'Shaughnessy R, Al-Olabi L, St-Onge J, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E, Chiaverini C, Chong WK, Duffourd Y, Glover M, Groesser L, Hadj-Rabia S, Hamm H, Happle R, Mushtaq I, Lacour JP, Waelchli R, Wobser M, Vabres P, Patton EE, Kinsler VA: Mosaic activating mutations in GNA11 and GNAQ are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis. J Invest Dermatol, 2016; 136: 770-778.
  • Thoma-Uszynski S, Uter W, Schwietzke S, Hofmann SC, HunzikerT, Bernard P, Treudler R, Zouboulis CC, Schuler G, Borradori L, Hertl M: BP230- and BP180-specific auto-antibodies in bullous pemphigoid J Invest Dermatol, 2004; 122: 1413-1422.
  • Torrelo A, Hadj-Rabia S, Colmenero I, Piston R, Sybert VP, Hilari-Carbonell H, Hernández-Martín A, Ferreres JC, Vañó-Galván S, Azorín D, de Salamanca JE, Requena L, Bodemer C, Happle R, García-Patos V, Fraitag S: Folliculocystic and collagen hamartoma of tuberous sclerosis complex. J Am Acad Dermatol, 2012; 66: 617-621. : http://dx.doi.org/10.1016/j.jaad.2011.04.002
  • Traidl-Hoffmann C, Mariani V, Thiel M, Gilles S, Müller MJ, Ring J, Jakob T, Behrendt H: Pollen pave their way by pollen associated lipid mediators (PALMs) Allergy Clin Immunol International, 2007; 2: 1-5.
  • Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, van Rooijen N, Davidson A, Ivashkiv LB: Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. P Natl Acad Sci Usa, 2010; 107 (7): 3012-3017.
  • Utikal J, Poenitz N, Gratchev A, Klemke CK, Nashan D, Tüting T, Goerdt S: Additional Her 2/neu gene copies in patients with Sézary syndrome Leukemia Res, 2006; 30: 755-760.
  • Väisänen L,, Has C,, Franzke C-W,, Hurskainen T,, Tuomi M-L, B, ruckner-Tuderman L,, Tasanen K: Molecular mechanisms of junctional epidermolysis bullosa: Coll 5 domain mutations decrease the thermal stability of collagen XVII J Invest Dermatol, 2005; 125: 1112-1118.
  • Valeyrie-Allanore L, Poulalhon N, Fagot JP, Sekula P, Davidovici B, Sidoroff A, Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol, 2008; 87: 300-303.
  • van Beek N, Knuth-Rehr D, Altmeyer P, Assaf C, Babilas P, Bayerl C, Benoit S, Dippel E, Effendy I, Eming R, Fischer M, Glaenz T, Gläser R, Goebeler M, Gollnick H, Götze S, Gross G, Hadaschik E, Herbst R, Hermes B, Homey B, Hunzelmann N, Jünger M, Kapp A, Kern JS, Körber A, Luger T, Mechtel D, Megahed M, Moll I, Peters KP, Pfeiffer C, Ring J, Röcken M, Sárdy M, Seitz CS, Stadler R, Steinbrink K, Sticherling M, Szeimies RM, Tronnier M, Ulrich J, Vogt T, Wagner N, Welzel J, Wenzel J, Wozel G, Zouboulis CC, Zillikens D, Schmidt E: Diagnostics of autoimmune bullous diseases in German dermatology departments. J Dtsch Dermatol Ges, 2012; 10 (7): 492-499. : http://10.1111/j.1610-0387.2011.07840.x
  • van den Akker PC, Jonkman MF, Rengaw T, Bruckner-Tuderman L, Has C, Bauer JW, Klausegger A, Zambruno G, Castiglia D, Mellerio JE, McGrath JA, van Essen AJ, Hofstra RM, Swertz MA: The International Dystrophic Epidermolysis Bullosa Patient Registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat, 2011; 32: 1100-1107.
  • van der Steen LP, Bakema JE, Sesarman A, Florea F, Tuk CW, Kirtschig G, Hage JJ, Sitaru C, van Egmond M: Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies. J Immunol, 2012; 189 (4): 1594-2601. : http://doi: 10.4049/jimmunol.1101763.
  • Van Vaerenbergh M, De Smet L, Blank S, Spillner E, Ebo D, Devreese B, Jakob T *, de Graaf DC *: IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology. Mol Immunol, 2015; 63: 449-455. : http://dx.doi.org/10.1016/j.molimm.2014.09.018
  • Veit G, Zimina E, Franzke C, Kutsch S, Daamen M, Gordon MK, Bruckner-Tuderman L, Koch M: Shedding of collagen XXIII is mediated by furin and depends on the plasma membrane microenviroment J Biol Chem, 2007; 282 (37): 27424-27435.
  • Villone D, Fritsch A, Koch M, Bruckner-Tuderman L, Hansen U, Bruckner P: Supramolecular interactions in the dermo-epidermal junction zone: collagen VII in anchoring fibrils tightly bind to fibrillar collagen I. J Biol Chem, 2008; 283: 24506-24513.
  • Volz A, Pfister-Wartha A, Bruckner-Tuderman L, Nashan D, Radny P: Mastix, a known herbal allergen, as causative agent in occupation-related dermatitis Contact Dermatitis, 2006; 54 (6): 346-347.
  • Volz A, Pfister-Wartha A Bruckner-Tuderman L, Braun-Falco M: Perifollikuläre Protrusionen – Elastolysis mediodermalis. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7 (1): 68-69.
  • von Bartenwerffer W, Has C, Arin MJ, Tantcheva-Poór I, Kreuter A, Kremer K, Arshah T, Hoffmann M, Eming SA, Kohlhase J, Krieg T, Bruckner-Tuderman L, Hartmann K: Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations. Eur J Dermatol, 2011; 21: 170-172.
  • von Bonin A, Rausch A, Mengel A, Hitchcock M, Krüger M, von Ahsen O, Merz C, Röse L, Stock C, Martin SF, Leder G, Döcke WD, Asadullah K, Zügel U: Inhibition of the IL-2 Inducible Tyrosine Kinase (Itk) Activity: A new Concept for the Therapy of Inflammatory Skin Diseases. Exp Dermatol, 2011; 20: 41-47.
  • Wachter T, Averbeck M, Hara H, Tesmann JP, Simon JC, Termeer CC, Denfeld RW: Induction of CD4+ T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells. J Immunol, 2003; 171 (2): 776-782.
  • Watt SA, Pourreyron C, Purdie K, Hogan C, Cole CL, Foster N, Pratt N, Bourdon JC, Appleyard V, Murray K, Thompson AM, Mao X, Mein C, Bruckner-Tuderman L, Evans A, McGrath JA, Proby CM, Foerster J, Leigh IM, South AP: Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene, 2011; 30: 4666-4677.
  • Weber A, Heinlein M, Dengjel J, Alber C, Singh PK, Häcker G: The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis. Embo Rep, 2016; 17 (5): 724-738.
  • Weber FC, Esser PR, Mueller T, Ganesan J, Pellegatti P, Simon MM, Zeiser R, Idzko M, Jakob T, Martin SF: Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity. J Exp Med, 2010; 207: 2609-2619.
  • Weber FC, Németh T, Csepregi JZ, Dudeck A, Roers A, Ozsvári B, Oswald E, Puskás LG, Jakob T, Mócsai A, Martin SF: Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med, 2015; 212: 15-22.
  • Weckesser S, Engel K, Simon-Haarhaus B, Wittmer A, Pelz K, Schempp C: Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance Phytomedicine, 2007; 14 (7-8): 508-516.
  • Weckesser S, Goebel H, Donauer J, Schempp C: Disseminated skin ulcerations associated with chronic renal failure Hautarzt, 2007; 58: 538-540.
  • Weckesser S, Hilger C, Lentz D, Jakob T: Anaphylactic reactions to bites of the pigeon tick Argas reflexus. Eur J Dermatol, 2010; 20: 244-245.
  • Weinberg F, Reischmann N, Fauth L, Taromi S, Mastroianni J, Köhler M, Halbach S, Becker AC, Deng N, Schmitz T, Uhl FM, Herbener N, Riedel B, Beier F, Swarbrick A, Lassmann S, Dengjel J, Zeiser R, Brummer T: The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior. EBioMedicine, 2017; 20: 79-97.
  • Weller K, Vetter C, Kähler K, Hauschild A, Eigentler T, Garbe C, Pföhler C, Tilgen W, Neuber K, Moll I, Krause M, Kneisel L, Nashan D, Thoelke A, Lommel K, Galli K, Letsch B, Bahmer FA, Näher H, Becker JC: Diagnostik und Therapie des Merkelzellkarzinoms – Leitlinien und Realität Deutsches Ärzteblatt, 2006; 103 (A279): 42.
  • Wenke A, Müller ML, Babapirali J, Rompel R, Hensen P: Development of lengths of stay and DRG cost weights in dermatology from 2003 to 2006. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7 (8): 680-687.
  • Wenzel D, Bayerl J, Nyström A, Bruckner-Tuderman L, Meixner A, Josef M, Penninger JM: iPSC-based cell therapy for recessive dystrophic epidermolysis bullosa. Sci Transl Med, 2014; 6 (online): 264ra165. : http://dx.doi.org/10.1126/scitranslmed.3010083
  • Wilken K, Schempp CM: Toxic phytodermatitis caused by Euphorbia helioscopia L. (sun spurge). Hautarzt, 2005; 56: 955-958.
  • Woelfle U, Laszczyk MN, Kraus M, Leuner K, Kersten A, Simon-Haarhaus B, Scheffler A, Martin SF, Müller WE, Schempp C: Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo. A role for the transient receptor potential canonical (subtype) 6. J Invest Dermatol, 2010; 130: 113-123.
  • Wolf C, Qian Y, Brooke MA, Kelsell DP, Franzke CW: ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phosholipase C γ1 and protein kinase C pathways. Sci Rep-uk, 2016; 6 (online): 39780. : http://dx.doi.org/10.1038/srep39780
  • Wölfle U, Elsholz FA, Kersten A, Haarhaus B, Müller WE, Schempp CM: Expression and functional activity of the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes. Skin Pharmacol Phys, 2015; 28 (3): 137-146.
  • Wölfle U, Elsholz FA, Kersten A, Haarhaus B, Schumacher U, Schempp CM: Expression of the human bitter taste receptor TAS2R38 in human tissue arrays and JEG-3 cells. Molecules, 2016; 21 (3) (online): 306. : http://dx.doi.org/10.3390/molecules21030306
  • Wölfle U, Esser PR, Simon-Haarhaus B, Martin SF, Lademann J, Schempp CM: UVB induced DNA damage, generation of reactive oxygen species and inflammation is effectively attenuated by the flavonoid luteolin in vitro and in vivo. Free Radical Bio Med, 2011; 50: 1081-1093.
  • Wölfle U, Haarhaus B, Kersten A, Fiebich B, Hug MJ, Schempp CM: Salicin from Willow Bark can Modulate Neurite Outgrowth in Human Neuroblastoma SH-SY5Y Cells. Phytother Res, 2015; 29 (10): 1494-1500.
  • Wölfle U, Haarhaus B, Schempp CM: The photoprotective and antioxidative properties of luteolin are synergistically augmented by tocopherol and ubiquinone. Planta Med, 2013; 79: 963-965.
  • Wölfle U, Haarhaus B, Schempp CM: Amarogentin Displays Immunomodulatory Effects in Human Mast Cells and Keratinocytes. Mediat Inflamm, 2015; 2015 (online): 630128. : http://doi.org/10.1155/2015/630128
  • Wölfle U, Haarhaus B, Seiwerth J, Cawelius A, Schwabe K, Quirin KW, Schempp CM: The herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivo. Int J Mol Sci, 2017; 18: 1814. : http://doi: 10.3390/ijms18081814
  • Wölfle U, Heinemann A, Esser PR, Haarhaus B, Martin SF, Schempp CM: Luteolin prevents solar radiation-induced matrix metalloproteinase-1 activation in human fibroblasts. A role for p38 mitogen-activated protein kinase and interleukin-20 released from keratinocytes. Rejuv Res, 2012; 15: 466-475.
  • Wölfle U, Hoffmann J, Haarhaus B, Mittapalli VR, Schempp CM: Anti-inflammatory and vasoconstrictive properties of Potentilla erecta – a traditional medicinal plant from the northern hemisphere. J Ethnopharmacol, 2017; 204: 86-94.
  • Wölfle U, Laszczyk MN, Kraus M, Leuner K, Kersten A, Simon-Haarhaus B, Scheffler A, Martin SF, Müller WE, Nashan D, Schempp CM: Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo. A role for the transient receptor potential canonical 6. J Invest Dermatol, 2009; 130: 113-123.
  • Wölfle U, Simon-Haarhaus B, Mefort I, Schempp C: Reseda luteola L. extract displays anti-proliferative and pro-apoptotic activities that are related to its major flavonoids. Phytother Res, 2010; 24: 1033-1036.
  • Wolf P, Georgas D, Tomi NS, Schempp CM, Hoffmann K: Extracorporeal photochemotherapy as systemic monotherapy of severe, refractory atopic dermatitis: results from a prospective trial. Photoch Photobio Sci, 2013; 12: 174-181. : http://dx.doi.org/10.1039/c2pp25203a
  • Yaktapour N *, Meiss F *, Mastroianni J, Zenz T, Andrlova H, Mathew NR, Claus R, Hutter B, Fröhling S, Brors B, Pfeifer D, Pantic M, Bartsch I, Spehl TS, Meyer PT, Duyster J *, Zirlik K *, Brummer T *, Zeiser R: BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia. J Clin Invest, 2014; 124: 5074-5084. : http://dx.doi.org/10.1172/JCI76539
  • Yakulov TA, Yasunaga T, Ramachandran H, Engel C, Muller B, Hoff S, Dengjel J, Lienkamp SS, Walz G *: Anks3 interacts with nephronophthisis proteins and is required for normal renal development. Kidney Int, 2015; 87 (6): 1191-1200.
  • Yalcin EG, He Y, Orhan D, Pazzagli C, Emiralioglu N, Has C *: Crucial role of posttranslational modifications of integrin a3 in interstitial lung disease and nephrotic syndrome. Hum Mol Genet, 2015; 24: 3679-3688. : http://dx.doi.org/10.1093/hmg/ddv111
  • Zafrakas M, Tarlatzis BC, Streichert T, Pournaropoulos F, Wölfle U, Smeets SJ, Wittek B, Grimbizis G, Brakenhoff RH, Pantel K, Bontis J, Günes C: Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. Int J Mol Med, 2008; 21 (3): 335-344.
  • Zapatero-Solana E, García-Giménez J, Guerrero-Aspizua S, García M, Toll A, Baselga E, Durán-Moreno M, Markovic J, García-Verdugo J, Conti CJ, Has C, Larcher F, Pallardó FV, Del Rio M: Oxidative stress and mitochondrial dysfunction in Kindler syndrome. Orphanet J Rare Dis, 2014; 21 (9): 211.
  • Zappel K, Bruckner-Tuderman L, Audring H, Kolde G, Blume-Peytavi U: Junktionale Epidermolysis bullosa non-Herlitz non-Herlitz mit Affektion der Harnröhre. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 50-56.
  • Zarei M *, Sprenger A, Gretzmeier C, Dengjel J *: Rapid combinatorial ERLIC-SCX solid phase extraction for in depth phosphoproteome analysis. J Proteome Res, 2013; 12: 5989-5995.
  • Ziemer M, Kardaun S, Liß Y, Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: A descriptive study of 17 cases from a national registry and review of the literature. Brit J Dermatol, 2012; 166 (3): 575-600. : http://dx.doi.org/10.1111/j.1365-2133.2011.10705.x
  • Ziemer M, Wiesend CL, Vetter R, Weiss J, Blaschke S, Norgauer J, Mockenhaupt M: Cutaneous adverse drug reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis Arch Dermatol, 2007; 143: 711-716.
  • Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, Hofmann S, Karlhofer F, Kautz O, Nitschke M, Opitz A, Quist S, Rose Ch, Schanz S, Schmidt E, Shimanovich I, Sticherling M, Ziller F: Recommendations for the use of immunapheresis in the treatment of autoimmune bullous diseases Journal der Deutschen Dermatologischen Gesellschaft, 2007; 5: 881-887.
  • Zimina E, Fritsch A, Schermer B, Bakulina AYU, Bashkurov M, Benzing T, Bruckner-Tuderman L: Extracellular phosphorylation of collagen XVII by ecto-casein kinase 2 inhibits ectodomain shedding. J Biol Chem, 2007; 282 (31): 22737-22746.
  • Zimina E, Hofmann S, Fritsch A, Kern J, Sitaru C, Bruckner-Tuderman L: Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII. J Invest Dermatol, 2008; 128 (11): 2736-2739.
  • Zimina EP, Bruckner-Tuderman L, Franzke C-W: Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment J Biol Chem, 2005; 280 (40): 34019-34024.
  • Zschocke I, Hartmann A, Schlöbe A, Cummerow R, Augustin M: Wirksamkeit und Nutzen eines 5-FU/Salicylsäurehaltigen Präparates in der Therapie vulgärer und plantarer Warzen - systemische Literaturübersicht und Metaanalyse. Journal der Deutschen Dermatologischen Gesellschaft, 2004; 2: 187-193.
  • Zschocke I., Bross F., Maier K., Vanscheidt W., Augustin M.: LQ Dermatol Psychosom 3, 2002. (in Druck)
  • Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Merk H, Ollert M, Rueff F, Schmid-Grendelmeier P Staubach P, Voigtmann I, Wedi B, Maurer M: S3-Leitlinie Urticaria (AWMF 013/028) Teil 1: Klassifikation und Diagnostik der Urtikaria. Allergo J, 2011; 20: 249-258.
  • Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Maurer M, Rueff F, Schmid-Grendelmeier P Staubach P, Voigtmann I, Wedi B: S3-Leitlinie Urticaria (AWMF 013/028) Teil II: Therapie der Urticaria. Allergo J, 2011; 20: 259-276.
  • Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Merk H, Ollert M, Rueff F, Schmid-Grendelmeier P Staubach P, Voigtmann I, Wedi B, Maurer M: S3-Leitlinie Urticaria (AWMF 013/028) Klassifikation und Diagnostik der Urtikaria. Allergologie, 2011; 34: 569-580.
Reviews/Übersichtsartikel in wissenschaftlichen Fachzeitschriften:
  • Abeliovich H, Dengjel J *: Mitophagy as a stress response in mammalian cells and in respiring S. cerevisiae. Biochem Soc T, 2016; 44: 541-545.
  • Albrecht K, Meiss F, Zeiss T, Nashan D, Reuter K: Psycho-oncological care for melanoma patients : Conception and implementation. Hautarzt, 2013; 64: 927-930.
  • Augustin M: Tratamiento coadyuvante de la dermatitis atópica con métodos. Medicina Biológica, 2003; 16 (3): 68-74.
  • Augustin M: Pharmako-Ökonomische Aspekte der Aknetherapie. Aktuel Dermatologie, 2003; 29: 99-101.
  • Augustin M: Die Positivliste auf der parlamentarischen Zielgeraden. Der Deutsche Dermatologe, 2003; 6: 416-418.
  • Augustin M: Gute Erfolge bei leichteren Ekzemen Heilberufe, 2004; 4: 18-19.
  • Augustin M: Innovatives Langzeitmanagement der atopischen Dermatitis: Kosten-Nutzen-Relation - Eine fallbezogene Analyse am Beispiel der Pimecrolimus 1 % Creme Hautarzt, 2004; 55 (7): 1-4.
  • Augustin M, Amon U, Braathen L, Bullinger M, Gieler U, Klein GF, Schultz-Amling W: Erfassung von Lebensqualität in der Dermatologie Leitlinie) Journal der Deutschen Dermatologischen Gesellschaft, 2004; 9: 802-806.
  • Augustin M, Brosig B, Hillert A, Hockmann J, Höring C.M, Kupfer J, Niemeier V, Schmidt-Ott G, Schultz-Amling W, Seikowski K, Simmich T, Stangier U: Leitlinie Psyhcosomatische Dermatologie. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 6: 494-502.
  • Augustin M, Gieler U, Zschocke I: Psychodermatology Has Grown out of its Infancy Dermatol Psychosom, 2004; 5: 3-4.
  • Augustin M, Maier K: Psychosomatic Aspects of Chronic Wounds. Dermatology and Psychosomatics, 2003; 4: 5-13.
  • Augustin M.: Education in Psychodermatology: Chronic venous insufficiency and venous leg ulcer. Dermatol Psychosom, 2002; 3. (in Druck)
  • Augustin M., Siegel A., Heuser A., Vanscheidt W.: Chronische Unterschenkelgeschwüre: Kostenbeurteilung zweier Behandlungsstrategien Praxis Journal, 2002; 1: 38-41.
  • Aumailley M, Has C, Tunggal L, Bruckner-Tuderman L: Molecular basis of inherited skin blistering disorders, and therapeutic implications Expert Reviews Mol Med, 2006; 8: 1-21.
  • Aumailley M,, Bruckner-Tuderman L,, Carter WG,, Deutzmann R,, Edgar D,, Ekblom P,, Engel J,, Engvall E,, Hohenester E,, Jones JC,, Kleinmann HK,, Marinkovich MP,, Martin GR,, Mayer U,, Meneguzzi G,, Miner JH,, Miyazaki K,, Patarroyo M,, Paulsson M,, Quaranta V,, Sanes JR,, Sasaki T,, Sekiguchi K,, Sorokin LM,, Talts JF,, Tryggvason K,, Uitto J,, Virtanen I,, von der Mark K,, Wewer UM,, Yamada Y,, Yurchenco PD: A simplified laminin nomenclature Matrix Biol, 2005; 24: 326-332.
  • Braun-Falco M: Genitale Papeln und Plaques MedReport, 2007; 31 (12): 11.
  • Braun-Falco M, Rödl D: Recombinant adeno-associated virus vectors for somatic gene therapy in Dermatology Expert Review of Dermatology, 2007; 2: 153-165.
  • Brockow K, Beyer K, Biedermann T, Fischer J, Gieler U, Giessler-Fichtner O, Gebert N, Jakob T, Klimek L, Kugler C, Reese I, Rietschel E, Ruëff F, Schnadt S, Siemens C, Szczepanski R, Worm M, Ring J, Lange L: Supportive care of patients with anaphylaxis – treatment options and shortcomings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany. Allergo J Int, 2016; 25 (6): 160-168. : http://dx.doi.org/10.1007/s40629-016-0128-y
  • Bruckner-Tuderman L: Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin, 2010; 28: 107-114.
  • Bruckner-Tuderman L: Epidermolysis bullosa care in Germany. Dermatol Clin, 2010; 28: 405-406.
  • Bruckner-Tuderman L: Neues über hereditäre, blasenbildende Hauterkrankungen. Hautarzt, 2013; 64: 7-11.
  • Bruckner-Tuderman L, Has C: Hereditäre blasenbildende Hauterkrankungen. Kinder- und Jugendmedizin Kinder- und Jugendmedizin, 2007; 5: 257-263.
  • Bruckner-Tuderman L, Has C: Hereditäre blasenbildende Hauterkrankungen Kinder- und Jugendmagazin, 2007; 5: 257-263.
  • Bruckner-Tuderman L, Has C: Molecular heterogeneity of blistering disorders: the paradigm of epidermolysis bullosa. J Invest Dermatol, 2012; 132 (E1): E2-E5.
  • Bruckner-Tuderman L, Has C: Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa. Matrix Biol, 2014; 33: 29-34.
  • Bruckner-Tuderman L, McGrath JA, Robinson C, Uitto J: Animal models for epidermolysis bullosa: update 2010. J Invest Dermatol, 2010; 130: 1485-1488.
  • Bruckner-Tuderman L, McGrath JA, Robinson EC, Uitto J: Progress in Epidermolysis Bullosa Research. Summary of DebRA International Research Conference 2012. J Invest Dermatol, 2013; 133: 2121-2126.
  • Bruckner-Tuderman L, von der Mark K, Pihlajaniemi T, Unsicker K: Cell interactions with the extracellular matrix. Cell Tissue Res, 2010; 339: 1-5.
  • Casetti F, Huber R, Schempp CM: Unverträglichkeitsreaktionen auf Pflanzen. Schweiz Z Ganzheitsmed, 2011; 23: 144-146.
  • Casetti F, Wölfle U, Gehring W, Schempp CM: Dermocosmetics for dry skin - a new role for botanical extracts. Skin Pharmacol Phys, 2011; 25: 289-293.
  • Casetti F, Wölfle U, Schempp CM: Koriander (Coriandrum sativum L.) – ein antimikrobiell wirksamer mediterraner Doldenblütler mit hautfreundlichen Eigenschaften. Zeitschrift für Phytotherapie, 2012; 33: 43-46.
  • Chen W, Ring J, Happle R: Congenital generalized hypertrichosis terminalis: a proposed classification and a plea to avoid the ambiguous term "Ambras syndrome". Eur J Dermatol, 2015; 25: 223-227.
  • Chronopoulos A, Mockenhaupt M, Pleyer U: Okuläre Beteiligung bei Stevens-Johnson-Syndrom und Toxisch epidermale Nekrolyse. Klin Monatsbl Augenh, 2012; 229 (5): 534-539.
  • Csorba K, Sitaru S, Sitaru C: Granulocyte-dependent Autoantibody-induced Skin Blistering. J Vis Exp, 2012; 68 (online). : http://4250. 10.3791/4250
  • Dengjel J, Abeliovich H *: Roles of mitophagy in cellular physiology and development. Cell Tissue Res, 2017; 367 (1): 95-109.
  • Diedrich B, Dengjel J: Insights into autosomal dominant polycystic kidney disease by quantitative mass spectrometry-based proteomics. Cell Tissue Res, 2017; 369 (1): 41-51.
  • Dissemond J, Augustin M, Eming SA, Goerge T, Horn T, Karrer S, Schumann H, Stücker M: Modern wound care - practical aspects of non-interventional topical treatment of patients with chronic wounds. J Dtsch Dermatol Ges, 2014; 12 (7): 541-554.
  • Dudda JC, Martin SF: Tissue-targeting of T cells by DCs and microenvironments Trends Immunol, 2004; 25: 417-421.
  • Edele F, Esser PR, Lass C, Laszczyk MN, Oswald E, Strüh CM, Rensing-Ehl A, Martin S: Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases Inflammation and Allergy - Drug Targets, 2007; 6: 236-244.
  • Ermuth T., Johnsen S., Vanscheidt W., Tanczos E., Augustin M., Peschen M.: Therapiefraktäres Ulcus cruris leukozytoklastisch-vaskulitischer Genese im Rahmen eines hereditären Thrombophilie-Syndroms. Akt. Dermatologie, 2002; 28: 170-172.
  • Esser PR, Martin SF *: Pathomechanisms of Contact Sensitization. Curr Allergy Asthm R, 2017; 17: 83. : https://doi.org/10.1007/s11882-017-0752-8
  • Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, Marinkovich MP, Martinez AE, McGrath JA, Mellerio JE, Moss C, Murrell DF, Shimizu H, Uitto J, Woodley D, Zambruno G: Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol, 2014; 70: 1103-1126.
  • Fine J-D, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman M, Leigh IM, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G: The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol, 2008; 58: 931-950.
  • Florea F, Koch M, Hashimoto T, Sitaru C: Autoimmunity against laminins. Clin Immunol, 2016; 170: 39-52. : http://doi: 10.1016/j.clim.2016.07.021
  • Florea F, Sitaru C: Relevance of immunofluorescence methods in clinical dermatology. CML Dermatology, 2010; 15: 29-45.
  • Franzke CW, Tasanen K, Schumann H, Bruckner-Tuderman L: Collagenous transmembrane proteins: collagen XVII as a prototype. Matrix Biol, 2003; 22 (4): 299-309.
  • Franzke C-W, Bruckner-Tuderman L: Collagenous Transmembrane Proteins - Recent Insights into Biology and Pathology. Invited Minireview J Biol Chem, 2004. (in Druck)
  • Franzke C-W, Bruckner P, Bruckner-Tuderman L: Collagenous transmembrane proteins:recent insights into biology and pathology. J Biol Chem, 2005; 280: 4005-4008.
  • Freudenberg MA, Esser PR, Jakob T, Galanos C, Martin SF: Innate and adaptive immunity in contact hypersensitivity. G Ital Dermatol Venereol, 2009; 144: 173-185.
  • Gilles S, Mariani V, Bryce M, Müller MJ, Ring J, Behrendt H, Jakob T, Traidl-Hoffmann C: Pollen allergens do not come alone: Pollen associated lipid mediators (PALMS) shift the human immue systems towards a TH2-dominated response. Allergy, Asthma and Clin Immunol, 2009; 5: 3-9.
  • Günther J., Augustin M.: Psoriasis. Diagnose, aktuelle und innovative Therapie. Ars Medici, 2002; 4: 165-168.
  • Gutermuth J, Köllisch G, Bewersdorff M, Braun A, Alessandrini F, Jakob T: Immunology highlights at high altitude: review of the fourth EAACI-GA2LEN Davos Meeting Allergy, 2006; 61 (10): 1197-1199.
  • Halbach S, Dengjel J, Brummer T: Quantitative Proteomics Analysis of Leukemia Cells. Methods Mol Biol, 2016; 1465: 139-148.
  • Happle R: Superimposed segmental dermatomyositis is a juvenile disorder. Eur J Dermatol, 2014; 24: 291-292.
  • Happle R: Wie häufig sind genetische Mosaike in der Haut? Hautarzt, 2014; 65: 536-541.
  • Happle R: Capillary malformations: a classification using specific names for specific skin disorders. J Eur Acad Dermatol, 2015; 29: 2295-2305.
  • Happle R: Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: a hypothesis. Eur J Med Genet, 2016; 59: 290-294. : http://dx.doi.org/10.1016/j.ejmg.2016.04.001
  • Happle R: Goltz syndrome and PORCN: a view from Europe. Am J Med Genet C, 2016; 172 (C): 21-23. : http://dx.doi.org/10.1002/ajmg.c.31469
  • Happle R: The categories of cutaneous mosaicism: a proposed classification. Am J Med Genet A, 2016; 170 (A): 452-459. : http://dx.doi.org/10.1002/ajmg.a.37439
  • Has C: Kindler syndrome: A new bullous dermatosis. Hautarzt, 2009; 60 (8): 622-626.
  • Has C: Mosaicism in the skin. Arch Dermatol, 2011; 147: 1094-1096.
  • Has C: Molecular genetic assays for inherited epidermolysis bullosa. Clin Dermatol, 2011; 29: 420-426.
  • Has C: Molecular therapies for inherited epidermolysis bullosa. G Ital Dermatol Venereol, 2016; 151 (4): 397-402.
  • Has C: Hemidesmosomes: how much plakins do they need? Exp Dermatol, 2016 (online): 263-264. : http://doi: 10.1111/exd.12939
  • Has C, Bruckner-Tuderman L: [Epidermolysis bullosa : Diagnosis and therapy]. Hautarzt, 2011; 62: 82-90.
  • Has C, Bruckner-Tuderman L: The genetics of skin fragility. Annu Rev Genom Hum G, 2014; 15: 245-268.
  • Has C, Giehl K: Rare diseases are common. Hautarzt, 2014; 65: 488-498.
  • Has C, He Y: Research Techniques Made Simple: Immunofluorescence Antigen Mapping in Epidermolysis Bullosa. J Invest Dermatol, 2016; 136 (7) (online): e65-71. : http://dx.doi.org/10.1016/j.jid.2016.05.093
  • Has C, He Y: Practical aspects of molecular diagnostics in genodermatoses. Hautarzt, 2016; 67 (1): 53-58. : http://doi: 10.1007/s00105-015-3721-y
  • Has C, Kern J: Collagen XVII Dermatol Clin, 2010; 28 (1): 61-66.
  • Has C, Kern JS, Bruckner-Tuderman L: Hereditary blistering disorders Hautarzt, 2004; 55 Suppl. 920: 922-930.
  • Has C, Kiritsi D: Molecular therapies for epidermolysis bullosa. Giorn Ital Dermat V, 2013; 148: 65-72.
  • Has C, Kiritsi D: The many facets of inherited skin fragility. Hautarzt, 2014; 65: 490-498.
  • Has C, Kiritsi D: Therapies for inherited skin fragility disorders. Exp Dermatol, 2015; 24 (5): 325-331. : http://doi: 10.1111/exd.12666
  • Has C, Technau-Hafsi K: Palmoplantar keratodermas: clinical and genetic aspects. J Dtsch Dermatol Ges, 2016; 14 (2): 123-139. : http://doi: 10.1111/ddg.12930
  • Has C, Technau-Hafsi K: Palmoplantar keratodermas: clinical and genetic aspects. J Dtsch Dermatol Ges, 2016; 14 (2): 123-140. : http://doi: 10.1111/ddg.12930.
  • Hennies J, Simon JC: Photo(chemo)-Therapie und immunmodulierende Therapeutika Med-Report, 2003; 27: 15.
  • Hilger C, Kühn A, Raulf M, Jakob T: Cockroach, tick, storage mite and other arthropod allergies: Where do we stand with molecular allergy diagnostics? Allergo Journal International, 2014; 23: 172-178.
  • Hoffmann J, Tasiopoulou G, Wölfle U, Schempp CM: Phytotherapie in der Dermatologie – ein Update. Hautnah Dermatologie, 2017; 33: 38-43.
  • Hoffmann K, Hertl M, Sitaru C: Molecular diagnosis of collagen vascular diseases and vasculitides. Hautarzt, 2016; 67 (1): 40-52. : http://Doi: 10.1007/s00105-015-3728-4
  • Hoffmann K, Hertl M, Sitaru C: Molecular diagnosis of autoimmune dermatoses. Hautarzt, 2016; 67 (1): 33-39. : http://doi: 10.1007/s00105-015-3723-9
  • Hofmann S, Jakob T: Molekulare Diagnostik bei Nahrungsmittel-abhängiger Anstrengungs-induzierter Anaphylaxie. Allergo J, 2013; 22: 308-311.
  • Hünefeld C, Mezger M, Kern JS, Nyström A, Bruckner-Tuderman L, Müller I, Handgretinger R, Röcken M: One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders. Exp Dermatol, 2013; 3: 162-167. : http://doi: 10.1111/exd.12084
  • Huss-Marp J, Raulf M, Jakob T: Spiking with recombinant allergens to improve allergen extracts: benefits and limitations for the use in routine diagnostics. Allergol Int, 2015; 24: 236-243.
  • Jakob T, Blank S, Spillner E, Ollert M: Rekombinante Insektengiftallergene: Ist das Bienen- oder doch das Wespengift schuld? CME Beitrag. Der Deutsche Dermatologe, 2011; 59: 759-761.
  • Jakob T, Forstenlechner P, Matricardi P, Kleine-TebbeJ: Molecular allergy diagnostics using IgE multiplex assays: methodological and practical considerations for use in research and clinical routine. Allergol Int, 2015 (online). : http://DOI 10.1007/s40629-015-0056-2
  • Jakob T, König T, Kunz S, Pfender N, Martin SF: Langerhanszellbiologie im Wandel. Allergologie, 2009; 32: 462-468.
  • Jakob T, Müller S, Rafei-Shamsabadi D, Bantleon F, Spillner E: Aktueller Stand und neue Entwicklungen in der Diagnostik mit rekombinanten Insektengiftallergenen. Allergologie, 2014; 37: 362-367.
  • Jakob T, Ollert M: Rekombinante Insektengiftallergene – Nutzen in der Abgrenzung von Kreuzsensibilisierungen und echten Doppelsensibilisierungen. Allergo J, 2011; 20: 22-23.
  • Jakob T, Rafei-Shamsabadi D, Spillner E, Müller S: Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics. Allergo Journal, 2017; 26 (3): 93-105.
  • Kamin A, Eigentler TK, Radny P, Bauer J, Weide B, Garbe C: Imiquimod in the treatment of extensive recurrent lentigo maligna J Am Acad Dermatol, 2005; 52 Suppl. 2: 51-52.
  • Kern J, Has C: Update on diagnosis and therapy of inherited epidermolysis bullosa. Expert Review of Dermatology, 2008; 3 (6): 721-733.
  • Kern JS, Bruckner-Tuderman L: Blasenbildende Genodermatosen: vom Gen zur molekularen Therapie. Spectrum Dermatologie, 2009; 2: 7-13.
  • Kimber I, Maxwell G, Gilmour N, Dearman RJ, Friedmann PS, Martin SF: Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency. Toxicology, 2012; 291: 18-24. : http://10.1016/j.tox.2011.11.007
  • Kimber I, Travis MA, Martin SF, Dearman RJ: Immunoregulation of skin sensitization and regulatory T cells. Contact Dermatitis. Contact Dermatitis, 2012; 67: 179-183. : http://10.1111/j.1600-0536.2012.02148.x.
  • Kiritsi D, Has C, Bruckner-Tuderman L: Laminin 332 in junctional epidermolysis bullosa. Cell Adhes Migr, 2012; 17 (7): 135-141.
  • Kiritsi D, Has C, Bruckner-Tuderman L: Laminin 332 in junctional epidermolysis bullosa. Cell Adhes Migr, 2013; 7: 135-141.
  • Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Kunkel G, Lepp U, Niggemann B, Rakoski J, Renz H, Saloga J, Simon JC: Die spezifische Immuntherapie (Hyposensibilisierung, “Allergie Impfung”) bei IgE vermittelten allergischen Atemwegserkrankungen Deutsches Ärzteblatt, 2003; 100 (24): A334-A339.
  • Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Kunkel G, Lepp U, Niggemann B, Rakoski J, Renz H, Saloga J, Simon JC: Spezifische Immuntherapie bei IgE-vermittelten allergischen Atemwegserkrankungen– Schlußwort Deutsches Ärzteblatt, 2003; 100 (24): A1688-A1690.
  • Kleine-Tebbe J, Jakob T: Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine. Allergol Int, 2015; 24: 185-197.
  • Kleine-Tebbe J, Ollert M, Jakob T: Molekulare Allergologie: Nomenklatur, Proteinfamilien, Datenbanken und potentieller Nutzen. Allergo J, 2010; 19: 390-395.
  • Klionsky DJ, Dengjel J: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy, 2016; 12 (1): 1-222.
  • Kohlhase M, Wölfle U, Schempp CM: Bitterstoffe als belebende Wirkstoffe für die Haut. Schweiz Z Ganzheitsmed, 2017; 29: 197-199.
  • Koppes SA, Engebretsen KA, Clausen ML, Jakasa I, Khnykin D, Brans R, Tončic RJ, Molin S, Puppels G, Riethmüller C, Berents T, Holm JO, Suomela S, Hummler E, Brandner J, Angelova-Fischer I, Agner T, Thierse HJ, John SM, Kezic S, Martin SF, Thyssen JP: Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis. Contact Dermatitis, 2017; 77: 1-16.
  • Lange M., Augustin M.: Basaliom. Wie man es erkennt und therapiert. Ars Medici 3, 2002; 3: 118-120.
  • la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G: Alerting and tuning the immune response by extracellular nucleotides. J Leukocyte Biol, 2003; 73 (3): 339-343.
  • Leuner K, Kraus M, Boehnke WH, Schempp C, Müller WE: Hyperforin-haltige Dermatika bei Atopischer Dermatitis – Neue Erkenntnisse zum Wirkmechanismus. Deutsche Apothekerzeitung, 2010; 150: 2155-2159.
  • Liß Y, Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen: Akute generalisierte exanthematische Pustulose und “drug reactions with eosinophilia and systemic symptoms". Allergo J, 2011; 20: 393-405.
  • Löffek S, Franzke CW, Helfrich I: Tension in Cancer. Int J Mol Sci, 2016; 17 (online): e1910.
  • Löffek S, Schilling O, Franzke CW: Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J, 2011; 38 (1): 191-208.
  • Loquai C, Grabbe S, Luger TA, Nashan D: Differenzialdiagnose pigmentierter Hauttumoren Chirurgische Praxis, 2006; 65: 475-494.
  • Loquai C, Grabbe S, Luger TA, Nashan D: Differenzialdiagnose pigmentierter Hauttumoren internist prax, 2006; 46: 535-554.
  • Martin S, Merfort I, Thierse HJ: Interactions of chemicals and metal ions with proteins and role for immune responses Mini Rev Med Chem, 2006; 6: 247-255.
  • Martin S, Weiss JM, Simon JC: Advances in allergy research - basic and clinical science make progress. Trends Immunol, 2002; 23 (7): 329-330.
  • Martin S, Weiss JM, Simon JC: Fortschritte in der Allergie und Lungenforschung: Bericht vom Internationalen Symposium ";Advances in Allergy Research", Freiburg 7.- 9. März 2002 Allergologie, 2002; 25: 356-360.
  • Martin S.F., Dudda J.C.: Instruktion von Effektor T-Zellen zur Einwanderung in entzündete Haut. Allergologie, 2005; 28: 105-112.
  • Martin SF: T-lymphocyte mediated immune responses to chemical haptens and metal ions - implications for allergic and autoimmune disease. Int Arch Allergy Imm, 2004; 134: 186-198.
  • Martin SF: Einfluss des angeborenen Immunsystems auf die Kontaktsensibilisierung. Med Report, 2009; 27: 13.
  • Martin SF: Einfluss des angeborenen Immunsystems auf die Kontaktsensibilisierung. Derma-MedReport, 2010; 34: 9-10.
  • Martin SF: Rolle des angeborenen Immunsystems bei der Kontaktallergie. Allergologie, 2010; 33: 66-70.
  • Martin SF: Immunologie der Kontaktallergie. Hautarzt, 2011; 62: 739-743.
  • Martin SF: Allergic contact dermatitis: it smells like an infection. Allergo J, 2011; 20: 81-86.
  • Martin SF: Rolle des angeborenen Immunsystems bei der Kontaktallergie. Dermatologie in Beruf und Umwelt, 2011; 59: 21-25.
  • Martin SF: Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol, 2012; 21 (online): 382-389. : http://10.1111/j.1600-0625.2012.01471.x
  • Martin SF: Kontaktdermatitis – von den Pathomechanismen zur Immuntoxikologie. MedReport, 2012; 36 (6): 2.
  • Martin SF: Allergic contact dermatitis: xenoinflammation of the skin. Curr Opin Immunol, 2012; 24: 720-729. : http://10.1016/j.coi.2012.08.003
  • Martin SF: Adaptation in the innate immune system and heterologous innate immunity. Cell Mol Life Sci, 2014; 71: 4115-4130. : http://DOI: 10.1007/s00018-014-1676-2
  • Martin SF: Kontaktallergie und Inflammasom. derm Praktische Dermatologie, 2014; 20: 282-287.
  • Martin SF: Immunological mechanisms in allergic contact dermatitis. Curr Opin Allergy Cl, 2015; 15: 124-130. : http://10.1097/ACI.0000000000000142
  • Martin SF: New concepts in cutaneous allergy. Contact Dermatitis, 2015; 72: 2-10. : http://10.1111/cod.12311
  • Martin SF: Mechanistic understanding of contact allergy. Special Issue “Cosmetic contact allergens”. Cosmetics, 2016; 3: 8. : http://doi:10.3390/cosmetics3010008
  • Martin SF: Mechanismen der Hautentzündung bei der Kontaktallergie. Aktuelle Dermatologie, 2016; 42: 344-348. : http://dx.doi.org/10.1055/s-0042-103772
  • Martin SF: Novel concepts of immune responses to chemicals in allergic contact dermatitis. Allergol Int, 2016; 25: 17-21.
  • Martin SF, Cavani A, Maggi E, Thierse HJ, Richter A, Sallusto F: T-cell priming and amplification: Exploiting key events in contact sensitization. ALTEX Congress Proceedings: VII World Congress on Alternatives & Animal Use in the Life Sciences. Altex-altern Tierexp, 2010; 27: 309-311.
  • Martin SF, Edele F: Die Rolle der Gewebe-Mikroumgebung bei der Kontaktallergie. Allergologie, 2008; 31: 56-60.
  • Martin SF, Esser P: Innate immune mechanisms in contact dermatitis and the resulting T cell responses. ALTEX Congress Proceedings: VII World Congress on Alternatives & Animal Use in the Life Sciences. Altex-altern Tierexp, 2010; 27: 293-295.
  • Martin SF, Esser PR: Kontaktallergenvermeidung: von der Grundlagenforschung zur in vitro Identifikation von Kontaktallergenen. Allergologie, 2011; 34: 529-537.
  • Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, Peiser M, Luch A, Wanner R, Maggi E, Cavani A, Rustemeyer T, Richter A, Thierse HJ, Sallusto F: T cell recognition of chemicals, protein allergens and drugs: towards the development of /in vitro/ assays. Cell Mol Life Sci, 2010; 67: 4171-4184.
  • Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M, Goebeler M: Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy, 2011; 66: 1152-1163.
  • Martin SF, Jakob T: From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Cl, 2008; 8: 289-293.
  • Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, Aalberse RC, Agache I, Asero R, Ballmer-Weber B, Barber D, Beyer K, Biedermann T, Bilò MB, Blank S, Bohle B, Bosshard PP, Breiteneder H, Brough HA, Caraballo L, Caubet JC, Crameri R, Davies JM, Douladiris N, Ebisawa M, Eigenmann PA, Fernandez-Rivas M, Ferreira F, Gadermaier G, Glatz M, Hamilton RG, Hawranek T, Hellings P, Hoffmann-Sommergruber K, Jakob T, Jappe U, Jutel M, Kamath SD, Knol EF, Korosec P, Kuehn A, Lack G, Lopata AL, Mäkelä M, Morisset M, Niederberger V, Nowak-Węgrzyn AH, Papadopoulos NG, Pastorello EA, Pauli G, Platts-Mills T, Posa D, Poulsen LK, Raulf M, Sastre J, Scala E, Schmid JM, Schmid-Grendelmeier P, van Hage M, van Ree R, Vieths S, Weber R, Wickman M, Muraro A, Ollert M: EAACI Molecular Allergology User's Guide. Pediat Allerg Imm-uk, 2016; 27 Suppl. 23: 1-250. : http://doi: 10.1111/pai.12563
  • Mockenhaupt M: Schwere Arzneimittelreaktionen der Haut. Hautarzt, 2005; 56: 24-31.
  • Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen: Klinik, Diagnostik und Therapie. Facharztwissen CME. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7 (2): 142-163.
  • Mockenhaupt M: The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immu, 2011; 7 (6): 803-815.
  • Mockenhaupt M: Epidemiologie von kutanen Arzneimittelreaktionen. Allergologie, 2012; 35 (3): 131-144.
  • Mockenhaupt M: Häufige Auslöser schwerer Arzneimittelreaktionen. HAUT, 2012; 02: 50-56.
  • Mockenhaupt M: Allopurinol is the most frequent cause of Stevens-Johnson syndrome and toxic epidermal necrolysis, but who cares? Expert Rev Dermatol, 2012; 7 (3): 213-215.
  • Mockenhaupt M: Schwere arzneimittel-induzierte Hautreaktionen: Stevens-Johnson-Syndrom und toxisch epidermale Nekrolyse. Hautarzt, 2014; 65 (5): 415-423. : http://10.1007/s00105-013-2694-y
  • Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg, 2014; 33 (1): 10-16.
  • Mockenhaupt M, Liß Y: Schwere bullöse arzneimittelinduzierte Hautreaktionen. Aktuelle Dermatologie, 2010; 36: 1-12.
  • Mockenhaupt M, Liß Y: Schwere arzneimittelinduzierte Hautreaktionen: Stevens-Johnson-Syndrom und Toxisch epidermale Nekrolyse. Allergo J, 2011; 4: 200-210.
  • Mrowietz U, Adamczyk A, Altmeyer P, Augustin M, Boehncke WH, Bonnekoh B, Frambach Y, Gambichler T, Ghoreschi K, Hertl M, Hund AC, Jacobi A, Kuhn A, Lippert U, Ludwig R, Luger T, Martin SF, Merk H, Norgauer J, Reich K, Rostami-Yazdi M, Sabat R, Schäkel K, Scharffetter-Kochanek K, Schön MP, Scola N, Sticherling M, Thaci D, Viehweg A, Wilsmann-Theis D, Zouboulis CC, Neureither M: Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten-Workshops. J Dtsch Dermatol Ges, 2012; 10 Suppl. s8: 1-15. : http://10.1111/j.1610-0379.2012.08047.x
  • Mühle C,, Jiang Q-J,, Charlesworth A,, Bruckner-Tuderman L,, Meneguzzi G,, Schneider H: Novel and recurrent mutations in the laminin-5 gene causing lethal junctional epidermolysis bullosa: Molecular basis and clinical course of Herlitz disease Hum Genet, 2005; 116: 33-42.
  • Müller ML, Forschner A, Wenke A, Luger TA, Rompel R, Roeder N, Hensen P: G-DRG Version 2008: Facts and analyses. Journal der Deutschen Dermatologischen Gesellschaft, 2008; 6 (6): 483-491.
  • Müller ML, Forschner A, Wenke A, Luger TA, Rompel R, Roeder N, Hensen P: G-DRG Version 2009: new developments. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7 (4): 318-327.
  • Müller S, Rafei-Shamsabadi D, Jakob T: Problemfälle der In-vitro-Diagnostik bei Hymenopterengiftallergie. Hautarzt, 2014; 65: 780-790.
  • Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairly JA, Fiveson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zilikens D, Doan S, Daniel BS, Werth VP: Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J Am Acad Dermatol, 2015; 72 (1): 168-174.
  • Mustafa MB, Porter SR, Smoller BR, Sitaru C: Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev, 2015; 14 (10): 930-951. : http://Doi: 10.1016/j.autrev.2015.06.005
  • Nashan D, Braun-Falco M, Reichenberger S, Szeimies RM, Bruckner-Tuderman L: Cutaneous metastases of visceral tumours – a review. J Cancer Res Clin, 2008; 135: 1-14.
  • Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R: Mycosis fungoides: a dermatological masquerader Brit J Dermatol, 2007; 156: 1-10.
  • Nashan D, Müller M, Grabbe S, Wustlich S, Enk A: Systemic therapy of disseminated malignant melanoma – an evidence based overview of the state-of –the-art in daily routine J Eur Acad Dermatol, 2007; 21: 1305-1318.
  • Nashan D, Müller ML, Braun-Falco M, Reichenberger S, Szeimies RM, Bruckner-Tuderman L: Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin, 2010; 135 (1): 1-14.
  • Nashan D, Radny P, Kösters NC, Nashan B: Skin tumors in organ-transplant recipients Hautarzt, 2007; 58: 48-50.
  • Norgauer J, Idzko M, Panther E, Hellstern O, Herouy Y: Xeroderma pigmentosum. Eur J Dermatol, 2003; 13 (1): 4-9.
  • Nyström A, Bruckner-Tuderman L: Gene Therapy for Epidermolysis Bullosa: Sticky Business. Mol Ther, 2016; 24: 2035-2036.
  • Nyström A, Bruckner-Tuderman L, Kern JS: Cell- and protein-based therapy approaches for epidermolysis bullosa. Methods Mol Biol, 2013; 961: 425-440. : http://doi: 10.1007/978-1-62703-227-8_29
  • Ogese M, Shaheda A, Alfirevic A, Betts C, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield G, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell A, Spraggs C, Whritenour J, Naisbitt DJ: New approaches to investigate drug-induced hypersensitivity. Chem Res Toxicol, 2017; 30: 239-259. : http://doi: 10.1021/acs.chemrestox.6b00333
  • Otten JV, Hashimoto T, Hertl M, Payne AS, Sitaru C: Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med, 2014; 14 (1): 69-95.
  • Panther E., Idzko M., Corinti S., Ferrari D., Herouy Y., Mockenhautp M., Dichmann S., Gebicke-Haerter P., diVirgilio F., Girolomoni G., Norgauer J.: The influence of lysophosphatidic acid on the functions of human dentritic cells. J Immunol, 2002; 169: 4129-4135.
  • Peiser MT, Tralau J, Heidler AM, Api JHE, Arts DA, Basketter J, English TL, Diepgen RC, Fuhlbrigge AA, Gaspari JD, Johansen AT, Karlberg I, Kimber JP, Lepoittevin M, Liebsch HI, Maibach, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel R, White IR, Luch A: Allergic Contact Dermatitis: Epidemiology, Molecular Mechanisms, In vitro Methods & Regulatory Aspects. Cell Mol Life Sci, 2012; 69 (online): 763-781.
  • Reimer A, Ott H: Komplizierte infantile Hämangiome in der kinderärztlichen Praxis. Kinderärztliche Praxis, 2016; 86 (3): 181-189.
  • Renkl AC, Wussler J, Eggers T, Ahrens T, Martin SF, Liaw L, Kon S, Uede T, Hirschfeld G, Simon JC, Weiss JM: Th1 Cytokine Like Properties of Osteopontin on T-cells, Macrophages and Dendritic Cells in Type 1 immune responses J Allergy Clin Immun, 2004; 1: 97-102.
  • Reuter J, Merfort I, Schempp C: Botanicals in Dermatology. An evidence based review. Am J Clin Dermatol, 2010; 11: 247-267.
  • Reuter J, Schempp C: Sonnenschutz bei Kindern Pina News, 2008; 17: 2.
  • Reuter J, Wölfle U, Korting HC, Schempp C: Welche Pflanze für welche Hauterkrankung? Teil 2: Dermatophyten, chronisch-venöse Insuffizienz, Photoprotektion, aktinische Keratosen, Vitiligo, Haarausfall, kosmetische Indikationen. J Dtsch Dermatol Ges, 2010; 8: 866-874.
  • Reuter J, Wölfle U, Weckesser S, Schempp C: Welche Pflanze für welche Hauterkrankung? Teil 1: Atopische Dermatitis, Psoriasis, Akne, Kondylome und Herpes simplex. J Dtsch Dermatol Ges, 2010; 8: 788-796.
  • Ring J, Plötz SG, Darsow U, Huss-Marp J, Braun-Falco M, Simon HU, Behrendt H: Anti-Interleukin-5 in the treatment of hypereosinophilic skin diseases (From Genes to Phenotypes) Immunol Allergy Clin, 2006; 17 Suppl. 2: 215-217.
  • Roujeau JC, Haddad C, Paulmann M, Mockenhaupt M: Management of Nonimmediate Hypersensitivity Reactions to Drugs in Clinical Review Articles. Immunol Allergy Clin, 2014; 34 (3): 473-487. : http://doi: 10.1016/j.iac.2014.04.012
  • Rovida C, Martin SF, Vivier M, Weltzien HU, Roggen E: Advanced tests for skin and respiratory sensitization assessment. ALTEX, 2013; 30: 231-252.
  • Rychlik R, Rusche H, Augustin M: Systematik der Nutzenbewertung von Arzneimitteln Gesundheit ökonomischer Qualitätsmanager, 2004; 9: 245-525.
  • Rylska M: Herpes Zoster - die Gürtelrose Diatra Journal, 2012; 2 (17): 2-12.
  • Schäkel K, Jakob T, Saloga J: Die immunregulatorische Bedeutung von dendritischen Zellen bei allergischen Erkrankungen. Allergo J, 2008; 17: 146-151.
  • Scheffler B, Schempp CM: Betulin aus Birkenkork – ein erstaunlicher Naturstoff für die Haut. Natur und Medizin, 2009; 2: 4-7.
  • Schempp C: Pflanzliche Externa nicht ohne Risiko Pharm Ztg, 2007; 152 (30): 1212-1214.
  • Schempp C, Wölfle U: Hyperforin – ein Multitalent für die Haut. HAUT, 2010; 10: 178-180.
  • Schempp CM: Ganzheitliche Dermatologie (Editorial). Schweiz Z Ganzheitsmed, 2011; 23: 132-133.
  • Schempp CM: Komplementärmedizin in der Dermatologie: nicht Alternative, sondern Ergänzung der akademischen Medizin. Schweiz Z Ganzheitsmed, 2017; 29: 192-193.
  • Schempp CM, Emde M, Wölfle U: Dermatologie im Darwinjahr 1: Die Evolution der Haut. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 7: 750-757.
  • Schempp CM, Muller KA, Winghofer B, Schopf E, Simon JC: Johanniskraut (Hypericum perforatum L.) - eine Pflanze mit Relevanz für die Dermatologie Hautarzt, 2002; 53 (5): 316-321.
  • Schempp CM, Schopf E, Simon JC: Durch Pflanzen ausgelöste toxische und allergische Dermatitis (Phytodermatitis) Hautarzt, 2002; 53 (2): 93-97.
  • Schempp CM, Windeck T, Hezel S, Simon JC: Topical treatment of atopic dermatitis with St. John's wort cream-a randomized, placebo controlled, double blind half-side comparison. (Zweitveröffentlichung, Übersetzung Übersetzung der Originalarbeit: Schempp CM, Hezel S und Simon JC: Behandlung der subakuten Atopischen Dermatitis mit Johanniskraut-Creme. Eine randomisierte, plazebokontrollierte Doppelblindstudie im Halbseitendesign. Hautarzt 54:248-253 (2003)) Phytomedicine, 2003; 10 Suppl. 4: 31-37.
  • Schempp CM, Wölfle U: Johanniskraut – eine wichtige Heilpflanze für die Dermatologie. Aromareport, 2011; 5: 10-13.
  • Schempp CM, Wölfle U: Bitterstoffe als neue Wirkstoffe für Neurodermitis. Umwelt Haut Allergie, 2017; 75: 22.
  • Schempp CM, Wölfle U, Meyer U, Schaette R: Johanniskraut (Hypericum perforatum L.) – Heilpflanze der Sommersonnwende. Merkurstab, 2011; 64 (6): 596-606.
  • Schempp CM, Wölfle U, Rispens JA, Schaette R: Koriander (Coriandrum sativum L.) – ein heilkräftiger und antimikrobiell wirksamer mediterraner Doldenblütler. Merkurstab, 2011; 64 (4): 339-345.
  • Schempp CM., Schöpf E., Simon JC.: Durch Pflanzen ausgelöste toxische und allergische Dermatitis (Phytodermatitis). Hautarzt, 2002. (in Druck)
  • Schmidt T, Sitaru C, Amber K, Hertl M: BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid? Brit J Dermatol, 2014; 171 (2): 212-219. : http://doi: 10.1111/bjd.12936
  • Schumann H: Epidermolysis bullosa. An Update. Hautarzt, 2009; 60 (8): 614-621.
  • Schwieger-Briel A, Has C: Blasenbildende Erkrankungen bei Kindern. Pädiatrische Praxis, 2016; 86: 135-142.
  • Seelinger G, Merfort I, Schempp C: Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med, 2008; 74: 1667-1677.
  • Seelinger G, Merfort I, Wölfle U, Schempp C: Anti-carcinogenic effects of luteolin and other flavonoids. Molecules, 2008; 13: 2628-2651.
  • Sesarman A, Vidarsson G, Sitaru C: The neonatal Fc receptor (FcRn) as therapeutic target in IgG mediated autoimmune diseases. Cell Mol Life Sci, 2010; 67: 2533-2550.
  • Sitaru C: Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease. J Invest Dermatol, 2009; 129: 822-824.
  • Sitaru C, Bauer J: Modern laboratory diagnostic workup in dermatology. Hautarzt, 2016; 67 (1): 4-5. : http://doi: 10.1007/s00105-015-3729-3
  • Soica C, Coricovac D, Dehelean C, Pinzaru I, Mioc M, Danciu C, Fulias A, Puiu M, Sitaru C: Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies. Recent Pat Nanotech, 2016; 10 (2): 128-145.
  • Spillner E, Blank S, Jakob T: Potenzial, Fallstricke und aktueller Status der molekularen Diagnostik am Beispiel der Insektengiftallergie. Allergo J, 2012; 21: 249-256.
  • Spillner E, Blank S, Jakob T: Hymenoptera allergens: From venom to venome. Frontiers in Immunology, 2014; 5 (online): 77.
  • Sprenger A, Küttner V, Bruckner-Tuderman L, Dengjel J: Global proteome analyses of SILAC-labeled skin cells. Methods Mol Biol, 2013; 961: 179-191.
  • Struck MF, Hilbert P, Mockenhaupt M, Reichelt B, Steen M: Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intens Care Med, 2010; 36 (1): 22-32.
  • Tantcheva-Poór I, Oji V, Has C: A multistep approach to the diagnosis of rare genodermatoses. J Dtsch Dermatol Ges, 2016; 14 (10): 969-986. : http://doi: 10.1111/ddg.13140.
  • Termeer C, Sleeman JP, Simon JC: Hyaluronan-magic glue for the regulation of the immune response? Trends Immunol, 2003; 24 (3): 112-114.
  • Torchia D, Happle R: Segmental hypomelanosis and hypermelanosis arranged in a checkerboard pattern are distinct naevi: flag-like hypomelanotic naevus and flag-like hypermelanotic naevus. J Eur Acad Dermatol, 2015; 29: 2088-2099.
  • Traidl-Hoffmann C, Jakob T, Behrendt H: Determinants of allergenicity. J Allergy Clin Immun, 2009; 123: 558-566.
  • Traidl-Hoffmann C, Kasche A, Mariani V, Jakob T, Müller M, Ring J, Behrendt H: Pollenassoziierte Lipidmediatoren (PALMs): Fettsäuremetabolite aus Pollen mit ungeahnter Wirkung auf das menschliche Immunsystem Med Welt, 2006; 57: 228-23.
  • Uitto J, Bruckner-Tuderman L, Christiano AM, McGrath JA, Has C, South AP, Kopelan B, Robinson EC: Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015. J Invest Dermatol, 2016; 136 (2): 352-358. : http://doi: 10.1016/j.jid.2015.10.050.
  • Uitto J, Has C, Bruckner-Tuderman L: Cell-based therapies for epidermolysis bullosa - from bench to bedside. J Dtsch Dermatol Ges, 2012; 10 (11): 803-807.
  • Uitto J, Has C, Vahidnezhad H, Youssefian L, Bruckner-Tuderman L: Molecular pathology of the basement membrane zone in heritable blistering diseases:The paradigm of epidermolysis bullosa. Matrix Biol, 2016 (online). : http://doi: 10.1016/j.matbio.2016.07.009
  • Uitto J, McGrath JA, Rodek U, Bruckner-Tuderman L, Robinson C: Progress in epidermolysis bullosa research: EB 2009 – towards treatment and cure. J Invest Dermatol, 2010; 130: 1778-1784.
  • van Agtmael T, Bruckner-Tuderman L: Basement membranes and human disease. Cell Tissue Res, 2010; 339: 167-188.
  • van de Poel S, Kunz S, Jakob T: Innate lymphoide Zellen: neue Mitspieler im immunologischen Orchester. Allergo J, 2013; 22: 462-463.
  • Vocanson M, Mutez V, Esser PR, Bachtanian E, Cluzel M, Nosbaum A, Martin SF, Nicolas JF: Contact hypersensitivity: T-cell based assay. Curr Opin Toxicol, 2017; 5: 39-45. : http://doi: 10.1016/j.cotox.2017.07.005.
  • Volz A, Has C, Schumann H, Bruckner-Tuderman L: Network epidermolysis bullosa: molecular pathomechanisms and novel therapeutic approaches Journal der Deutschen Dermatologischen Gesellschaft, 2007; 5: 274-279.
  • Volz A, Bruckner-Tuderman L: Hereditäre und autoimmune Dermatosen mit Blasenbildung. pädiatrie-hautnah, 2005; 2: 66-71.
  • Weber FC, Martin SF: 1x1 der Allergologie: Neutrophile Granulozyten. Allergo J, 2013; 22: 100-101.
  • Weiss JM, Renkl A, Simon JC: Zellmigrations- und adhäsionsprozesse bei Immunreaktionen vom Spättyp Allergo Journal, 2003; 12: 133-136.
  • Weller K, Vetter C, Kähler K, Hauschild A, Eigentler T, Garbe C, Pföhler C, Tilgen W, Neuber K, Moll I, Krause M, Kneisel L, Nashan D, Thoelke A, Lommel K, Galli K, Letsch B, Bahmer FA, Näher H, Becker JC: Diagnostik und Therapie des Merkelzellkarzinoms – Leitlinien und Realität Deutsche Ärzteblatt, 2007; 103 (42A): 2791.
  • Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P: Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol, 2009; 20: 931-941.
  • Wölfle U: Ximenia americana - Porträt einer Heilpflanze. Zeitschrift für Phytotherapie, 2008; 29: 150-153.
  • Wölfle U, Haarhaus B, Schempp CM: Bitterstoffe als regenerationsfördernde Wirkstoffe für die Haut. Haut, 2017; 3: 146-148.
  • Wölfle U, Kohlhase M, Schempp CM: Die Haut mag’s bitter. DHZ - Deutsche Heilpraktiker Zeitschrift, 2017; 3: 22-25.
  • Wölfle U, Martin S, Emde M, Schempp C: Dermatology in the Darwin anniversary. Part 2: Evolution of the skin-associated immune system. Journal der Deutschen Dermatologischen Gesellschaft, 2009; 10: 862-869.
  • Wölfle U, Schempp CM: Flavonoide als vielseitige Wirkstoffe für die Haut – Fokus Luteolin. Schweiz Z Ganzheitsmed, 2017; 29: 195-196.
  • Wölfle U, Seelinger G, Bauer G, Meinke M, Lademann J, Schempp CM: Reactive molecule species and antioxidants in the skin. Skin Pharmacol Phys, 2014; 27: 316-332.
  • Wölfle U, Seelinger G, Schempp CM: Topical application of St. John’s Wort (Hypericum perforatum L.). Planta Med, 2014; 80: 109-120.
  • Zeiser R, Schnitzler M, Andrlova H, Hellige T, Meiss F: Immunotherapy for malignant melanoma. Curr Stem Cell Res Ther, 2012; 7 (3): 217-228.
Buchbeiträge:
  • Augustin M: Infektion und Abwehr In: Mensch, Körper, Krankheit. Medizinisches Lehrbuch. München: Urban & Fischer, 2003; 79-100.
  • Augustin M: Pharmacoeconomics in atopic dermatitis In: Ruzicka T, Reitamo S (Hrsg.): Tacrolimus ointment - a topical immunomodulator for atopic dermatitis Springer Verlag, Heidelberg, Berlin, New York 2004, 2004.
  • Augustin M, Hoch Y: Phytotherapie in der Dermatologie In: Phytotherapie in der Dermatologie Urban & Fischer, München 2004, 2004.
  • Augustin M, Maier K, Sommer B: Patientenklientel und Patientenzufriedenheit. In: Sattler G, Sommer B, Hanke C.W (Hrsg.): Lehrbuch der Liposuktion. Stuttgart, New York: Thieme Verlag, 2003.
  • August M., Peschen M., Petres J.: Innovation und Qualität in der operativen Dermatologie. In: Fortschritte der operativen und onkologischen Dermatologie. Congress Compact Verlag Band 17, 2002.
  • Becker AC, Dengjel J: Autophagosomal proteome analysis by protein correlation profiling-SILAC. In: Humana Press (Hrsg.): Methods Mol Biol New York: Springer Verlag, 2014; 271-279.
  • Biedermann T, Worm M, Jakob T, Friedl TK, Rueff F: Nahrungsmittelallergie. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 2012 Berlin, Heidelberg, New York: Springer Verlag, 2013; 460-472.
  • Braun-Falco M: Kapitel C6.3: Neurokutane Erkrankungen In: Hengge U, Ruzicka T (Hrsg.) Roter Faden Dermatologie und Venerologie Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 2006; 424-430.
  • Braun-Falco M: Bullous ichthyotic erythroderma Brocq In: Land F (Ed.): Encyclopedic Reference on Molecular Mechanisms of Disease Berlin, Heidelberg, New York: Springer, 2006.
  • Braun-Falco M: Pachyonychia congenita In: Land F (Ed.): Encyclopedic Reference on Molecular Mechanisms of Disease Berlin, Heidelberg, New York: Springer, 2006.
  • Braun-Falco M: Palmoplantar keratoderma Unna-Vörner-Thost In: Land F (Ed.): Encyclopedic Reference on Molecular Mechanisms of Disease Berlin, Heidelberg, New York: Springer, 2006.
  • Bruckner-Tuderman L: Biology of the extracellular matrix. In: Bologna JL, Jorizzo JL, Rapini RP, eds. (Hrsg.): Dermatology, Vol 2 London: Mosby, 2003; 1483-1495.
  • Bruckner-Tuderman L: Basement membranes. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LS, Katz SI, eds. (Hrsg.): Fitzpatricks's Dermatology in General Medicine. 6th Ed., Vol I, I. Auflage. New York: McGraw-Hill, 2003; 1483-1495.
  • Bruckner-Tuderman L: Blasenbildende Erkrankungen In: Braun-Falco O, Plewig G, Wolff HH, Burgdorf W, Landtaler M (Hrsg.): Dermatologie und Venerologie, 5. Auflage. Auflage. Springer Verlag, 2005; 593-606.
  • Bruckner-Tuderman L: Biology of the extracellular matrix. In: Bolognia JL, Jorizzo JL, Schaffer JV (Hrsg.): Dermatology 3rd Ed., 2. Auflage. London: Elsevier-Saunders, 2012; 1585-1598.
  • Bruckner-Tuderman L, Payne AS: Epidermal and Dermal Adhesion. In: Goldsmith L, Katz SI, Gilchrest B, Paller AS, Leffell D, Wolff K (Hrsg.): Fitzpatrick´s Dermatology in General Medicine, 8th Ed. New York: McGraw-Hill Medical, 2012; 569-585.
  • Bruckner-Tuderman L, Stanley JR: Epidermal and Epidermal/Dermal Cohesion In: Fitzpatrick's Dermatology in General Medicine, 7. Auflage. New York: McGraw-Hill Medical, 2007.
  • Chronopoulos A, Mockenhaupt M, Pleyer U: Okuläre Beteiligung bei Stevens-Johnson-Syndrom und bei Toxisch epidermaler Nekrolyse. In: Pleyer U (Hrsg.): Entzündliche Augener-krankungen, chapt. 4, section 4.5 Heidelberg: Springer Verlag, 2013.
  • Esser P, Martin SF: Innate immune mechanisms in contact dermatitis and the resulting T cell response. In: Erwin L. Roggen (Hrsg.): Progress towards novel testing strategies for in vitro assessment of allergens. Research Signpost, 2011; 131-144.
  • Esser PR, Kimber I, Martin SF: T cell priming assay. Correlation of contact sensitizer potency with T cell frequency and TCR repertoire diversity. In: Martin SF (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology. Heidelberg: Springer Verlag, Chapter 8, 2013; 101-114 (104).: http://10.1007/978-3-0348-0726-5_8
  • Esser PR, Kimber I, Martin SF: Human T cell priming assay. Correlation of contact sensitizer potency with T cell frequency and TCR repertoire diversity. In: S.F. Martin (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology. Chapter 8. Experientia Supplementum. Heidelberg: Springer, 2014; 101-114 (104).: http://doi: 10.1007/978-3-0348-0726-5_8
  • Faulhaber D, Nashan D: Differentialdiagnosen kutaner Lymphome In: In Klinik, Diagnostik und Therapie primär kutaner maligner Lymphome unimed-Verlag, 2006.
  • Faulhaber D, Nashan D: Klinische Differenzialdiagnosen kutaner Lymphome In: Stadler & Kremer (Hrsg.): Kutane maligne Lymphome- Klinik, Diagnostik und Therapiestrategien unimed-Verlag, 2007.
  • Franzke CW: Das ADAM17/EGFR-System als wichtiger Regulator der epidermalen Hautbarriere und Immunhomöostase. In: C. Cornwell (Hrsg.): Spitzenforschung in der Ästhetischen Dermatologie und Dermatochirurgie Lampertheim: ALPHA Informations GmbH, 2015.
  • Gaspari AA, Katz SI, Martin SF *: Contact Hypersensitivity (Update). 4.2.1. In: Current Protocols in Immunology. 4.2.1. - 4.2.7. Weinheim: Wiley, 2016.: http://doi: 10.1002/0471142735.im0402s113
  • Gibbs S, Martin SF, Corsini E, Thierse HJ: Identification of contact allergens by in vitro cell culture based methods. In: Rustemeyer T, Elsner P, John SM, Maibach HI (Hrsg.): Kanerva’s Occupational Dermatology, 2. Auflage. Heidelberg: Springer Verlag, 2012; 1155-1168.
  • Happle R: Mosaizismus und epidermale Nävi. In: Plewig G, Landthaler M, Burgdorf WHC, Hertl M, Ruzicka T (Hrsg.): Braun-Falco’s Dermatologie, Venerologie und Allergologie. , 6. Auflage. Berlin: Springer Verlag, 2012; 942-962.
  • Happle R: Seltsame Paarungen: Zwillingsflecken und ihre Syndrome. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie, Bd. 23 Berlin: Springer Medizin, 2013; 30-38.
  • Happle R: Mosaicism in Human Skin: Understanding Nevi, Nevoid Skin Disorders, and Cutaneous Neoplasia In: Monographie Berlin: Springer-Verlag, 2014.
  • Happle R: Type 2 segmental manifestation of neurocutaneous syndromes. In: Hagel C, Bejamin R (Hrsg.): Panteliadis CP. Neurocutaneous Disorders: A Clinical, Diagnostic and Therapeutic Approach, 2nd ed. München: Elsevier GmbH, 2016; 37-42.
  • Has C: Genodermatosen. In: 1000 Fragen Dermatologie Heidelberg: Springer, 2014.
  • Has C: Kindler syndrome. In: D. Murrell (Hrsg.): Blistering Diseases Berlin, Heidelberg: Springer Verlag, 2015.
  • Has C, Bruckner-Tuderman L: Epidermolysis bullosa In: Traupe H, Hamm H (Hrsg.): Pädiatrische Dermatologie Heidelberg: Springer Verlag, 2006; 27-40.
  • Has C, Bruckner-Tuderman L: Inherited bullous diseases. In: Krieg et al (Hrsg.): Therapy of Skin Diseases Berlin, Heidelberg: Springer Verlag, 2010; 549-559.
  • Has C, Bruckner-Tuderman L: Junctional EB with Integrin alpha3 mutations. In: D. Murrell (Hrsg.): Blistering Diseases Berlin, Heidelberg: Springer Verlag, 2015.
  • Has C, Bruckner-Tuderman L: Collagen XVII in junctional EB, Blistering Diseases. In: D. Murrell (Hrsg.): Blistering Diseases Berlin, Heidelberg: Springer Verlag, 2015.
  • Has C, Kiritsi D, Jonkmann M: Acantholytic forms of epidermolysis bullosa. In: D. Murrell (Hrsg.): Blistering Diseases Clinical Features, Pathogenesis, Treatment. Berlin, Heidelberg: Springer Verlag, 2015.
  • Has C, Nyström A: Epidermal Basement Membrane in Health and Disease. In: Jeffrey Miner, Curr Top Membr. (Hrsg.): Basement Membranes Philadelphia: Elevier, 2015; 117-170.
  • Has C, Sitaru C: Molecular dermatology comes of age. In: Has C, Sitaru C (Hrsg.): Molecular Dermatology New York, Heidelberg, Dodrecht, London: Humana Press, 2013; 1-16.
  • Has C, Bruckner-Tuderman L: Epidermolysis bullosa in Pädiatrische Dermatologie In: Springer 2005 (Hrsg.): Epidermolysis bullosa in Pädiatrische Dermatologie Hrsg. Traupe H, Hamm H, 2005.
  • Hensen P, Müller M: Kodierleitfaden Dermatologie 2007 In: Deutsche Dermatologische Gesellschaft und DRG Research Group Münster (Hrsg.): Kodierleitfaden Dermatologie 2007 Münster: Schüling Verlag, 2007.
  • Hensen P, Müller ML: Kodierleitfaden Dermatologie 2008 In: Kodierleitfaden Dermatologie 2008 Münster: Schüling-Verlag, 2008.
  • Hilger C, Kuehn A, Raulf M, Jakob T: Allergien auf Schaben, Zecken, Vorratsmilben und andere Gliederfüßer: molekulare Aspekte. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 315-328.
  • Hofmann S, Bruckner-Tuderman L: Bullous Pemphigoid, Mucous Membrane Pemphigoid, Pemphigoid gestationis, Epidermolysis bullosa acquisita, Epidermolysis bullosa, Pemphigus vulgaris, Pemphigus foliaceus, IgA Pemphigus, Dermatitis herpetiformis, Linear IgA Dermatosis In: F. Lang (Hrsg.): Encyclopedia of Molecular Mechanisms of Disease, 2. Auflage. Heidelberg: Springer Verlag, 2008.
  • Hofmann SC, Jakob T: Bullous autoimmune diseases. In: Y. Shoenfeld and P. L. Meroni (Hrsg.): The General Practice Guide to Autoimmune Diseases, European Autoimmunity Standardization Initiative EASI Lengerich, Berlin, Bremen, Miami, Riga, Viernheim, Wien, Zag: Pabst Science Publisher, 2012; 127-134.
  • Hofmann SC, Jakob T: Molekulare Diagnostik bei nahrungsmittelabhängiger anstrengungs­induzierter Anaphylaxie. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 245-256.
  • Hölzle E, Hönigsmann H, Scharffetter-Kochanek K, Schwarz T, Simon JC, Röcken M: Phototherapie In: Plewig G , Prinz J (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 2002 Berlin: Springer, 2003; 566-572.
  • Huss-Marp J, Raulf M, Jakob T: Verbesserung von Allergenextrakten durch Zusatz von rekombinanten Einzelallergenen: Nutzen und Limitierungen. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 139-148.
  • Jäger S, Strüh CM, Schempp CM, Scheffler A, Martin SF: Ein neuartiger Triterpenextrakt aus Mistel induziert Apoptose in B16.F10 Melanomzellen. In: R. Scheer et al. (Hrsg.): Die Mistel in der Tumortherapie 3 Essen: KVC Verlag, 2013; 119-123.
  • Jakob T: Nutzen und Grenzen der Molekularen Allergiediagnostik. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 2012 Berlin, Heidelberg, New York: Springer Verlag, 2013; 265-269.
  • Jakob T: Molekulare Allergiediagnostik bei Nahrungsmittelallergie. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 2012 Berlin, Heidelberg, New York: Springer Verlag, 2013; 466-469.
  • Jakob T: Molecular diagnosis of allergic diseases. In: Barker J, Burgdorf W (Hrsg.): The Challanges of Skin Disease in Europe. European Dermatology Forum White Book 4th Edition Berlin: ABW Wissenschaftsverlag, 2013; 95-96.
  • Jakob T, Alessandrini F, Gutermuth J, Köllisch G, Javaheri A, Aguilar A, Ollert M, Behrendt H: Phenotyping Allergy in the Laboratory Mouse In: Hrabe de Angelis M, Chambon P, Brown S (Hrsg.): Standards of Mouse Phenotyping Weinheim: WILEY-CH, 2006; 253-281.
  • Jakob T, Blank S, Spillner E: Optimierte Diagnostik der Insektengiftallergie durch rekombinate Allergene. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 257-276.
  • Jakob T, Forstenlechner P, Matricardi P, Kleine-Tebbe J: Molekulare Allergiediagnostik im Multiplex-Verfahren. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 149-174.
  • Jakob T, Hengge U: Immunsystem der Haut In: Hengge U, Ruzicka T (Hrsg.): Dermatologie und Venerologie Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 2006; 19-28.
  • Jakob T, Martin SF: Konzepte der Langerhansfunktion im Wandel In: Jung K, Fuchs Th (Hrsg.): Fortschritte der Allergologie und Immunologie München-Deisenhofen: Dustri-Verlag, 2009; 166-174.
  • Kern JS, Has C: Weitere mit Spaltbildung unterhalb Lamina densa In: von Stebut-Borschitz et al., Facharztprüfung Dermatologie - 1000 Fragen, MN 281020101 Stuttgart: Thieme, 2013.
  • Kern JS, Has C: Weitere bullöse Autoimmunerkrankungen mit Spaltung unterhalb der Lamina densa. In: 1000 Fragen Dermatologie Heidelberg: Springer, 2014.
  • Kleine-Tebbe J, Jakob T: Molekulare Allergiediagnostik mit IgE-Einzelbestimmungen (Singleplex): Methodische und praktische Aspekte. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 91-137.
  • Kleine-Tebbe J, Ollert M, Radauer C, Jakob T: Einführung in die molekulare Allergologie: Proteinfamilien, Datenbanken und potenzieller Nutzen. In: Kleine-Trebbe J, Jakob T (Hrsg.): Molekulare Allergiediagnostik Berlin, Heidelberg, New York: Springer Verlag, 2015; 1-13.
  • Koo JYM, Lee CS, Kestenbaum T, Ginsburg I, Baldwin H, Hogarty T, Kushon D, Fried R, Koblenzer P, Koblenzer C, Gould W, Shepherd M.E, Cotteril J.A, Augustin M, Panconesi E: International Consensus on Care of Psychodermatological Patients. In: Koo JYM, Lee CS (Eds) (Hrsg.): Psychocutaneous Medicine. New York: Dekker, 2003.
  • Maier K, Sattler G, Sommer B, Augustin M: Doppelblind-randomisierte, intra-individuelle Vergleichsstudie zur Wirksamkeit von Prilocain und Lidocain in der Tumeszenz-Lokalanästhesie. In: Augustin M, Peschen M, Petres J, Schöpf E (Hrsg.): Innovation in der operativen und onkologischen Dermatologie. Freiburg: Congress Compact Verlag, 2003; 49-54.
  • Maier K, Sommer B, Sattler G, Peschen M, Augustin M: Haltbarkeit, Verträglichkeit und Wirksamkeit von Bicarbonat-gepuffertem Mepivacain - eine experimentelle Studie. In: Augustin M, Peschen M, Petres J, Schöpf E (Hrsg.): Innovationen in der operativen und onkologischen Dermatologie. Feiburg: Congress Compact Verlag, 2003; 55-60.
  • Mandera R, Schempp CM: Die Blutwurz, Potentilla erecta. In: (L.) Räuschel. Jahrbuch für Goetheanismus Niefern: Tycho Brahe Verlag, 2015.
  • Martin S: Chemical-induced contact hypersensitivity in the mouse model, in "Drug Hypersensitivity" In: W. Pichler (Hrsg.): Karger Book Series “Chemical Immunology and Allergy” Basel, Schweiz: Karger Verlag, 2007; 34-46.
  • Martin S, Simon JC: Immunology of allergic contact dermatitis In: Ring J, Weidinger S, Darsow V (Hrsg.): Skin and Environment Perception and Protection Proceedings of the 10th EADV Congress; Munich Germany 10-14 October 2001 Bologna: Monduzzi, 2002; 81-84.
  • Martin SF: Induction of contact hypersensitivity in the mouse model. In: Has C, Sitaru C (Hrsg.): Molecular Dermatology: Methods and Protocols. Humana Press Heidelberg: Springer Verlag, 2013; 325-335.
  • Martin SF: Animal models of inflammatory skin diseases. In: Sylvie Chollet-Martin (Hrsg.): Encyclopedia of inflammatory diseases.Section: Inflammatory processes and cells. Heidelberg: Springer, 2014.
  • Martin SF, Edele F: Die Rolle der Gewebe-Mikroumgebung bei der Kontaktallergie. In: Ed. W.-M. Becker (Hrsg.): Proceedings-Band: 2 (Allergie-Kongress 2007) Lübeck: Dustri-Verlag Dr. K. Feistle, 2008; 1-6.
  • Martin SF, Esser PR: Chemical allergen-induced skin cell activation. In: Emanuela Corsini and Henk van Loveren (Hrsg.): Molecular Immunotoxicology Weinheim: Wiley, 2014; 91-116 (1st Edition, Chapter 5).
  • Martin SF, Jakob T *: Contact Dermatitis. In: Anthony Gaspari, Stephen K. Tyring and Dan Kaplan (Hrsg.): Clinical and Basic Immunodermatology Basel: Springer International Publishing, 2017; 411-429.: https://doi.org/10.1007/978-3-319-29785-9_23
  • Martin SF, Richter A, Cavani A, Thierse HJ, Maggi E, Dietz L, Esser PR, Schmucker S, Pennino D, Geiger R, Sallusto F: The use of T-cells for the identification of contact allergens. In: Erwin L. Roggen (Hrsg.): Progress towards novel testing strategies for in vitro assessment of allergens. Research Signpost, 2011; 117-130.
  • Martin SF, Schmucker SS, Richter A: Tools and methods for identification and analysis of rare antigen-specific T lymphocytes. In: Martin SF (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology Heidelberg: Springer Verlag, Chapter 6, 2013; 73-88 (104).: http://10.1007/978-3-0348-0726-5_6
  • Martin SF, Schmucker SS, Richter A: Tools and methods for identification and analysis of rare antigen-specific T lymphocytes. In: S.F. Martin (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology. Chapter 6. Experientia Supplementum. Heidelberg: Springer, 2014; 73-88 (104).: http://10.1007/978-3-0348-0726-5_6
  • Meiss F, Zeiser R: Vismodegib. Small Molecules in Oncology. In: Uwe M. Martens (Hrsg.): Recent Results in Cancer Research Springer, 2014; 405-417.
  • Meiß F: Hauttumoren, Kapitel 14 In: Engelhardt M, Berger DP, Mertelsmann R, Duytser J (Hrsg.): Das Blaue Buch Berlin-Heidelberg: Springer Verlag, 2016; 463-477.
  • Meiß F: Kapitel: 7.5.7 Primär kutane T-Zell-Lymphome (CTCL); 8.8 Hauttumoren, 8.8.1 Melanom, 8.8.2 Basalzellkarzinom, 8.8.3 Plattenepithelkarzinom der Haut, 8.8.4 Merkelzellkarzinom In: Dietmar P. Berger, Roland Mertelsmann (Hrsg.): Das Rote Buch - Hämatologie und Internistische Onkologie, 6. Auflage. München: ecomed Medizin, 2017.
  • Meiß F, Schwabe M, Veelken H, Zeiser R: 8.8 Hauttumoren, 8.8.1 Melanom In: Dietmar P. Berger, Rupert Engelhardt, Roland Mertelsmann (Hrsg.): Das Rote Buch - Hämatologie und Internistische Onkologie Hamburg: ecomed Medizin, 2013; 1008-1018.
  • Meiß F, Schwabe M, Veelken H, Zeiser R: 8.8 Hauttumoren, 8.8.2 Basalzellkarzinom In: Dietmar P. Berger, Rupert Engelhardt, Roland Mertelsmann (Hrsg.): Das Rote Buch - Hämatologie und Internistische Onkologie Hamburg: ecomed Medizin, 2013; 1019-1021.
  • Meiß F, Schwabe M, Veelken H, Zeiser R: 8.8 Hauttumoren, 8.8.3 Plattenepithelkarzinom der Haut In: Dietmar P. Berger, Rupert Engelhardt, Roland Mertelsmann (Hrsg.): Das Rote Buch - Hämatologie und Internistische Onkologie Hamburg: ecomed Medizin, 2013; 1022-1025.
  • Meiß F, Schwabe M, Veelken H, Zeiser R: 8.8 Hauttumoren, 8.8.4 Merkelzellkarzinom In: Dietmar P. Berger, Rupert Engelhardt, Roland Mertelsmann (Hrsg.): Das Rote Buch - Hämatologie und Internistische Onkologie Hamburg: ecomed Medizin, 2013; 1026-1030.
  • Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen. In: Braun-Falco et al. (Hrsg.): Dermatologie und Venerologie (Kap. 31), 5. Auflage. Auflage. Springer Verlag, 2005.
  • Mockenhaupt M: Epidemiology and Causes of Severe Cutaneous Adverse Reactions to Drugs In: Pichler W (Hg), Drug Hypersensitivity, 1. Auflage. Karger Verlag, 2007; 18-31.
  • Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen: klinisches Bild, Definition, Diagnosekriterien und diagnostische Maßnahmen In: CME Praktische Fortbildung Dermatologie, 2. Auflage. Akademos Verlag, 2007.
  • Mockenhaupt M: Severe cutaneous adverse reactions. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, Braun-Falco O (Hrsg.): Dermatology and Venerology, 3. Aufl. Kap. 34 Heidelberg: Springer Medizin Verlag, 2008; 473-484.
  • Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Revuz J, Roujeau JC, Kerdel F, Allanore L (Hrsg.): Life Threatening Dermatoses and Emergencies in Dermatology, 1, Kap. 9. Auflage. Heidelberg: Springer Verlag, 2009; 87-95.
  • Mockenhaupt M: Severe Cutaneous Adverse Reactions. In: Burgdorf W, Plewig G, Wolff H, Landthaler M (Hrsg.): Braun-Falco’s Dermatology, 3, Kap. 34. Auflage. Heidelberg: Springer Verlag, 2009; 473-484.
  • Mockenhaupt M: Epidemiology of cutaneous adverse drug reactions (cADR). In: French LE (Hrsg.): Adverse Cutaneous Drug Eruptions, Book Series: Chemical Immunology and Allergy, 97. Auflage. Basel: Karger Verlag, 2012; 1-17.
  • Mockenhaupt M: Hypersensitivitätssyndrom – Drug reaction with eosiniphilia and systemic symptoms (DRESS) / Drug-induced hypersensitivity syndrome (DIHS). In: DDG (Hrsg.): Kutane Arzneimittelreaktionen, E-Learning Platform/E-Book: Dermokrates Dermokrates, 2012. (download: http://https://dermokrates.com/)
  • Mockenhaupt M: Schwere blasenbildende Hautreaktionen und deren Differentialdiagnosen. In: Lehnhardt M. et al (Hrsg.): Verbrennungschirurgie Heidelberg: Springer Verlag, 2015 (Kap. 37).
  • Mockenhaupt M: Das Dokumentationszentrum schwerer Hautreaktionen (dZh). In: Lehnhardt M. et al (Hrsg.): Verbrennungschirurgie Heidelberg: Springer Verlag, 2015 (Kap. 38).
  • Mockenhaupt M, Ziemer M: Erythema multiforme majus, Stevens-Johnson syndrome, Toxic epidermal necrolysis and Graft-versus-Host disease. In: Kirtschig G, Cooper S (Hrsg.): Gynecologic Dermatology London: JP Medical Printers, Ltd, 2015; 79-88 (Kap. 18).
  • Müller ML: Evaluation und Nutzenbewertung In: Gesundheitsökonomie, Gesundheitssysteme und öffentliche Gesundheitspflege: Ein praxisorientiertes Kurzlehrbuch Köln: Deutscher Ärzteverlag, 2008.
  • Müller ML: Digitale Sprachatlanten am Beispiel von VIVALDI und ALD-I. Interoperabilität durch die "Geolinguistic Document Architecture (GDA)" In: G. Blaikner-Hohenwart u.a. (Hrsg.): Festschrift für Hans Goebl zum 65. Geburtstag Salzburg: Ladinometria, 2008.
  • Nashan D: Jung aussehen als legitimer Wunsch an die Medizin? Dermatologie und Anti-Aging Medizin. In: Maio G (Hrsg.): Altwerden ohne alt zu sein? Alber Verlag, 2011.
  • Nashan D, Schumann H, Meis J, Kliesch S: Harninkontinenz: Übersicht zu Klinik, Prävention und Therapie dermatologischer Folgeerkrankungen. In: A.M. Raem, H. Fenger, G.F. Kolb et al (Hrsg.): Handbuch Geriatrie, 1. Auflage 9-2005. Auflage. Deutsche Krankenhausverlagsgesellschaft mbH, 2005; 1159-1161.
  • Nyström A, Bruckner-Tuderman L, Kern JS: Cell- and protein-based therapy approaches for epidermolysis bullosa. In: Molecular Dermatology, Methods in Molecular Biology Volume 961 Heidelberg: Springer Verlag, 2013; 425-440.
  • Nyström A, Has C: Epidermal Basement Membrane in Health and Disease. In: Current Topics in Membranes Waltham, M.A., USA: Elsevier, 2015; 117-170 (76).
  • Pfister-Wartha A: Erkrankungen der Haut: Allergien, Mykosen In: Ulrich Scharmer et al (Hrsg.): Rationale Pharmakotherapie, Kapitel 2.8.1 Med. Komm. Verlag, 2009; 95-99.
  • Radny P: Therapie bei Haut- und Weichteilmetastasen in Management des Melanoms In: Claus Garbe (Hrsg.): Onkologie aktuell 03/2006 Springer Verlag, 2006.
  • Reuter J, Merfort I, Seelinger G, Wölfle U, Schempp CM: Botanicals in Dermatology and skin health. In: Cooper R, Kronenberg F (Hrsg.): Botanical Medicine. From Bench to Bedside. New Rochelle, N.Y.: Mary Ann Liebert Inc., 2009; 33-65.
  • Ring J, Jakob T: Allergic skin diseases. In: Barker J, Burgdorf W (Hrsg.): The Challanges of Skin Disease in Europe. European Dermatology Forum White Book 4th Edition Berlin: ABW Wissenschaftsverlag, 2013; 55-56.
  • Runnebaum M, Runnebaum I: Alopecia androgenetica In: Hausarzt (Hrsg.): Alopecia androgenetica Jg., 2004.
  • Runnebaum M, Bruckner-Tuderman L: Genitale Missempfindungen: eine Herausforderung für Diagnostik und Therapie In: Plewig G, Kaudewitz P, Sander CA (Hrsg.): Fortschritte der Praktischen Dermatologie und Venerologie 2004 Springer Verlag Berlin, Heidelberg, 2005; 364-368.
  • Scheffler A, Edlund U, Schempp CM: Betulin als Heilmittel für die Haut. In: Jachens L (Hrsg.): Dermatologie. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. Berlin: Salumed-Verlag, 2012; 426-440.
  • Schempp C: Haut und Pflanzen In: Plewig G, Thomas P (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie Heidelberg: Springer Medizin Verlag, 2007; 270-273.
  • Schempp C: Evolution der Haut und des hautassoziierten Immunsystems. In: Jahrbuch für Goetheanismus 2009 Niefern: Tycho Brahe Verlag, 2010; 21-79.
  • Schempp CM: Durch Pflanzen ausgelöste toxische und allergische Hautreaktionen (Phytodermatitis) In: Augustin M, Hoch Y (Hrsg.): Pyhtotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 311-317.
  • Schempp CM: Beinwell (Symphytum officinale L.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urbaun und Fischer, 2004; 99-100.
  • Schempp CM: Tormentillwurzel / Blutwurz (Potentilla erecta L.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 247-249.
  • Schempp CM: Schöllkraut (Chelildonium majus L.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 215-217.
  • Schempp CM: Teebaumöl (Malaleuca alternifolia CHEEL.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 239-244.
  • Schempp CM: Ratanhia (Krameria triandra RUIZ. et PAV.) In: Augustin M, Hoch Y (Hrsg.): Phytogherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 194-195.
  • Schempp CM: Walnuss (Juglans regia L.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 252-253.
  • Schempp CM: Terpentinöl (Terebinthinae aetheroleum) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 245-246.
  • Schempp CM: Evolution der Haut und des hautassoziierten Immunsystems. In: Jahrbuch für Goetheanismus 2009 Niefern: Tycho Brahe Verlag, 2009; 21-79.
  • Schempp CM: Das hautassoziierte Immunsystem. In: Jachens L (Hrsg.): Dermatologie. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. Berlin: Salumed-Verlag, 2012; 31-38.
  • Schempp CM: Hauterkrankungen – Neues zum Hautschutz, Problem Sauerstoffradikale. In: Hofmann F, Reschauer G, Stößel U (Hrsg.): Arbeitsmedizin im Gesundheitsdienst. Freiburg: FFAS, 2014; 174-179.
  • Schempp CM, Huber R: Die Haut. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 681-683.
  • Schempp CM, Huber R: Atopische Dermatitis / Neurodermitis. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 683-690.
  • Schempp CM, Huber R: Psoriasis. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 691-694.
  • Schempp CM, Huber R: Akne. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 695-698.
  • Schempp CM, Huber R: Condylomata acuminata. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 698-699.
  • Schempp CM, Huber R: Herpes simplex. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 699-700.
  • Schempp CM, Huber R: Herpes zoster. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 700-701.
  • Schempp CM, Huber R: Sonnenschutz und aktinische Keratosen. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 701-703.
  • Schempp CM, Huber R: Vitiligo. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 703-704.
  • Schempp CM, Huber R: Alopecia areata und androgenetische Alopezie. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 704-705.
  • Schempp CM, Huber R: Wunden. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 705-710.
  • Schempp CM, Huber R: Urtikaria. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 710-712.
  • Schempp CM, Huber R: Ästhetische Dermatologie. In: Huber R, Michalsen A (Hrsg.): Checkliste Komplementärmedizin Stuttgart: Thieme Haug Verlag, 2014; 712-718.
  • Schempp CM, Simon JC: Johanniskraut (Hypericum perforatum L.) In: Augustin M, Hoch Y (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2004; 128-136.
  • Schempp CM, Wölfle U: Phytotherapie in der Dermatologie. In: Jachens L (Hrsg.): Dermatologie. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. Berlin: Salumed-Verlag, 2012; 441-460.
  • Schempp CM.: Durch Pflanzen ausgelöste toxische und allergische Hautreaktionen In: Augustin M., Hoch Y. (Hrsg.): Phytotherapie bei Hauterkrankungen München: Urban und Fischer, 2002.
  • Schiller M, Nashan D, Sunderkötter C: Spinocellular Carcinoma. In: Encyclopedia of Molecular Mechanisms of Disease Heidelberg: Springer Verlag, 2009.
  • Schmidt M, Goebeler M, Martin SF: Methods to investigate the role of TLRs in allergic contact dermatitis. Toll-like receptors: Methods and Protocols. In: Humana Press (Hrsg.): Methods Mol. Biol. Heidelberg: Springer, 2016; 319-340.: http://doi: 10.1007/978-1-4939-3335-8_20
  • Schumann H: Epidermolysis bullosa und dermatologische Betreuung in der Palliativmedizin In: B. Zernikow (Hrsg.): Palliativversorgung von Kindern, Jugendlichen und jungen Erwachsenen Heidelberg: Springer Verlag, 2008.
  • Schumann H: Chronische Wunden. In: Ulrich Scharmer et al (Hrsg.): Rationale Pharmakotherapie, Kapitel 2.8.2 Med. Komm. Verlag, 2009; 100-103.
  • Schwieger-Briel A, Kiritsi D, Bruckner-Tuderman L: Blasen im Kindealter: Differentialdiagnosen und Therapien. In: Fortschritte der praktischen Dermatologie und Venerologie Springer-Medizin-Verlag, 2011.
  • Sesarman A, Sitaru C: Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII. In: Has C, Sitaru C, John M. Walker (Hrsg.): Molecular Dermatology: Methods and Protocols in Series Methods in Molecular Biology New York: Humana Press, 2013.: http://10.1007/978-1-62703-227-8 25
  • Simon JC, Pflieger D, Hennies J, Schöpf E: UVA1 Phototherapie In: Dummer R (Hrsg.): Physikalische Therapie in der Dermatologie Darmstadt: Steinkopff Verlag, 2003; 17-22.
  • Sorokin L, Bruckner-Tuderman L: Skin development In: Unsicker K, Krieglstein K (eds.) Cell Signaling and Growth Factors in Development Weinheim: Wiley-VCH, 2006; 679-717.
  • Sprenger A, Küttner V, Bruckner-Tuderman L, Dengjel J: Global proteome analyses of SILAC labeled skin cells. In: Molecular Dermatology, Methods in Molecular Biology Volume 961 Heidelberg: Springer Verlag, 2013; 179-191.
  • Strüh CM, Jäger S, Kersten A, Schempp CM, Scheffler A, Martin SF, : Solubilisierte riterpenoide verstärken die antitumoralen Effekte von wässrigen Mistelextrakten im Maus Melanommodell. In: R. Scheer et al. (Hrsg.): Die Mistel in der Tumortherapie 3 Essen: KVC Verlag, 2013; 107-117.
  • Technau K: Komplette Fachredaktion In: Netters Dermatologie Stuttgart: Thieme Verlag, 2006.
  • Technau K, Rath W et al.: Geburtshilfe und Perinatalmedizin. In: Dermatologische Erkrankungen Stuttgart: Georg Thieme Verlag, 2010; 11.16.
  • Termeer C, Prehm P, Simon JC: Low molecular weight Oligosaccharides of Hyaluronan potently activate Dendritic Cells In: Kennedy, Phillips, Williams, Hascall (Hrsg.): Hyaluronan Chemical Biochemical and Biological Aspects Woodhead Publishing, 2002; 121-129.
  • Weber R, Richert L, Doelfs P, Tscheulin D, Schöpf E, Augustin M: Simulation der Effekte eines DRG-gestützten Entgeltsystems auf die Erlöse einer Universitäts-Hautklinik. In: Augustin M, Peschen M, Petres J, Schöpf E (Hrsg.): Innovation in der operativen und onkologischen Dermatologie. Freiburg: Congress Compact Verlag, 2003; 11-16.
  • Weltzien HU, Martin SF, Nicolas JF: T cell responses to contact allergens. In: Martin SF (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology Heidelberg: Springer Verlag, Chapter 4, 2013; 41-49 (104).: http://10.1007/978-3-0348-0726-5_4
  • Weltzien HU, Martin SF, Nicolas JF: T cell responses to contact allergens. In: S.F. Martin (Hrsg.): T Lymphocytes as Tools in Diagnostics and Immunotoxicology, Chapter 4, Experientia Supplementum. Heidelberg: Springer, 2014; 41-49 (104).: http://doi: 10.1007/978-3-0348-0726-5_4
  • Worm M, Jakob T: Mechanisms of IgE Regulation In: Ring J, Przybilla B, Ruzicka T (Hrsg.): Handbook of Atopic Eczema, 2nd Ed. Berlin-Heidelberg: Springer, 2006; 265-274.
Fallbeispiele:
  • Abdalla EM, Has C: A plakophilin-1 gene mutation in an egyptian family with ectodermal dysplasia-skin fragility syndrome. Mol Syndromol, 2014; 5: 304-306.
  • Arnold AW, Kleine MU, Happle R: Phacomatosis melanorosea without extracutaneous features: an unusual type of phacomatosis pigmentovascularis. Eur J Dermatol, 2012; 22: 473-475.
  • Aslan D, Akata RF, Schröder J, Happle R, Moog U, Bartsch O: Oculoectodermal syndrome: report of a new case with a broad clinical spectrum. Am J Med Genet A, 2014; 164: 2947-2951.
  • Baican A, Chiriac G, Baican C, Dima V, Ciuce D, Fritsch A, Sitaru C: Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita. J Dermatol, 2010; 37: 280-282.
  • Baican A, Chiriac G, Torio-Padron N, Sitaru C: Childhood epidermolysis bullosa acquisita associated with severe dental alterations: a case presentation. J Dermatol, 2013; 40 (5): 410-411. : http://10.1111/1346-8138.12107
  • Boente MC, Asial R, Primc NB, Happle R: Angora hair nevus. A further case of an unusual epidermal nevus representing a hallmark of angora hair nevus syndrome. J Dermatol Case Rep, 2013; 7: 9-51.
  • Bortnick R, Hummel J, Häffner K, Schwieger-Briel A: Infantiles bullöses Pemphigoid. Monatsschr Kinderh, 2014; 162 (2): 176.
  • Braun-Falco M, Hofmann S: Tophaceous gout in the finger pads. Clin Exp Dermatol, 2010; 35: e22-23.
  • Braun-Falco M, Meiß F: Cutaneous histoplasmosis. Lancet Infect Dis, 2008; 8: 734.
  • Büsing V, Kern J, Bruckner-Tuderman L, Hofmann S: Recalcitrant pemphigus vulgaris responding to systemic tacrolimus. Dermatology, 2010; 221: 122-126.
  • Butzmann CM, Kern JS, Stanislawski G, Meiss F: Insect bite-like reaction in a patient with chronic lymphocytic leukemia. J Dtsch Dermatol Ges, 2014; 12: 734-737.
  • Cheng MJ, Chen WC, Happle R, Song ZQ: Familial disseminated comedones without dyskeratosis: report of an affected family and review of the literature. Dermatology, 2014; 228: 303-306.
  • Cifuentes L, Kiritsi D, Chen W, Pennino J, Ring J, Weidinger S, Has C: A case of junctional epidermolysis bullosa with prurigo-like lesions and reduction of collagen XVII and filaggrin. Brit J Dermatol, 2013; 169: 195-198.
  • De la Fuente S, Hernández-Martín A, Happle R, Torrelo A: Type 2 mosaicism in familial glomangiomatosis. Actas Dermosifiliogr, 2014; 94: 361-362.
  • Dubiel W, Kiehlmann I, Happle R: Linear collagen naevus: an unusual connective tissue disorder. Acta Derm-venereol, 2014; 94: 361-362.
  • Eigentler TK, Utikal J, Huber MA, Meiss F, Schneider LA: Erstes Netzwerktreffen der zertifizierten Hauttumorzentren. J Dtsch Dermatol Ges, 2015; 13 (8): 847-848.
  • Faber M, Schmidt V, Jakob T: Papules, plaques and nodules on hands and elbow. J Dtsch Dermatol Ges, 2011; 9: 643-645.
  • Fink C, Happle R, Enk A, Haenssle HA: Phacomatosis spilorosea: visual diagnosis and associated pathologies of a rare entity. J Eur Acad Dermatol, 2016; 30: e69-e70.
  • Geissler E, Laaff H, Technau K, Bruckner-Tuderman L, Nashan D: Necrobiosis lipoidica. Kasuistische Vielfalt einer Diagnose. Hautarzt, 2011; 62: 621-624.
  • Gross CM, Klöcker M, Jakob T, Klecha D: Dermatologische Nebenwirkungen von Serotonin-Noradrenlin-Reuptake-Inhibitoren. Nervenarzt, 2008; 79: 1304-1309.
  • Guarneri C, Lentini M, Cannavò SP, Happle R: A case of hypertrichotic smooth muscle hamartoma: is it an amelanotic Becker naevus? Clin Exp Dermatol, 2015; 40: 577-579.
  • Haiges D, Kurz P, Laaff H, Meiss F, Kutzner H, Technau-Hafsi K: Malignant PEComa. J Cutan Pathol, 2017 (online). : http://doi: 10.1111/cup.13061.
  • Happle R: Superimposed linear psoriasis: a historical case revisited. J Dtsch Dermatol Ges, 2011; 9: 1027-1028.
  • Happle R: Melanocytic nevi, genetic engineering, and journalistic disinformation. J Dtsch Dermatol Ges, 2015; 13: 1278-1279.
  • Happle R, Franco-Guío MF, Santacoloma-Osorio G: Phylloid hypermelanosis: a cutaneous marker of several different disorders? Pediatr Dermatol, 2014; 31: 504-506.
  • Happle R, Kroll P: Nevoid hypertrichosis of the face in a 3-month-old girl with Aicardi syndrome. Eur J Dermatol, 2013; 23: 547-548. : http://dx.doi.org/10.1684/ejd.2013.2082
  • Has C, Danescu S, Volz A, Nöh F, Technau K, Bruckner-Tuderman L: Incontinentia pigmenti in a newborn with a novel nonsense mutation in the NEMO gene Brit J Dermatol, 2007; 156: 392-393.
  • Hoffmann K, Casetti F, Schempp CM: Methotrexate-associated photosensitization. Hautarzt, 2015; 66 (6): 459-461.
  • Hoffmann K, Zobel M, Grawikov T, Hoffmann K: Alternative zu herkömmlichen Behandlungsmethoden. Der gepulste Farbstofflaser bei ausgedehnten Vernarbungen. Ästhetische Dermatologie & Kosmetologie, 2015; 7 (5): 30-31.
  • Hofmann S, Technau K, Müller AMS, Lübbert M, Bruckner-Tuderman L: Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib J Am Acad Dermatol, 2007; 56 Suppl. 1: 68-72.
  • Huber R, Bross F, Schempp C, Gründemann C: Arnica and stinging nettle for treating burns - a self-experiment. Complement Ther Med, 2011; 19 (5): 276-280.
  • Kartal D, Borlu M, Has C, Fölster-Holst R: A novel mutation in the FERMT1 gene in Turkish siblings with Kindler syndrome. J Eur Acad Dermatol, 2016; 30 (7): 1233-1235. : http://dx.doi.org/10.1111/jdv.13163
  • Kavaklieva S, Yordanova I, Bruckner-Tuderman L, Has C: Acral peeling skin syndrome resembling epidermolysis bullosa simplex in a 10-month-old boy. Case Reports in Dermatology, 2013; 5 (2): 210-214.
  • Kern J, Braun-Falco M: Neutrophilic dermatosis of the hands associated with CLL. J Dtsch Dermatol Ges, 2010; 8 (6): 469-470.
  • Kiritsi D, Diaz-Cascajo C, Happle R, Jakob T, Kern J: A band-like balding disorder. Lancet, 2014; 383 (9917): e14. : http://doi: 10.1016/S0140-6736(13)60804-1
  • Lennartz L, Has C, Lehmann P: Congenital bullous poikiloderma (Kindler syndrome) - new mutation. J Dtsch Dermatol Ges, 2012; 10 (12): 919-920.
  • Livingstone E, Hillen U, Hafner C, Piel S, Groesser L, Schadendorf D, Happle R: Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman. Brit J Dermatol, 2015; 172: 1642-1645.
  • Miernik B, Casetti F, Panning M, Huzly D, Meyer H, Technau-Hafsi K: Multilocular Facial Necrosis in a Young Boy: A Quiz. Acta Derm-venereol, 2017; 97 (2): 299-301. : http://dx.doi.org/10.2340/00015555-2499
  • Miernik B, Schmidt V, Technau-Hafsi K, Kern JS, Meiss F: Alitretinoin in the treatment of palmoplantar mycosis fungoides: a new and promising therapeutic approach. Clin Exp Dermatol, 2015; 40 (4): 445-447.
  • Möbes M, Pfaff L, Usadel S, Technau-Hafsi K: Verkrustete Papulopusteln, Plaques und Ulzerationen. J Dtsch Dermatol Ges, 2017; 15 (1): 104-107.
  • Müller S, Kiritsi D: Epidermolysis bullosa simplex complicated by allergic contact dermatitis caused by a hydrocolloid dressing. Contact Dermatitis, 2017; 76: 178-192.
  • Nanda A, Khawaja F, Al-Sabah H, Happle R: Type 2 segmental Hailey-Hailey disease with systematized bilateral arrangement. Int J Dermatol, 2014; 53: 476-478.
  • Niedermeier A, Pfützner W, Ruzicka T, Thomas P, Happle R: Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol, 2014; 39: 351-353.
  • Norgauer J, Rohwedder A, Schaller J: Human papilloma virus and Grzybowski's generalized eruptive keratoacanthoma. J Am Acad Dermatol, 2003; 49: 771-772.
  • Ohashi A, Kiniwa Y, Kosho T, Suga T, Has C, Kubo H, Okuyama R: A case of Kindler syndrome with severe esophageal stenosis. Int J Dermatol, 2015; 54 (4): e106-108. : http://doi: 10.1111/ijd
  • Ormaechea N, Hernández-Martín A, Happle R, Colmenero I, Torrelo A: Nevus of striated muscle: a new clinicopathologic entity. Pediatr Dermatol, 2014; 31: 254-256.
  • Patrizi A, Tabanelli M, Grzeschik KH, Misciali C, Neri I, Happle R: Multiple basal cell carcinomas in a 38-year-old woman with Goltz syndrome. Dermatology, 2012; 224: 97-100. : http://dx.doi.org/10.1159/000336204
  • Recke A, Rose C, Schmidt E, Bröcker EB, Zillikens D, Sitaru C: Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting. J Am Acad Dermatol, 2009; 61: 333-336. : http://dx.doi.org/10.1016/j.jaad.2008.10.061
  • Schaefer W, Kern JS, Meiss F: Centrifugally spreading erythematous plaques with collarette scaling and pustules. J Dtsch Dermatol Ges, 2015; 13 (5): 464-467.
  • Schauer F, Renkl A, Technau-Hafsi K, Rafei-Shamsabadi D, Behzad M, Eming R, Kern J: Pruritic intertriginous vesiculopustular eruption. J Dtsch Dermatol Ges, 2014; 12 (9): 827-830. : http://doi: 10.1111/ddg.12329
  • Schnopp C, Braun-Falco M, Köhn FM: Lymphangioma cavernosum subcutaeum Deut Med Wochenschr, 2006; 131: 1599-1600.
  • Sendi-Naderi A, Lüdecke HJ, Unger S, Kern J, Wolff G, Bruckner-Tuderman L, Nashan D: A familial case of tricho-rhino-phalangeal syndrome type III with a novel missense mutation in exon 6 of the TRPS1 gene. J Eur Acad Dermatol, 2010; 24 (5): 612-614.
  • Struck MF, Illert T, Liss Y, Bosbach ID, Reichelt B, Steen M: Toxic epidermal necrolysis in pregnancy: case report and review of the literature. J Burn Care Res, 2010; 31 (5): 816-821.
  • Tekin B, Yucelten D, Happle R: Phacomatosis melanorosea: a further case of an unusual skin disorder. Acta Derm-venereol, 2016; 96: 280-282.
  • Torrelo A, Azorín D, Noguera L, Hernández-Martín A, Happle R, Requena L: Segmental prurigo pigmentosa. Pediatr Dermatol, 2014; 31: 523-525.
  • Torrelo A, Vicente A, Navarro L, Planaguma M, Bueno E, González-Sarmiento R Hernández-Martín A Noguera-Morel L, Requena L, Colmenero I, Parareda A, González-Enseñat MA, Happle R: Early-onset acral basal cell carcinomas in Gorlin syndrome. Brit J Dermatol, 2014; 171: 1227-1229.
  • Vale TC, Santos DM, Maciel RO, Cardoso F, Happle R: Photoletter to the editor: A neurocutaneous rarity: phacomatosis pigmentokeratotica. J Dermatol Case Rep, 2014; 8: 58-59.
  • Volz A, Metze D, Böhm M, Bruckner-Tuderman L, Nashan D: Idiopathic eruptive macular pigmentation in a 7-year-old-girl: case report and discussion of differences from erythema dyschromicum perstans Brit J Dermatol, 2007; 157: 839-840.
  • Volz A, Technau K, Bross F: Operative Lippenreduktionsplastik bei therapieresistenter Cheilitis granulomatosa. J Dtsch Dermatol Ges, 2010; 8 (4): 303-305.
  • Weckesser S, Laszczyk M, Müller ML, Schempp C, Schumann H: Topical Treatment of Necrotising Herpes Zoster with Betulin from Birch Bark Forsch Komplementmed, 2010; 17: 271-273.
  • Welte T, Arnold F, Technau-Hafsi K, Neumann-Haefelin E, Wobser R, Zschiedrich S, Walz G, Kramer-Zucker A: Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case Report. Transplant Direct, 2016; 17 (2) Suppl. 4 (online): e70. : http://dx.doi.org/10.1097/TXD.0000000000000582
  • Wessbecher R, Technau-Hafsi K, Meiss F, Schauer F: Papulopustular lesions of the face and scalp. J Dtsch Dermatol Ges, 2017; 15 (7): 755-757.
  • Yang Z, Hartmann B, Xu Z, Ma L, Happle R, Schlipf N, Zhang LX, Xu ZG, Wang ZY, Fischer J: Large deletions in the NSDHL gene in two patients with CHILD syndrome. Acta Derm-venereol, 2015; 95: 1007-1008.
  • Zhou Q, Neubauer J, Kern JS, Grotz W, Walz G, Huber TB: Calciphylaxis. Lancet, 2014; 383 (9922): 1067. : http://dx.doi.org/10.1016/S0140-6736(14)60235-X
Kurzbeiträge / short communications:
  • Adışen E, Onder M, Erdem O, Happle R: Superimposed linear lichen planus in a 4-year-old girl. Int J Dermatol, 2014; 53: e541-e542.
  • Braun-Falco M: Reply to Letter to the editor by Dr. Carmelo Urso: "Cleft formation and consumption of the epidermis in cutaneous melanocytic lesions, what are they?" Hum Pathol, 2006; 37: 247.
  • Bruckner-Tuderman L: Can type VII collagen injections cure dystrophic epidermolysis bullosa? Mol Ther, 2009; 171: 6-7.
  • Dengjel J, Abeliovich H: Musical chairs during mitophagy. Autophagy, 2014; 10: 706-707. : http://dx.doi.org/10.4161/auto.28150
  • Eisenberg T, Abdellatif M, Zimmermann A, Schroeder S, Pendl T, Harger A, Stekovic S, Schipke J, Magnes C, Schmidt A, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, Carmona-Gutierrez D Pietrocola F, Pieber TR, Sigrist SJ, Linke WA, Mühlfeld C, Sadoshima J, Dengjel J, Kiechl S, Kroemer G, Sedej S, Madeo F: Dietary spermidine for lowering high blood pressure. Autophagy, 2017; 13 (4): 767-769.
  • Eisenberg T, Schroeder S, Büttner S, Carmona-Gutierrez D, Pendl T, Andryushkova A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Magnes C, Sinner F, Sedej S, Pieber TR, Dengjel J, Sigrist S, Kroemer G, Madeo F: A histone point mutation that switches on autophagy. Autophagy, 2014; 10: 1143-1145. : http://dx.doi.org/10.4161/auto.28767
  • Fölster-Holst R, Nellen RG, Jensen JM, Poblete-Gutiérrez P, Steijlen PM, Schwarz T, Happle R, Van Geel M, Frank J: Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease. Brit J Dermatol, 2012; 166: 464-466. : http://dx.doi.org/10.1111/j.1365-2133.2011.10593.x
  • Gentzsch S, Kern JS, Loeckermann S, Geissler E, Seufert J, Bernard C, Kohlhase J, Bruckner-Tuderman L, Meiss F: Iatrogenic Vitamin D Deficiency in a Patient with Gorlin Syndrome: The Conundrum of Photoprotection. Acta Derm-venereol, 2014; 94: 459-460. : http://dx.doi.org/10.2340/00015555-1714
  • Groot AJ, Cobzaru C, Weber S, Saftig P, Blobel CP, Kopan R, Vooijs M, Franzke CW: Epidermal ADAM17 is dispensable for notch activation. J Invest Dermatol, 2013; 133 (9): 2286-2288. : http://dx.doi.org/10.1038/jid.2013.162
  • Happle R: Phacomatosis pigmentokeratotica is a "pseudodidymosis". J Invest Dermatol, 2013; 133: 1923-1925. : http://dx.doi.org/10.1038/jid.2013.74
  • Happle R: Nevus sebaceus is a mosaic RASopathy. J Invest Dermatol, 2013; 133: 597-600. : http://dx.doi.org/10.1038/jid.2012.447
  • Happle R: The Baykal phenomenon: large congenital melanocytic nevi involving the breast tend to spare the nipple and areola. J Eur Acad Dermatol, 2016; 30: e181-e183. : http://dx.doi.org/10.1111/jdv.13493
  • Happle R: An unusual linear hypermelanosis reflecting lyonization in women with Börjeson-Forssman-Lehmann syndrome. J Eur Acad Dermatol, 2016; 30: 323-324. : http://dx.doi.org/10.1111/jdv.12717
  • Happle R, Salhi A: Do giant melanocytic naevi tend to spare the umbilicus? Acta Derm-venereol, 2016; 96: 998-999. : http://dx.doi.org/10.2340/00015555-2442
  • Happle R, Tinschert S, Happle-Tinschert: syndrome can be caused by a mosaic SMO mutation and is suggested to be a variant of Curry-Jones syndrome. Brit J Dermatol, 2016; 175: 1108. : http://dx.doi.org/10.1111/bjd.14924
  • Has C: Processing of the laminin-332 α chain: from bedside to bench. Brit J Dermatol, 2014; 170: 1008-1009.
  • Has C, Schwieger-Briel A, Schlipf N, Hausser I, Chmel N, Rösler B, Technau K, Jakob T, Zimmer A, Fischer J: Target-sequence capture and high throughput sequencing identify a de novo CARD14 mutation in an infant with erythrodermic pityriasis rubra pilaris. Acta Derm-venereol, 2016; 96: 989-990. : http://dx.doi.org/10.2340/00015555-2446
  • Hofmann SC, Fischer JEriksson C, Bengtsson Gref O, Biedermann T, Jakob T: IgE detection to α/β/γ-gliadin and its clinical relevance in wheat-dependent exercise-induced anaphylaxis. Allergy, 2012; 67: 1457-1460. : http://dx.doi.org/10.1111/all.12020
  • Hofmann SC, Pfänder N, Weckesser S, Huss-Marp J, Jakob T: Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immun, 2011; 127: 265-267. : http://dx.doi.org/10.1016/j.jaci.2010.06.042
  • Hofmann SC, Pfender N, Weckesser S, Blank S, Huss-Marp J, Spillner E, Jakob T: Reply: Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immun, 2011; 128: 248. : http://dx.doi.org/10.1016/j.jaci.2011.02.020
  • Jakob T, Hilger C, Hentges F: Clinical relevance of sensitisation to cross reactive lipocalin Can f 6. Allergy, 2013; 68: 690-691. : http://dx.doi.org/10.1111/all.12107
  • Kern JS, Gehring W, Kreisel W, Hertl M, Technau-Hafsi K, Bruckner-Tuderman L, Hofmann SC: Overlap of IgA pemphigus and linear IgA dermatosis in a patient with ulcerative colitis: a mere coincidence? Acta Derm-venereol, 2014; 94 (2): 228-230.
  • Kumar V, Behr M, Kiritsi D, Scheffschick A, Grahnert A, Homberg M, Schwieger-Briel A, Jakob T, Bruckner-Tuderman L, Magin TM: Keratin-dependent TSLP expression suggests a link between skin blistering and atopic disease. J Allergy Clin Immun, 2016; 138: 1461-1464. : http://dx.doi.org/10.1016/j.jaci.2016.04.046
  • Müller S, Rafei-Shamsabadi D Technau-Hafsi K, Renzel S, Jakob T: Bullous Delayed Pressure Urticaria Responding to Omalizumab. Acta Derm-venereol, 2016; 96 (3): 416-417. : http://dx.doi.org/10.2340/00015555-2224
  • Müller S, Schempp CM, Jakob T: Failure of omalizumab in the treatment of solar urticarial. J Eur Acad Dermatol, 2016; 30: 524-525. : http://dx.doi.org/10.1111/jdv.12922
  • Oswald E, Fisch P, Jakob T, Bruckner-Tuderman L, Martin SF, Rensing-Ehl A: Reduced numbers of circulating gamma delta T cells in patients with bullous pemphigoid. Exp Dermatol, 2009; 18: 991-993. : http://dx.doi.org/10.1111/j.1600-0625.2009.00875.x
  • Pigors M, Schwieger-Briel A, Leppert J, Kiritsi D, Kohlhase J, Bruckner-Tuderman L, Has C: Molecular Heterogeneity of Epidermolysis Bullosa Simplex: Contribution of EXPH5 Mutations. J Invest Dermatol, 2014; 134: 842-845. : http://dx.doi.org/10.1038/jid.2013.373
  • Puzik A, Möller J, Meiss F, Kontny U, Rössler J: Side Effects of Interferon Therapy in Adolescent Melanoma. Pediatr Hemat Oncol, 2014; 31: 380-381. : http://dx.doi.org/10.3109/08880018.2013.838725
  • Rafei-Shamsabadi D, Müller S, Pfützner W, Spillner E, Rueff F, Jakob T: Recombinant allergens rarely allow identification of Hymenoptera venom allergic patients with negative specific IgE to whole venom preparations. J Allergy Clin Immun, 2014; 134: 493-494. : http://dx.doi.org/10.1016/j.jaci.2014.05.035
  • Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M: Reply: The EuroSCAR study: Cannot agree with the conclusions. J Am Acad Dermatol, 2008; 59: 899-900. : http://dx.doi.org/10.1016/j.jaad.2008.07.005
  • Schroeder S, Pendl T, Zimmermann A, Eisenberg T, Carmona-Gutierrez D Ruckenstuhl C, Mariño G, Pietrocola F, Harger A, Magnes C, Sinner F, Pieber TR, Dengjel J, Sigrist SJ, Kroemer G, Madeo F: Acetyl-coenzyme A: a metabolic master regulator of autophagy and longevity. Autophagy, 2014; 10: 1335-1337.
  • Schwarz N, Stadie V, Kreft B, Happle R, Marsch WCh, Fiedler E: Systematized linear porokeratosis: Concept of type 2 segmental manifestation implies an increased cancer risk. J Dermatol, 2012; 39: 953-954. : http://dx.doi.org/10.1111/j.1346-8138.2012.01607.x
  • Sitaru C, Thiel J: The need for markers and predictors of Rituximab treatment resistance. Exp Dermatol, 2014; 23 (4): 236-237. : http://dx.doi.org/10.1111/exd.12331
  • Traidl-Hoffmann C, Jakob T, Behrendt H: Response to Adaptive Immunity as Determinant of Allergenicity. J Allergy Clin Immun, 2009; 124: 171-172.
  • Vos B, Köhler J, Stretz E, Müller S, Przybilla B, Soubeiran E, Ruëff F, Jakob T: Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom. J Allergy Clin Immun, 2013; 131: 1225-1227. : http://dx.doi.org/10.1016/j.jaci.2012.07.041
  • Wäsch R, Jakob T, Technau K, Finke J, Engelhardt M: Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation. Ann Hematol, 2012; 91: 287-289. : http://dx.doi.org/10.1007/s00277-011-1235-y
Vorträge:
  • Amtage D: Topische Psoriasistherapie "Calcipotriol-Betamethasondipropionat: Erste Erfahrungen". 2005 (133. Tagung der Vereinigung Südwestdeutscher Dermatologen, Karlsruhe).
  • Braun-Falco M: Lichen ruber und Lichen sclerosus et atrophicus an der Genitalschleimhaut der Frau 2006 (Interdisziplinäre Fortbildung der Universitäts-Hautklinik und der Universitäts-Fauenklinik in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V., Freiburg, 11.01.).
  • Braun-Falco M: Gentherapie bei Sjögren-Larsson Syndrom 2006 (11. Tagung der Arbeitsgruppe Dermatologische Genetik der Arbeitsgemeinschaft Dermatologischer Forschung (ADF), Aachen, 23.03.).
  • Braun-Falco M: Moderne Behandlungskonzepte von Genodermatosen 2006 (Fortbildungsveranstaltung der Universitätshautklinik Leipzig, Leipzig, 26.04.).
  • Braun-Falco M: HIV associated erythema elevatum diutinum 2006 (Annual tricontinental meeting – Straßbourg, Basel, Freiburg, Straßbourg, 30.6.).
  • Braun-Falco M: Picassos Angst vor Geschlechtskrankheiten am Beispiel der Blauen Periode 2006 (Interne Fortbildungsveranstaltung der Universitätshautklinik Freiburg, 26.07.).
  • Braun-Falco M: Histomorphologische Kritierien zur Diagnositk des Malignen Melanoms 2006 (Interne Fortbildungsveranstaltung der Universitätshautklinik Freiburg, 02.08.).
  • Braun-Falco M: Lichen ruber und Lichen sclerosus et atrophicus an der Genitalschleimhaut 2006 (Mittwochskolloquium des Department Universitäts-Frauenklinik Freiburg, 08.11.).
  • Braun-Falco M: Stammzellen der Haut 2006 (Interne Fortbildungsveranstaltung, Universitäts-Hautklinik Freiburg, Freiburg, 15.11.).
  • Braun-Falco M: Stammzellen der Haut 2006 (Fortbildungsseminar, Universitätshautklinik Graz, 21.11.).
  • Braun-Falco M: Kutane Nebenwirkungen der therapie mt monoklonalen Antikörpern 2006 (Fortbildung der Universtitätshautklinik Freiburg im Wintersemester 2007, 13.12.).
  • Braun-Falco M: Stammzellen der Haut – Behandlungspotential für Genodermatosen 2006 (Jahrestagung der Selbsthilfe-Gruppe Ichthyose e.V. , CVJM-Haus Solling, Dassel, 02.09.).
  • Bruckner-Tuderman L: Processing of collagen XVII-relvance for autoantigenicity 2005 (Final EU Project Meeting "Pemphigoids & Immunity", Rom, 28.01.2005).
  • Bruckner-Tuderman L: Netzwerk für Epidermolysis Bullosa: Molekulare Pathomechanismen und neue Therapie-Strategien 2005 (Tagung der Deutschen Dermatologischen Gesellschaft, Dresden, 20.04.2005).
  • Bruckner-Tuderman L: The Pathogenesis of Epidermolysis Bullosa, "Future Therapy: Gene Therapy?" 2005 (Second Scandinavian EB Conference on Epidermolysis Bullosa for Health Care Professionals, Stockholm, 24.04.-26.04.2005).
  • Bruckner-Tuderman L: Genetische blasenbildende Dermatosen 2005 (Aktuelle Trends in der pädiatrischen Dermatologie, Bochum, 30.04.2005).
  • Bruckner-Tuderman L: Fragilität der Haut 2005 (Fortbildungsveranstaltung Universität Tübingen mit niedergelassenen Dermatologen, Tübingen, 02.07.2005).
  • Bruckner-Tuderman L: Epithelial Adhesion Disorders 2005 (Kick-off Meeting des EU-Forschungsprojekts "Geneskin", Rom, 11.07.2005).
  • Bruckner-Tuderman L: Transmembranous collagens as cell adhesion molecules 2005 (Gordon Conference, New London, N.H., USA, 22.07.-29.07.2005).
  • Bruckner-Tuderman L: Adhesion Molecules and the Basement Membrane in Epidermal Blistering Diseases 2005 (Tagung der European Tissue Repair Society, Stuttgart, 15.09.-17.09.2005).
  • Bruckner-Tuderman L: Coordinated actions of the network 2005 (Epidermolysis Bullosa - Netzwerkmeeting, Tübingen, 21.09.2005).
  • Bruckner-Tuderman L: Netzwerk Epidermolysis bullosa: molekulare Pathomechanismen und neue therapeutische Strategien 2005 (Netzwerksprecher-Treffen des Bundesministeriums für Bildung und Forschung (BMBF), Mainz, 04.10.2005).
  • Bruckner-Tuderman L: How can molecular biology advance our understanding of dermatological disorders? 2005 (14th European Academy of Dermatology & Venereology (EADV) Congress, London, 12.10.-15.10.2005).
  • Bruckner-Tuderman L: The Molecular Architecture of the Dermo-Epidermal Junction 2005 (Extracellular Matrix - A Bridge to Scandinavia, Sonderforschungsbreich 492, Münster, 28.09.-30.09.2005).
  • Bruckner-Tuderman L: Modern Standards in Diagnosis and Management of Bullous Diseases 2006 (4th EADV Spring Symposium, Saariselkä, Finnland, 9.-12.2.).
  • Bruckner-Tuderman L: Bullöse Dermatosen: morphologische und molekulare Diagnostik 2006 (Histologie Kongress Freiburg, organisiert durch Herrn Dr. Laaff, Freiburg, 1.-2.4.).
  • Bruckner-Tuderman L: Pathogenesis and modern diagnostics of bullous skin diseases 2006 (Jahrestagung der Rumänisch-Dermatologischen Gesellschaft, Cluj, Rumänien, 27.-29.4.).
  • Bruckner-Tuderman L: Molecular biology and pathology of kindlin-1 2006 (Gordon Research Conference on Basement membranes, Il Ciocco, Lucca, Italien, 18.-23.6.).
  • Bruckner-Tuderman L: Biology of the dermal epidermal basement membrane zone 2006 (FECTS-ISMB Meeting, Oulu, Finnland, 30.6.-5.7.).
  • Bruckner-Tuderman L: Puringene und Fieberschübe 2006 (20. Fortbildungswoche für praktische Dermatologie und Venerologie, München, 23.-24.7.).
  • Bruckner-Tuderman L: Neo-antigens and antigen processing in linear IgA bullous dermatosis 2006 (36th ESDR (European Society for Dermatological Research) Annual Meeting, Paris, 6.-8.9.).
  • Bruckner-Tuderman L: Epithelial adhesion disorders 2006 (2nd Meeting zum EU-Projekt “GENESKIN”, Rom, 15.9.).
  • Bruckner-Tuderman L: Molecular and diagnostic aspects of skin fragility 2006 (Hellerstrom Memorial Lecture, Stockholm, 21.9.).
  • Bruckner-Tuderman L: Network Epidermolysis bullosa 2006 (Meeting des Ichthyose-Netzwerks NIRK, Münster, 29.9.).
  • Bruckner-Tuderman L: Update and Summary of current research on EB 2006 (EB Conference 2006, Dublin, Irland, 10.-12.10.).
  • Bruckner-Tuderman L: Transmembrane collagens 2006 (Final international Meeting of the DFG Priority Program 1086 “Genetic and molecular analysis of basement membranes and basement membrane anchorage”, Freiburg, 10.-12.11.).
  • Bruckner-Tuderman L: Human phenotypes and animal models in skin blistering 2006 (Symposium des SFB 589 „Skin Diseases – Human Genetics – Animal Models”, Köln, 1.12.).
  • Bruckner-Tuderman L, Schumann H: Integrierte Versorgung von chronischen Wunden 2005 (133. Tagung der Vereinigung Südwestdeutscher Dermatologen, Karlsruhe, 11.11.-12.11.2005).
  • Dudda JC, Bachtanian E, Martin SF: Dendritic cells govern induction and reprogramming of tissue-selective T cell trafficking by soluble factors 2005 (3rd EAACI-Davos Meeting "Basic Immunology in Allergy and Clinical Immunology", Davos, 3.-6. Februar, 2005).
  • Dudda JC, Lembo A, Bachtanian E, Mariani N, Tchaptchet S, Galanos C, Martin SF, Freudenberg M: TLR9 drives Th1 differentiation to Propionibacterium acnes. 2005 (36. Jahrestagung der Deutschen Gesellschaft für Immunologie (DGfI), Kiel, 21.-24.09.2005).
  • Ermuth, T: Freie Vorträge: Operative Dermatologie 2005 (Tagung der Deutschen Dermatologischen Gesellschaft).
  • Ermuth T: EBM 200 plus, AOP gemäß § 115 b 2005 (Qualitätszirkel Dermatologie Freiburg-Stadt).
  • Ermuth T: Hautdefekte und ihre operative Versorgung. Nahttechniken mit praktischen Übungen, 6 Fortbildungspunkte 2005 (Ausrichtung des operativen Workshops, 24.09.2005).
  • Franzke CW, Has C, Schulte C, Väisänen L, Tasanen K, Aumailley M, Bruckner-Tuderman L: The C-terminus of BP180 / collagen XVII is important for its adhesive function 2005 (ESDR, Tübingen, September 2005).
  • Franzke CW, Has C, Schulte C, Väisänen L, Tasanen K, Aumailley M, Bruckner-Tuderman L: The distal C-terminus of collagen XVII is important for its adhesive functions 2005 (Posterpräsentation Gordon Research Conference "Collagens", 2005).
  • Grosber, Mockenhaupt M: Dokumentationszentrum schwerer Hautreaktionen (dZh) 2004 (Fortbildungsveranstaltung Universitäts-Hautklinik Freiburg, 21.04.04).
  • Grosber M, Mockenhaupt M: Exanthem bei HIV-Infektion 2004 (Fortbildungsveranstaltung Universitäts-Hautklinik Freiburg, 09.06.04).
  • Has C, Baer C, Bruckner-Tuderman L: Kindlin und Kindler-Syndrom 2006 (ADF, 23.-25.3.).
  • Has C, Bruckner-Tuderman L: Diagnostisches Vorgehen bei Epidermolysis bullosa 2006 (Arbeitsgemeinschaft Dermatologische Histologie, 22.-24.9.).
  • Haustein UF, Bork K, Vieluf D, Raab B, Mockenhaupt M: Stevens-Johnson syndrome and erythema exsudativum multiforme majus. 2005 (8th Congress of the European Society of Pediatric Dermatology (ESPD), 05.-07.05.05, Budapest, Abstractband).
  • Herz C, Aumailley M, Schlötzer-Schrehardt U, Bruckner-Tuderman L, Has C: Molecular biology and pathology of kindlin-1 2006 (Network Epidermolysis bullosa, 13.-14.7.).
  • Hofmann S: Myfortic in der Therapie bullöser Autoimmundermatosen (AG Autoimmunbullöse Dermatosen) 2006 (ADF 2006, Aachen, 23.3.).
  • Hofmann SC: Differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita 2005 (Regiotagung, 24. Juni 2005, Freiburg).
  • Hofmann SC: Analysis of IgA-reactivity to the shed ectodomain of BP 180 2005 (Final meeting "Pemphigoids & Immunity", 28. Januar 2005, Rom).
  • Hofmann SC: Morbus Duhring - Die Zöliakie der Haut 2005 (Duhring-Seminar der Deutschen Zöliakie Gesellschaft, 9. September 2005, Eußenheim).
  • Hofmann SC: Klinische und diagnostische Besonderheiten beim bullösen Pemphigoid, Symposium Bullöse Autoimmundermatosen 2005 (Tagung der Deutschen Dermatologischen Gesellschaft 2005, 21. April 2005, Dresden).
  • Huyke C, Mühlan C, Scheffler A, Schempp C: Behandlung aktinischer Keratosen mit Betulin-Oleogel im Vergleich zu Kryotherapie und der Kombination von Kryotherapie plus Betulin-Oleogel 2006 (5. Kongress für Phytopharmaka und Phytotherapie, 28.-30. September 2006, Berlin).
  • Huyke C, Laszczyk M, Scheffler A, Ernst R, Schempp CM: Topische Behandlung aktinischer Keratosen mit Birkenkorkextrakt - eine Pilotstudie 2005 (Kongress für Phytopharmaka und Phytotherapie 2005).
  • Jocher A: Typ-I-Allergien, Kreuzallergien/Hyposensibilisierung 2005 (09.03.2005, Baden-Baden).
  • Jocher A: Neurodermitis-Schulung für Eltern in Kooperation mit dem Josefshaus (Kinderklinik Prof. Forster) 2005 (Kooperation mit dem Josefshaus (Kinderklinik Prof. Forster)).
  • Jocher A, Hornstein S, Schulte-Mönting J, Schempp C: Antiinflammatorische Wirkung von Salvia officinalis im UV-Erythemtest 2006 (5. Kongress für Phytopharmaka und Phytotherapie, 28.-30. September 2006, Berlin).
  • Jocher A, Kessler S, Hornstein S, Schulte-Mönting J, Schempp CM: Der UV-Erythemtest als Modell zur Untersuchung der anti-inflammatorischen Wirkung von topisch angewendeten Dermatika 2005 (Tagung südwestdeutscher Dermatologen in Karlsruhe 2005).
  • Jocher A, Stump J, Großjohann B, Franke G, Schempp CM: Anti-inflammatorische Wirkung von Aloe vera Gel (97,5 %) im UV-Erythemtest 2005 (Tagung südwestdeutscher Dermatologen in Karlsruhe 2005).
  • Kautz O: Hautbeteiligung bei "Lupus Erythematodes" 2006 (Selbsthilfe-Gesprächsgruppe "Lupus Erythematodes" der Rheuma-Liga Baden-Württemberg e.V., Arbeitsgemeinschaft Freiburg; Innungskrankenkasse Freiburg, 10.10.).
  • Lass C, Martin SF, Schempp C, Nicolas J-F, Vocanson M, Merfort I: The allergenic potential of sesquiterpene lactones in phytomedicines from Arnica - an immunologic revision. 2005 (5. Freiburger Immunologen Meeting, Emmendingen, 11. Oktober 2005).
  • Lickert M: Operative Therapie des Rhinophyms bei der Vereinigung der operativen Dermatologen. 2003 (VOD-Tagung, Berlin).
  • Lickert M: Operative Therapie des malignen Melanoms. 2003 (Malignes Melanom-Fortbildung, Tumorzentrum Freiburg).
  • Liß Y, Mockenhaupt M: Schwere Hautreaktionen: Wie hoch ist das Risiko und was macht das dZh? 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg, 11.10.).
  • Loquai C, Grabbe S., Luger TA, Nashan D: Differentialdiagnose pigmentierter Hauttumoren 2005 (Chirurgische Praxis (angenommen)).
  • Martin S: T cell instruction for tissue-selective migration by dendritic cells and local microenvironment 2004 (University of California, San Diego, USA).
  • Martin S: Programming and reprogramming of T cell migration patterns by Dendritic cells and microenvironments 2004 (Colloquium des SFB 633, Deutsches Rheumaforschungszentrum (DRFZ), Berlin).
  • Martin S: Dendritic cells and local microenvironment program T cells for tissue-selective migration 2004 (Howard Hughes Medical Institute, University of Washington, Seattle, USA).
  • Martin S: Contact Dermatitis: from innate to adaptive immune responses in skin 2006 (Kantonsspital St. Gallen, Seminars in Experimental Medicine, St. Gallen, Schweiz, 7.4.).
  • Martin S: Stimulation of T-cells following exposure to chemical allergens 2006 (2nd International Drug Hypersensitivity Meeting, Liverpool, Great Britain, Symposium "Chemical Allergy", 18.-21.4.).
  • Martin S: Immunologische Effekte von Chemikalien und Pflanzeninhaltsstoffen am Beispiel der Kontaktallergie 2006 (Birken GmbH, Öschelbronn, 4.4.).
  • Martin S: Environmental instruction for tissue-specific T cell migration 2006 (4th Amsterdam Zoo Meeting Cell Adhesion and Inflammation, Symposium “Dendritic cell trafficking and cellular interactions”, Amsterdam, 4.-7.10.).
  • Martin S: Wie findet die T-Zelle in die Haut? Untersuchung zur Hautspezifität von T-Lymphozyten 2006 (Universitätsklinikum Tübingen, Hautklinik, 25.1.).
  • Martin S: Allergic Contact Dermatitis to Arnica: Lessons from Basic Research 2006 (Regiotagung der Dermatologischen Kliniken der Universitäten Freiburg im Breisgau, Straßburg und Basel; Straßburg, 30.6.).
  • Martin S: Tissue-specific T cell migration and role of the tissue microenvironment 2006 (Novartis, Basel, 29.9.).
  • Martin S: Tumorgenese und Tumortherapie aus immunologischer Sicht 2006 (Carl Gustav Carus-Institut, Öschelbronn, 20.9.).
  • Martin S: Untersuchungen zur Kontaktallergie im Mausmodell 2006 (9. Wissenschaftliche Tagung der IGTp, Freiburg, 12.9.).
  • Martin S: Studies on chemical-induced contact hypersensitivity in the mouse model 2006 (44. Wissenschaftliche Tagung der GV-SOLAS/7th Scientific Conference of ESLAV, Freiburg, 11.9.).
  • Martin S: DC Vakzinierung und Gewebetargeting von T-Zellen 2006 (6. Workshop „Tumorvakzinierung mit Dendritischen Zellen“, Freiburg, 13.10.).
  • Martin S: Das allergene Potential von Inhaltsstoffen der Arnika - eine immunologische Revision 2006 (Verleihung des Sebastian-Kneipp-Preises, Bad Wörishofen, 3.11.).
  • Martin S, Dudda JC, Burghard S, Bachtanian E, Lembo A, Galanos C, Freudenberg MA: Lack of IL-12R reveals an obligatory role for TLR4 in hapten-induced contact hypersensitivity 2006 (4th EAACI Ga2len Da2vos Meeting, Garmisch-Partenkirchen, 16.- 19. Februar).
  • Martin SF: Keynote Lecture: "Immunologische Pathomechanismen der Kontaktallergie: Effektorzellen und Migration" 2005 (34. Arbeitssitzung der Deutschen Kontaktallergie-Gruppe (DKG), Freudenberg).
  • Martin SF: "Dendritische Zellen steuern T-Zellen in periphere Gewebe: Implikationen für immunologische Tumortherapie" 2005 (5. Workshop "Tumorvakzinierung mit Dendritischen Zellen", Institut für Immunbiologie, Freiburg).
  • Martin SF: "Chemical-induced contact hypersensitivity in mice: effector cells and tissue-specific migration" 2005 (Colloquium des SFB 548, Hautklinik der Johannes-Gutenberg-Universität Mainz).
  • Martin SF: "Guiding T cells to peripheral tissues: a role for dendritic cells and secondary lymphoid tissues" 2005 (2. Duderstädter/Göttinger Workshop "Onkologische Therapien mit Immunzellen").
  • Martin SF: "Generation of Tissue-specific T Cell Homing Subsets by Dendritic Cells and Tissue Microenvironment" 2005 (Symposium in honor of Michael J. Bevan's 60th birthday, Unversity of Washington, School of Medicine, Dept. of Immunology, Seattle, USA).
  • Martin SF, Bachtanian E, Dudda JC: Induction and reprogramming of tissue-selective T cell trafficking by Dendritic cells. 2005 (Meeting of the European Macrophage and Dendritic cell Society (EMDS), Amsterdam 6.-8. October 2005).
  • Martin SF, Bachtanian E, Dudda JC: Disparate allergenic potential of TNCB and DNFB in ß2 microglobulin deficient mice is associated with regulatory T cell fuction. 2005 (19th Meeting of the European Research Group for Experimental Contact Dermatitis (ERGECD), Flörsheim, 22.-24. April 2005).
  • Martin SF, Bachtanian E, Dudda JC: Tissue-specific Dendritic cells program and modulate tissue-selective T cell migration. 2005 (19th meeting of the European Research Group for Experimental Contact Dermatitis (ERGECD), Flörsheim, 22.-24. April 2005).
  • Martin SF, Dudda JC, Bachtanian E, Lembo A, Galanos C, Freudenberg MA: Impaired IL-12 function leads to the development of a TLR4-dependent contact hypersensitivity to chemicals. 2005 (5. Freiburger Immunologen Meeting, Emmendingen, 11.Oktober 2005).
  • Merfort I, Lass C, Wagner S, Schempp C, Martin SF: The allergenic sesquiterpene lactones and the transcription factor NF-KB. 2005 (19th meeting of the European Research Group for Experimental Contact Dermatitis (ERGECD), Flörsheim, 22.-24.04.2005).
  • Mockenhaupt: Syphilis (Lues) 2002 (Syphilis (Lues) Fortbildungsveranstaltung). : http://Abt. für Innere Medizin, Freiburg
  • Mockenhaupt M: Schwere Hautreaktionen in Zusammenhang mit Antiepileptika 2004 (Klinisch-pharmakologisches Kolloquium Sommersemester 2004, Regensburg, 25.05.04).
  • Mockenhaupt M: Von der Urethritis bis zu Systemmanifestationen 2004 (Triangulum-Venerologie, Brixen, Italien, 18.06.04).
  • Mockenhaupt M: Heimliche Hautschäden bei artefiziellen Störungen. 2005 (Interdisziplinäres Fortbildungssymposium der Universitäts-Hautklinik Freiburg und der Universitätsklinik für Psychiatrie und Psychotherapie Freiburg, 16.02.05).
  • Mockenhaupt M: Immunomodulating therapy of SCAR: Evaluation of treatment efficacy in a cohort of 281 patients with SJS/TEN. 2005 (Internationales Minisymposium SCAR, Groningen, Niederlande, 18.04.05).
  • Mockenhaupt M: Schwere Hautreaktionen im Zusammenhang mit Non-Opiod-Analgetika. 2005 (Der Hauptstadtkongreß für Anästhesiologie und Intensivtherapie (HAI), Berlin, 09.-11.06.05).
  • Mockenhaupt M: Schwere Hautreaktionen und ihre Risikofaktoren. 2005 (UAW-Ausschuß der Arzneimittelkommission der Deutschen Ärzteschaft (AkdÄ), Berlin, 17.06.05).
  • Mockenhaupt M: Schwere Hautreaktionen: Welche Rolle spielen NSAIDS und Coxibe? 2005 (Pharmacia, Advisory Board, Potsdam, 16.07.05).
  • Mockenhaupt M: Schwere arzneimittelinduzierte Hautreaktionen: Was ist neu in Klinik? Ätiopathogenese und Therapie. 2005 (Fortbildungsveranstaltung der Universitäts-Hautklinik Heidelberg, 14.09.05).
  • Mockenhaupt M: Toxisch epidermale Nekrolyse: Klinik, Äthiopathogenese und Therapie. 2005 (Interdisziplinäre Fortbildungsveranstaltung im BG-Klinikum Bergmannstrost, Halle, 05.10.05).
  • Mockenhaupt M: Schwere Hautreaktionen im Kindesalter – die Rolle von Infektionen und Arzneimitteln 2006 (Universitäts-Kinderklinik, Freiburg, 18.1.).
  • Mockenhaupt M: Pharmakovigilanz am Beispiel schwerer arzneimittelinduzierter Hautreaktionen 2006 (Arzneimittelkommission der Universitätsklinik Freiburg, Sitzung am 6.4.).
  • Mockenhaupt M: Severe Cutaneous Drug Reactions 2006 (Danish Dermatological Society Meeting, Odense, Dänemark, 5.-6.5.).
  • Mockenhaupt M: Schwere Hautreaktionen: Klassifikation und Management 2006 (Allergologisches Kolloquium, Universitäts-Hautklinik der LMU München, 30.5.).
  • Mockenhaupt M: Clinical features, etiology and pathogenetic aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis 2006 (EAACI-Allergiekongreß in Wien, Österreich, 10.-14.6.).
  • Mockenhaupt M: Multiforme Exantheme 2006 (Herbsttagung des Ärzteverbandes Deutscher Allergologen – Regionalgruppe Nord in Hamburg, 4.11.).
  • Mockenhaupt M: Hypersensitivitätssyndrom: Überbegriff für Arzneimittelunverträglichkeit oder spezifische Reaktionsform? 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V., Universitäts-Hautklinik, Freiburg, 8. 11.).
  • Mockenhaupt M: Pharmakovigilanz am Beispiel schwerer arzneimittelinduzierter Hautreaktionen 2006 (Eröffnungssymposium des Pharmakovigilanz-Netzes Freiburg, 15.11.).
  • Mockenhaupt M, Liß Y: Schwere Hautreaktionen: Klinische Erscheinungsformen und Differentialdiagnosen 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg, 28.6.).
  • Mockenhaupt M, Liß Y: Schwere Hautreaktionen: Überlegungen zur Pathogenese und Therapie 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg, 18.10.).
  • Mockenhaupt M.: Schwere Hautreaktionen: Was ist neu in klinischer Einteilung, Ätiopathogenese und Therapie? 2002 (Seminarveranstaltung im Wintersemester 2001/02 an der Universitäts-Hautklinik Würzburg, 07.02.02).
  • Mockenhaupt M.: Epidemiology and etiology of severe cutaneous adverse reactions. 2002 (Vortrag im Institut für Umweltmedizinische Forschung, Düsseldorf, 09.07.02).
  • Mockenhaupt M.: Severe cutaneous adverse reactions (SCAR) 2002 (Experience of the German Registry. 17th annual meeting of the Italian Group for Epidermiological Research in Dermatology (GISED), Erolano, Italien, 11./12.10.02).
  • Mockenhaupt M.: Modellprojekt zur Quantifizierung von Arzneimittelrisiken. 2002 (Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Bonn, 25.01.02).
  • Nashan D: Empfehlungen zur Diagnostik, Therapie und Nachsorge des Malignen Melanoms. 2005 (Ausgearbeitet für das Tumorzentrum der Universität Freiburg).
  • Nashan D: Neues aus der dermatologischen Onkologie. 2005 (Fortbildungsveranstaltung der Universitätshautklinik Freiburg, 12.01.2005).
  • Nashan D: Das maligne Melanom - Neues zur Nachsorge und Therapie. 2005 (Seminar zur Dermato-Onkologie, Universitätshautklinik Köln, 25.02.2005).
  • Nashan D: Schmerztherapie - ein Standard für die Dermatologie. 2005 (DDG, Dresden, 22.04.2005).
  • Nashan D: Therapie des malignen Melanoms im Stadium IV - ein unlösbares Problem? 2005 (Fortbildungsveranstaltung der Universitätshautklinik Münster, 29.04.2005).
  • Nashan D: Hautveränderungen und ihre Bedeutung nach Herztransplantation. 2005 (12. Seminar der herztransplantierten Patienten im Herz-Zentrum Bad Krozingen, 04.06.2005).
  • Nashan D: Stadienbasierte Nachsorge des malignen Melanoms. 2005 (Fortbildungssymposium "Malignes Melanom", Universitätshautklinik Essen, 03.12.2005).
  • Nashan D: Empfehlungen zur Diagnostik, Therapie und Nachsorge des Malignen Melanoms 2006 (Ausgearbeitet für das Tumorzentrum der Universität Freiburg).
  • Nashan D.: Melanome des weiblichen Genitaltraktes 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg, 11.1.2006).
  • Nashan D.: A case of modern intoxication 2006 (Dreiländertagung, 31.6., Strasbourg).
  • Nashan D.: Fall einer modernen Intoxikation 2006 (Fortbildungsveranstaltung der Universiäts-Hautklinik Freiburg. 7.2006).
  • Nashan D.: Melanom – ein up-date 2006 (Qualitätszirkel Singen, 25.10.2006).
  • Nashan D.: Melanome des weiblichen Genitaltraktes 2006 (Fortbildung in der Gynäkologie der Universität Freiburg, 11.2006).
  • Pfister-Wartha A: Berufsdermatosen im Gesundheitsdienst 2005 (19. Freiburger Symposium für Arbeitsmedizin im Gesundheitsdienst 09/2005).
  • Pfister-Wartha A: Durch Allergien bedingte Hauterkrankungen 2005 (Allergologie-Aufbaukurs für HNO-Ärzte 12/2005).
  • Radny P: Lokaltherapien von Hauttumoren 2005 (Onkologisches Symposium Freiburg 17.06.2005).
  • Radny P: Lokale Chemotherapie mit Elektroporation bei epithelialen Tumoren 2005 (2. Tübinger Symposium Dermatologische Onkologie 2005).
  • Radny P: Innovative Konzepte bei der Therapie von Hautmetastasen 2005 (Fortbildung UKF Abteilung für Strahlentherapie September 2005).
  • Radny P: Selective Electrochemical Tumour Ablation (SECTA) with intralesional Bleomycin 2006 (3rd meeting of the European Association of Dermato-Oncology, Rom, 23.-25.6.).
  • Radny P: Selective Electrochemical Tumour Ablation (SECTA) with intralesional Bleomycin 2006 (Regiotagung Straßbourg, Juni).
  • Radny P, Luger TA, Bruckner-Tuderman L, Nashan D: Prolonged disease-free interval in advanced melanoma with Interferon-alpha and Interleukin-2 – A case series of 17 patients 2006 (6th International Conference on the Adjuvant Therapy of Malignant Melanoma).
  • Radny P, Eigentler TK, Garbe C: Electroporation in skin cancer 2005 (The 10th World Congress on Cancers of the Skin).
  • Radny P, Eigentler TK, Garbe C: Local disease management of melanoma metastases with electroporation plus intralesional bleomycin 2005 (6th World Congress on Melanoma, Vancouver, September 2005).
  • Radny P, Eigentler TK, Garbe C, Nashan D: Lokales Mangagement von Tumoren und Metastasen der Haut mit Elektroporation 2005 (10. ADO Jahrestagung, Magdeburg Oktober 2005).
  • Schacht V: Lymphatic vessels as a prognostic marker in malignant melanoma 2005 (Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie, 29.09.-01.10.2005, Magdeburg).
  • Schacht V: Expression of podoplanin in lymphatic endothelial cells and basal keratinocytes results in enhanced inflammation in a podoplanin transgenic mouse model, Lymphologica. 2005 (12. Kongress der Gesellschaft Deutschsprachiger Lymphologen, 07.-08.10.2005, Bochum).
  • Schacht V: A potential role of the lymphatic glycoprotein podoplanin in skin carcinogenesis and inflammation. 2005 (66th Annual Meeting of The Society for Investigative Dermatology 2005, 04.-07.05.2005, St. Louis, USA).
  • Schempp, CM.: Behandlung der subakuten Atopischen Dermatitis mit Johanniskraut-Creme. Eine randomisierte, placebokontrollierte Doppelblindstudie im Halbseitendesign. 2002 (Phytopharmaka und Phytotherapie 10.-12.10.02, Berlin).
  • Schempp C: Neue Standards und Entwicklungen in der Photodermatologie 2006 (Gemeinsame Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg und des Berufsverbandes Deutscher Dermatologen. Freiburg, 08.02.).
  • Schempp C: Neurodermitis als Zeitkrankheit: Ursachen, Prophylaxe und Behandlung 2006 (Biofach 2006, Congress-Centrum Nürnberg, 16.02.).
  • Schempp C: Therapie der Psoriasis unter Berücksichtigung neuer Biologika 2006 (Akademie für Ärztliche Fortbildung Südbaden, Freiburg, 12.04.).
  • Schempp C: Psoriasis - wie sieht sie aus, was kann man tun? 2006 (Informationsveranstaltung der Universitäts-Hautklinik in Zusammenarbeit mit dem Rheumazentrum Südbaden und dem Deutschen Psoriasisbund. Freiburg, 17.06.).
  • Schempp C: Brennender Busch und Johanniskraut. Eine botanische Wanderung für Dermatologen 2006 (3. Görlitzer Dermatologischen Frühjahrstagung, 5. Mai, Görlitz).
  • Schempp C: Haut und Pflanzen. Risiko und Nutzen lokal angewendeter Pflanzenextrakte 2006 (20. dermatologische Fortbildungswoche, München, 25. Juli).
  • Schempp C: Work-related allergies in animal keepers and veterinaries 2006 (Scientific meeting of GV-SOLAS, ESLAV and IGTp, 10.-12. September, Freiburg).
  • Schempp C: Möglichkeiten und Grenzen der Phytotherapie in der Dermatologie 2006 (Jahrestagung der Schweizerischen Gesellschaft für Medizinische Pharmakologie, Wädenswil, 26. Oktober).
  • Schempp CM: Neue Entwicklungen auf dem Gebiet der Naturstoff-Therapeutika 2005 (133. Tagung Südwestdeutscher Dermatologen, 11.-12.22.2005, Karlsruhe).
  • Schempp CM: Hautschädigung zur Angstreduktion. 2005 (Interdisziplinäres Fortbildungssymposium der Universitäts-Hautklinik Freiburg und der Universitätsklinik für Psychiatrie und Psychotherapie Freiburg, 16.02.05).
  • Schempp CM.: Auf dem Vormarsch: Johanniskraut für die Haut. 2002 (Expopharm 10.-13.10.2002, Berlin).
  • Schmid S, Fritsch A, Bruckner-Tuderman L: Correlation between triple helix stability of collagen VII and skin fragility in dystrophic epidermolysis bullosa 2006 (ESDR, Paris, 09.09.).
  • Schumann H: Die Rolle der duplex-kontrollierten Schaumsklerosierung von Nahrvenen beim Ulcus cruris venosum 2006 (Jahrestagung der Arbeitsgemeinschaft dermatologische Angiologie, 13. - 14.5., Tübingen).
  • Schumann H: Modernes Wundmanagement: Von der Therapie der kausalen Faktoren bis zur phasengerechten Versorgung der Wunde 2006 (Wiesbadener Dermatologenabend am 5.7.).
  • Schumann H: Neues vom Netzwerk Epidermolysis bullosa 2006 (Jahrestagung der Interessengemeinschaft Epidermolysis bullosa, Schmitten, 1.10.).
  • Schumann H: Eine prospektive, randomisierte, kontrollierte Studie zur Untersuchung des Effektes von wassergefilterter Infrarot A Bestrahlung auf die Heilung von chronischen Ulcera cruris 2006 (Symposium der Dr. med. h.c. Erwin Braun Stiftung, Liestal, Schweiz, 3.-4.11.).
  • Volz A: Auflösung des Diagnosequiz – Idiopathische eruptive makulöse Pigmentierung 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg in).
  • Volz A: Papulopustulöse Hautveränderungen unter Therapie mit dem monoklonalen Antikörper Cetuximab (Erbitux®) 2006 (Fortbildungsveranstaltung der Universitäts-Hautklinik Freiburg in Verbingung mit dem Berufsverband der Deutschen Dermatologen e.V., Freiburg, 13.12.).
  • Volz A, Lütke Volksbeck S, Schmitt-Gräff A, Nashan D, Bruckner-Tuderman L, Technau K: Ausgeprägte kutane Beteiligung bei Kikuchi-Fujimoto- Krankheit 2006 (14. Jahrestagung der Arbeitsgemeinschaft Dermatologische Histologie).
  • Wiesend C, Mockenhaupt M: Schwere Hautreaktionen: Ein Leitfaden 2004 (Fortbildungsveranstaltung Universitäts-Hautklinik Freiburg, 07.04.04).
Konferenzbeiträge:
  • Augustin M: Kostenmanagement bei chronischen Wunden. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 49.
  • Augustin M: Aktuelle Entwicklungen der Pharmako-Ökonomie in der Dermatologie. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 56.
  • Augustin M, Berger K, Kugland B, Ehlken B, Hofmaier A: Ressourcenverbrauch und Behandlungskosten der Psoriasis vulgaris in Deutschland. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 154.
  • Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U: Weiterentwicklung pharmako-ökonomischer Methoden zur Erfassung von Lebensqualität in der Dermatologie: Validierung eines umfassenden FLQA-Core-Fragebogens. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 152.
  • Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schröder W., Roujeau JC: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol, 2002; 138: 1019-1024.
  • Baer C, Aumailley M, Schlötzer-Schrehardt U, Bruckner-Tuderman L, Has C: The focal contact protein kindlin-1 is phosphorylated and involved in maintenance of actin cytoskeleton integrity and keratinocyte motility 2006 (SID Annual Meeting, 3.-6. Mai).
  • Baer C, Locatelli A, Tadini G, Morand V, Bruckner-Tuderman L, Has C: Mutation detection and expression studies in patients with the Kindler syndrome J Invest Dermatol, 2005; 125: A117.
  • Braun-Falco M: The depiction of prostitution in Picasso’s paintings of the Blue period 2006 (History of Dermatology-session, 4th EADV Spring Symposium, Lapland, Finnland, 9-12. Februar).
  • Braun-Falco M: Regenerationspotential durch Stammzellen der Haut – Realität und Vision 2006 (1. Linzer Anti-Aging-Kongress 2006, Linz, Österreich, 22.04.).
  • Braun-Falco M: Stem cells in Dermatology 2006 (Session “Molecular, genetics and immune biology", 61. Brazilian Meeting of Dermatology, Curitiba City, 08.09.).
  • Braun-Falco M: Stem cells in Dermatology 2006 (Breakfast discussion, 61. Brazilian Meeting of Dermatology, Curitiba City, 09.09.).
  • Braun-Falco M: Gene therapy for genodermatoses 2006 (Main conference, 61. Brazilian Meeting of Dermatology, Curitiba City, 09.09.).
  • Bross F, Földi E, Zschocke I, Augustin M: Lebensqualität bei Lymphödemen - Effekte der komplexen physikalischen Entstauungstherapie. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 147.
  • Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann S, Lacour JP, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M: Multicenter Prospective Study of the humoral autoimmune response in a large cohort of bullous pemphigoid patients J Invest Dermatol, 2006; 117 (European Society of Dermatological Research, Paris).
  • Drapeau M., Perry J.C. & Körner A.: An exploratory Study of the Old and the New CCRT Categories and Borderline Personality Disorder 2002 (International Meeting of the Society for Psychotherapy Research, June, Santa Barbara, USA).
  • Dudda J, Simon J.C, Martin S: Role of Dendritic cells in establishment and reprogramming of tissue selective CD8+ T cell trafficking to gut versus inflamed skin. Immunobiology, 2003; 208: 193 (34. Jahrestagung der Deutschen Gesellschaft für Immunobiology).
  • Dudda JC, Bachtanian E, Martin SF: Modulation of tissue selective CD8+T cell trafficking Immunobiology, 2004; 209: 308 (Joint Annual Meeting of the German and Dutch Societies for Immunology, Maastricht, Netherlands, October 20-23).
  • Dudda JC, Martin SF: Reprogramming of tissue-selective CD8+ T cell trafficking. Clin Invest Med, 2004 (12th International Congress of Immunology. Montreal, Quebec, Canada, 18.-23. Juli 2004).
  • Dudda JC, Simon JC, Martin SF: Role of Dendritic cells in establishment and reprogramming of tissue selective CD8+ T cell trafficking to gut versus inflamed skin 2004 (ADF Tagung, Dresden, 26.-28. Februar 2004).
  • Edele F, Bachtanian E, Martin S: Tissue targeting of cytotoxic T cells by dendritic cell immunization for melanoma defence Exp Dermatol, 2006; 15 (202) (33. ADF Tagung, Aachen, 23.-25. März).
  • Edele F, Bachtanian E, Martin S: Dendritic cell immunization to induce tissue-targeting of cytotoxic T cells for melanoma defence 2006 (4th Amsterdam ZOO Meeting, Amsterdam, October 4-7).
  • Engel K, Schmidt U, Simon-Haarhaus B, Schempp C: Antientzündliche und antiproliferative Wirksamkeit eines auf 4% Usninsäure eingestellten CO2-Extraktes aus Usnea barbata L. Z Phytother, 2006; 27 Suppl. 22 (5. Kongress für Phytopharmaka und Phytotherapie, Berlin, 28.-30. September).
  • Engel K, Schmidt U, Simon-Haarhaus B, Schempp CM: Antientzündliche und antiproliferative Wirksamkeit eines CO2-Extraktes aus Usnea barbata (Bartflechte) JDDG, 2005; 3: 167.
  • Engel K, Weckesser S, Simon-Haarhaus B, Pelz K, Wittmer A, Schempp CM: Wirksamkeit von Pflanzenextrakten gegen dermatologisch relevante pathogene Keime. Phytother Res, 2005; 26: 24 (Tagung der Vereinigung Südwestdeutscher Dermatologen, Karlsruhe).
  • Franzke CW, Has C, Schulte C, Aumailley M, Balda B-R, Bruckner-Tuderman L: The laminin 5-binding domain of BP180/collagen XVII is important for structural integrity and adhesive functions J Invest Dermatol, 2004; 123: A15.
  • Franzke CW, Schlüter S, Has C, Höping D, Balda B-R, Bruckner-Tuderman: Truncation of the distal C-terminus of collagen XVII impacts the physiologic adhesion functions J Invest Dermatol, 2004; 123.
  • Franzke CW, Schlüter S, Has C, Höping D, Balda B-R, Bruckner-Tuderman L: Deletion of the distal part of the C-Terminus of BP180/collagen XVII causes a mild phenotype of junctional epidermolysis bullosa Arch Dermatol Res, 2004; 295: 390.
  • Franzke C-W, Tasanen K, Borradori L, Bruckner-Tuderman L: Shedding of collagen XVII/BP 180: specific structural motifs influence cleavage from sell surface. J Invest Dermatol, 2003; 121: 254-254.
  • Franzke C-W, Tasanen K, Brandt K, Echtermeyer F, Bruckner-Tuderman L: The ectodomain of the transmembrane collagen XVII alters keratinocyte motility. Arch Dermatol Res, 2003; 294: 509-509.
  • Franzke CW, Schulte C, Aumailley M, Tasanen K, Väisänen L, Has C, Bruckner-Tuderman L: The most distal C-Terminus of collagen XVII is important for structural integry and integration into the cell membrane Arch Dermatol Res, 2005; 296: 453.
  • Freudenberg MA, Dudda JC, Bachtanian E, Burghard S, Lembo A, Galanos C, Martin S: Simultaneous defects in Toll-like receptor 4 and IL-12 receptor function result in resistance of mice to chemical-induced contact hypersensitivity 2006 (20th Meeting of the European Macrophage and Dendritic cell Society (EMDS), Freiburg 5.-7. Oktober).
  • Grosber M, Schlingmann J, Mockenhaupt M: Generalized bullous fixed drug eruption (GBFDE) versus toxic epidermal necrolysis (TEN): clinical and etiological differences Allergologie, 2004; 27: 177 (Drug Hypersensitivity Meeting, Bern, 04.05.-08.05.04).
  • Grosber M, Schlingmann J, Mockenhaupt M: Clinical and etiologie differences between toxic epidermal necrolysis (TEN) and generalized bullous fixed drug eruption (GBFDE). J Invest Dermatol, 2004; 123: 411 (6th International Congress on Cutaneous Adverse Drug Reactions (ADR); Satellite Congress of the 34th European Society for Dermatological Research (ESDR), Wien, 09.09.-11.09.04).
  • Grosber M, Wiesend C, Mockenhaupt M: Stevens-Johnson-Syndrom (SJS) und Toxisch epidermale Nekrolyse (TEN) versus akute generalisierte exanthematische Pustulose (AGEP): Klinik, Epidermiologie und Ätiologie Allergo Journal, 2004; 13: 385 (20. Fortbildungskongreß "Fortschritte der Allergologie, Immunologie und Dermatologie", Davos, 01.09.-04.09.04).
  • Grosber M, Wiesend C, Mockenhaupt M: Klinik, Epidemiologie und Ätiologie schwerer Hautreaktionen Allergo Journal, 2004; 13: S21 (Allergie-Kongreß, Aachen, 15.09.-19.09.04).
  • Haddad C, Sassolas B, Fagot JP, Roujeau JC, Sekula P, Mockenhaupt M, Le Louet H: C56 - Imputabilité des médicaments dans le syndrome de Stevens-Johnson et la nécrolyse épidermique toxique: évaluation d'un algorithme spécifique Ann Dermatol Vener, 2006; 133 (4): 36 (Journees Dermatologiques in Paris, Frankreich, 7.12.).
  • Haddad C, Sassolas B, Hellmer A, Bouwes-Bavnick JN, Halevy S, Naldi L, Sidoroff A, Mockenhaupt M, Roujeau JC, Le Louet H: A new method for assessing drug causality in SJS or TEN J Invest Dermatol, 2006; 126: 111 (Meeting on cutaneous adverse drug reactions and ESDR, in Paris, Frankreich, 7.-9.9.).
  • Halevy S, Ghislain P-D, Mockenhaupt M, Fagot J-P, Bouwes-Bavinck J N, Sidoroff A, Naldi L, Dunant A, Schlingmann J, Roujeau J-C: TEN and allopurinol use J Eur Acad Dermatol, 2004; 18 Suppl. 2: 43-96 (13th Congress of European Academy of Dermatology and Venerology, Florence, 17.11.-21.11.04).
  • Has C, Franzke CW, Bruckner-Tuderman L: Shedding of collagen XVII/BP180: specific structural motifs influence cleavage from cell surface. Arch Dermatol Res, 2004; 295: 332.
  • Hellstern MO., Norgauer J., Schöpf E., Herouy Y.: FXIII-mediated Downregulation of the urokinase-type plasminogen activator (uPA) and ist receptor (CD87) in venous ulcers. J Invest Dermatol, 2002; 119: 716.
  • Herouy Y., Hildenbrand T., Idzko M., Panther E., Bandemir E., Hartmann M., Norgauer J.: Elevated expression of EMMPRIN (CD147) and membrane-type matrix metalloproteinases in chronic wounds. J Invest Dermatol, 2002; 119: 748.
  • Herz C, Aumailley M, Schulte C, Schlötzer-Schrehardt U, Bruckner-Tuderman L, Has C: Kindlin-1 regulates polarity and motility of epidermal keratinocytes 2006 (36th ESDR Annual Meeting, 7.-9. September).
  • Herzog C, Has C, Franzke C-W, Echtermeyer FG, Kröger S, Gustafsson E, Fässler R, Bruckner-Tuderman L: Dystroglycan in skin an cutaneous cells: ß-subunit is shed from the cell surface. J Invest Dermatol, 2003; 121: 255.
  • Hofmann S: Ectodomain-specific monoclonal antibody detects the shed form of collagen XVII in blister fluids 2006 (XX. FECTS Meeting, Oulo, Finnland, 4.7.).
  • Hofmann S, Schönau V, Franzke C, Sorokin LM, Bruckner-Tuderman L: The shed ectodomain of collagen XVII is present in blister fluids of autoimmune and non-autoimmune bullous dermatoses J Invest Dermatol, 2006; 122 (European Society of Dermatological Research 2006, Paris).
  • Hofmann SC, Technau K, Müller AMS, Lübbert M, Bruckner-Tuderman L: Bullous Pemphigoid associated with hypereosinophilic syndrome J Invest Dermatol, 2005; 125: A16 (European Society for Dermatological Research 2005, Tübingen).
  • Huilaja L, Hurskainen T, Autio-Hermainen H, Hofmann S, Räsänen J, Franzke C, Bruckner-Tuderman L, Tasanen K: Localization of transmembrane collagen XVII during placental development 2006 (XX. FECTS Meeting, Oulo, Finnland).
  • Huyke C, Mühlan C, Scheffler A, Schempp C: Behandlung aktinischer Keratosen mit Betulin-Oleogel im Vergleich zu Kryotherapie und der Kombination von Kryotherapie plus Betulin-Oleogel Z Phytother, 2006; 27 Suppl. 29.
  • Huyke C, Laszczyk M, Scheffler A, Ernst R, Schempp CM: Topische Behandlung aktinischer Keratosen mit Birkenkorkextrakt - eine Pilotstudie JDDG, 2005; 3: 182.
  • Jocher A, Hornstein S, Schulte-Mönting J, Schempp C: Antiinflammatorische Wirkung von Salvia officinalis im UV-Erythemtest Z Phytother, 2006; 27: 10.
  • Jocher A, Kessler S, Hornstein S, Schulte Mönting J, Schempp CM: Re-Evaluation und Optimierung des UV-Erythemtests als Modell für die antiinflammatorische Wirkung topisch angewendeter Dermatika. JDDG, 2005; 3: 224.
  • Jocher A, Engel K, Weckesser S, Schulte-Mönting J, Schempp CM: Antiinflammatorische Wirkung von Salvia officinalis im UV-Erythemtest Phytother Res, 2005; 26: 10.
  • Just H, Keller A, Schumann H: Spektrum der Kompressionstherapien bei venösen Ulcera am Beispiel einer dermatologischen Wundambulanz 2005.
  • Kern JS, Bruckner-Tuderman L, Has C: Novel mutations and genotype-phenotype correlations in dystrophic epidermolysis bullosa J Invest Dermatol, 2005; 124: A447.
  • Kern JS, Müller M, Bruckner-Tuderman L, Has C: Mutation detection in large genes: how to overcome the bottleneck of data analysis? J Invest Dermatol, 2005; 125: A130.
  • Kiechle S, Has C, Földi E, Kohlhase J, Bruckner-Tuderman L, Schacht V: Genetic analysis of patients with primary lymphedema reveals novel polymorphisms in the podoplanin gene, but no pathogenic mutations 2006 (Gordon Research Conference “Molecular Mechanisms in Lymphatic Function & Disease", Les Diablerets, Schweiz, 3.-8.9.).
  • Körner A., Drapeau M., Geyer M. & Perry J.C.: Self-Assessment of interpersonal behavior with the Relationship Patterns Questionnaire: Results from a sample representative for the German population Nord J Psychiat, 2002; 56 (45): 18-19 (18th world congress on psychotherapy.).
  • Körner A., Geyer M. & Brähler E.: Persönlichkeitsdiagnostik mit dem NEO-Fünf-Faktoren Inventar. 2002 (Poster auf der DKPM-Tagung in Ulm, März 2002).
  • Kries E v, Siegrist B, Kuch M, Seitz U, Augustin A, Mockenhaupt M, Liß Y, Kühr J: Toxisch Epidermale Nekrolyse (TEN) - Fallbeschreibung eines 14 Jahre alten Mädchens 2006 (Tagung der Deutschen Gesellschaft für Kinder- und Jugendmedizin in Mainz, 15.-17.9.).
  • Kunstfeld R, Hirakawa S, Hong Y-K, Schacht B, Lange-Asschenfeldt B, Velasco P, Wu Y, Hicklin D, Bohlen P, Detmar M: VEGF-A plays a key role in the induction fo chronic inflammation and the associated lymphangiogenic response 2004; 123: A34 (Annual Meeting of the European Society for Dermatological Research, Vienna, Austria 09.-11.09.2004).
  • Lass C, Vocanson M, Nicolas JF, Merfort I, Schempp C, Martin S: Antiinflammatory versus allergenic effects - The two faces of sesquiterpene lactones in phytomedicines from Arnica 2006 (4th EAACI Ga2len Da2vos Meeting, Garmisch-Partenkirchen, 16.- 19. Februar).
  • Lass C, Vocanson M, Schempp C, Nicolas JF, Merfort I, Martin S: The allergenic potential of sesquiterpene lactones in phytomedicines from Arnica - an immunologic revision 2006 (33. ADF Tagung, Aachen, 23.-25. März).
  • Lass C, Vocanson M, Schempp C, Nicolas JF, Merfort I, Martin S: The allergenic potential of Arnica in phytomedicines - an immunologic revision Exp Dermatol, 2006; 15: 189-190.
  • Lass C, Vocanson M, Wagner S, Schempp C, Nicolas JF, Merfort I, Martin S: Anti-inflammatory and immune regulatory mechanisms prevent CD8+ T cell-mediated contact hypersensitivity to Arnica montana L. in immunocompetent mice J Invest Dermatol, 2006.
  • Laszczyk M, Scheffler A, Simon-Haarhaus B, Schempp C: Pharmakologische Charakterisierung eines Triterpen-Trockenextraktes aus Birkenkork (Betulae cortex) Z Phytother, 2006; 27 Suppl. 26.
  • Liß Y, Mockenhaupt M for the RegiSCAR-study group: Erythema exsudativum multiforme majus versus Stevens-Johnson syndrome: differences in clinical pattern and etiology J Invest Dermatol, 2006; 126: 106 (Meeting on Cutaneous adverse drug reactions and ESDR in Paris, Frankreich, 7.-9.9.).
  • Lonjou C, Sekula P, Ledger N, Borot N, de Toma C, Halevy S, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M: A European genetic study of Stevens-Johnson syndrome and Toxic epidermal necrolysis: HLA-B association with specific high risk drugs J Invest Dermatol, 2006; 126: 37 (Meeting on cutaneous adverse drug reactions and ESDR, in Paris, Frankreich, 7.-9.9.).
  • Martin S, Dudda JC, Bachtanian E, Burghard S, Liller S, Lembo A, Galanos C, Freudenberg MA: Natural mutations in IL-12Rb2 and TLR4 result in increase or loss of chemical-induced contact hypersensitivity responses J Invest Dermatol, 2006; 381 (126) Suppl. 3: 66 (36th Annual Meeting of the European Society for Dermatological Research (ESDR), Paris, September 6-9).
  • Martin S, Dudda JC, Bachtanian E, Burhard S, Liller S, Lembo A, Galanos C, Freudenberg MA: Natural mutations in IL-12Rb2 and TLR4 result in increase or loss of chemical-induced contact hypersensitivity responses J Invest Dermatol, 2006; 381 (126) Suppl. 3: 66 (Meeting of the European Immunodermatology Society (EIS), Paris, 7.9.).
  • Martin S, Dudda JC, Bachtanian E, Liller S, Lembo A, Galanos C, Freudenberg MA: A physiological role for TLR4 and IL-12Rb2 and in chemical-induced contact hypersensitivity 2006 (20th meeting of the European Research Group for Experimental Contact Dermatitis (ERGECD), Lyon, 20.-22. Oktober).
  • Martin S, Dudda JC, Burghard S, Bachtanian E, Lembo A, Galanos C, Freudenberg MA: Failure of the IL-12/IL-12R system results in TLR4-dependent hapten-induced contact hypersensitivity Exp Dermatol, 2006; 15 (190) (33. ADF Tagung, Aachen).
  • Martin S, Dudda JC, Burghard S, Bachtanian E, Lembo A, Galanos C, Freudenberg MA: Protection of mice lacking TLR4 and IL-12Rb2 from chemical-induced contact hypersensitivity 2006 (16th European Congress of Immunology, Paris, September 6-9).
  • Martin S, Simon J.C, Dudda J: Contact hypersensitivity to TNCB but not DNFB in ß2m deficient mice. Immunobiology, 2003; 208: 81 (34. Jahrestagung der Deutschen Gesellschaft für Immunologie).
  • Martin S, Simon JC, Dudda JC: Contact hypersensitivity to TNCB but not to DNFB in ß2 microglobulin deficient mice 2004 (ADF Tagung, Dresden, 26.-28. Frebruar 2004).
  • Martin SF: Steuerung Gewebe-spezifischer T-Zellmigration durch Dendritische Zellen und Gewebe-Mikroumgebung. 2004 (40. Tagung der Gesellschaft für Lungen- und Atmungsforschung i.V. in der Deutschen Gesellschaft für Pneumologie, Bochum 2. und 3. Dezember 2004).
  • Martin SF: Breakout Session: Migration of Tumor-specific T cells. J Immunother, 2004 (Workshop on Immune monitoring for Cancer Therapy of the International Society for Biological Therapy of Cancer (iSBTc), San Francisco, USA November 4).
  • Martin SF: Effector cells in contact hypersensitivity: "Programming of tissue-selctive trafficking by Dendritic cells and different tissue microenvironments" 2004 (Accompanying paper in Allergologie und Fortschritte der Allergologie und Immunologie, DGAI München, 15.-19. September 2004), Dustri Verlag (Hrsg).
  • Martin SF: T cell instruction for tissue-selective migration - the role of dendritic cells and local tissue microenvironments 2004 (1. Walberberg Immunology Symposium, Walberberg, 14.-16.07.2004).
  • Martin SF, Bachtanian E, Dudda JC: Contact hypersensitivity to Trinitro- but not Dinitrophenyl in ß2m-deficient mice Immunobiology, 2004; 209: 381 (Joint Annual Meeting of the German and Dutch Societies for Immunology, Maastricht, Netherlands October 20-23).
  • Martin SF, Bachtanian E, Dudda JC: Dendritische Zellen und die lokale Gewebe-Mikroumgebung programmieren T-Zellen für Gewebe-spezifische Migration 2004 (4. Workshop "Tumorvakzinierung mit Dendritischen Zellen", Freiburg 15.10.04).
  • Martin SF, Dudda JC: Dissection of the contact hypersensitivity response to TNCB and DNFB in ß2m-deficient mice Clinical Investigative Medicine, 2004; 27 (12th International Congress of Immunology, Montreal, Quebec, Canada 18.-23. Juli 2004).
  • Meiß F, Penski V, Müller M, Gumpp V, Nashan D: Multiple primäre Melanome in einem Melanomkollektiv J Dtsch Dermatol Ges, 2006; 4 (9): 811.
  • Mockenhaupt M: Clinical features, etiology and pathogenetic aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN) Allergologie, 2004; 27: 147 (Drug Hypersensitivity Meeting, Bern, 04.05.-08.05.04).
  • Mockenhaupt M: Immuno-modulating therapy in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis J Eur Acad Dermatol, 2004; 18 Suppl. 2: 6-42 (13th Congress of European Academy of Dermatology and Venerology, Florence, 17.11.-21.11.04).
  • Mockenhaupt M: Diagnose und Differentialdiagnose von Toxisch epidermaler Nekrolyse und akuter generalisierter exanthematischer Pustulose. JDDG, 2005; 3 Suppl. 1: WS05:01 (DDG-Tagung, Dresden, 20.-23.04.05).
  • Mockenhaupt M: Arzneimittelreaktionen an der Schleimhaut JDDG, 2005; 1 (3) Suppl. 1: S09/06 (DDG-Tagung, Dresden, 20.-23.04.05).
  • Mockenhaupt M: Experience with international research networks in dermatology – part II 2006 (EDEN Symposium in Rom, Italien, 14.-16.12.).
  • Mockenhaupt M, and Sekula P for the RegiSCAR-study group: Sequelae and impairment after Stevens-Johnson syndrome and toxic epidermal necrolysis J Invest Dermatol, 2006; 126: 106 (Meeting on cutaneous adverse drug reactions and ESDR, in Paris, Frankreich, 7.-9.9.).
  • Mockenhaupt M, Liß Y, and all colleagues of the EuroSCAR-study group: HIV-infection and Severe Cutaneous Adverse Reactions: Frequency and Risk Factors in Europe 2006 (International Symposium of Adverse Drug Reaction (ADR) in Yokohama, Japan, 9.-10.2.).
  • Mockenhaupt M, Liß Y, Vieluf D, Haustein UF, Bork K: Pharmacovigilance in Germany: example of drug-induced severe cutaneous adverse reactions (SCAR) Int J Clin Pharm Th, 2006; 44 (10): 501 (1. Deutscher Pharmakovigilanz-Tag in Würzburg, 25.10.).
  • Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavnick JN, Sidoroff A, Schlingmann J, Roujeau JC, Flahault A: Epidemiology and Drug Risks of Severe Cutaneous Adverse Drug Reactions (ADR) in Europe 2006 (International Symposium of Adverse Drug Reaction (ADR) in Yokohama, Japan, 9.-10.2.).
  • Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schlingmann J, Roujeau JC, Flahault A: Stevens-Johnson syndrome and toxic epidermal necrolysis: Results on drug risks based on the EuroSCAR-study. J Invest Dermatol, 2005; 125 (A47): 448 (35th European Society for Dermatological Research (ESDR) Annual Meeting, 22.-24.09.05, Tübingen).
  • Mockenhaupt M.: Severe cutaneous adverse reactions (SCAR): Therapeutic approaches. (Conference Book of abstracts). 2002 (26th Annual Meeting of the Israel Society of Dermatology and Venerology. Dead Sea, Israel, 05.06.-06.06.02.).
  • Mockenhaupt M.: Usefulness of a registry of severe cutaneous adverse reactions. J Invest Dermatol, 2002; 119 (3) (5th International Congress on Cutaneous Adverse Drug Reactions, Satellite congress of the 32th ESDR Annual Meeting, Genf, 18.-21.09.02.).
  • Mockenhaupt M., Norgauer J.: Cutaneous adverse drug reactions: Stevens-Johnson syndrome an toxic epidermal necrolysis. 2002; 14: 143-150 (Allergy & Clinical Immunology International.).
  • Mockenhaupt M., Schlingmann J., Schöpf E.: Severe cutaneous adverse reactions: Time latency between beginning of drug use and onset of reaction. Brit J Dermatol, 2002: 146-542 (The 10th Meeting of The British Epidermo-Epidemiology Society (BEES), London, 14.02.02).
  • Mockenhaupt M., Schlingmann J., Schröder-Bernhardi D., Schöpf E.: Linking registry data on severe skin reactions with patient data from computerized medical practices:experience of a pilot study. Pharmacoepidem Dr S, 2002; 11: 102-102 (18th International Conference on Pharmacoepidemiology (ICPE), Edinburgh, 19.-21.08.02).
  • Nashan D, Loquai C, Frind Ch, Luger TA, Grabbe St: Side effects of non-pegylated interferon alpha in the adjuvant treatment of 72 melanoma patients. 2005 (World Congress on Melanoma, Vancouver 6.-10.09.2005).
  • Pourreyron C, Jones C, Volz A, O’Toole EA, Chen M, Hart IR, Bruckner-Tuderman L Salis-Alanis JC, McGrath JA, Leigh IM: Patients with recessive dystrophic epidermolysis bullosa develop squamous cell carcinoma regardless of type VII collagen NC1 domain expression J Invest Dermatol, 2006; 126 (8): 32.
  • Radny P, Eigentler TK, Nashan D, Garbe C: Lokales Management von Tumoren und Metastasen der Haut mit Elektroporation. JDDG, 2005; 3: 846 (15. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie).
  • Rensing-Ehl A., Gaus B, Bruckner-Tuderman L, Martin S: Number and function of CD4+CD25+ regulatory T cells in patients with bullous pemphigoid Exp Dermatol, 2006; 15 (220) (33. ADF Tagung, Aachen, 23.-25. März).
  • Sassolas B, Fagot JP, Dunant A, Mockenhaupt M, Roujeau JC: C55 - Les signes et symptômes initiaux du syndrome de Stevens-Johnson et de la nécrolyse épidermique toxique: étude de 379 patients Ann Dermatol Vener, 2006; 133 (4): 36 (Journees Dermatologiques in Paris, Frankreich, 7.12.).
  • Schacht V, Dadras S, Johnson L, Jackson DG, Hong Y-K, Detmar M: Upregulation of the Lymphatic Marker Podoplanin in Human Squamous Cell Carcinomas and Germ Cell Tumors J Invest Dermatol, 2004; 122: A17 (Annual Meeting of the Society of Investigative Dermatology (SID), Providence, Massachusetts 28.04.-01.05.2004).
  • Schacht V, Dadras S, Kremer B, Bruckner-Tuderman L, Detmar M: Differential expression of the lymphatic marker podoplanin in human squamous cell carcinomas and basal cell carcinomas. Arch Dermatol Res, 2005; 296: 406.
  • Schacht V, Dadras S, Kremer L, Bruckner-Tuderman L, Detmar M: Differential Expression of the Lymphatic Marker Podoplanin in Human Squamous Cell Carcinomas and Basal Cell Carcinomas J Invest Dermatol, 2004; 123: A56 (Annual Meeting of the European Society for Dermatological Research, Vienna, Austria 09.-11.09.2004).
  • Schacht V, Meadows K, Bruckner-Tuderman L, Detmar M: The lymphatic glycoprotein podoplanin enhances inflammation in a podoplanin transgenic mouse model. J Invest Dermatol, 2005; 125: A35.
  • Schacht V, Meadows K, Kremer B, Bruckner-Tuderman L, Detmar M: A potential role of the lymphatic glycoprotein podoplanin in skin carcinogenesis and inflammation. J Invest Dermatol, 2005; 124: A2.
  • Schlingmann J, Mockenhaupt M, Fagot J-P, Flahault A, Roujeau J-C: Evaluation of Treatment Efficacy in a Cohort of 281 Patients with Stenvens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) J Invest Dermatol, 2004; 123: 367 (6th International Congress on Cutaneous Adverse Drug Reactions (ADR); Satellite Congress of the 34th European Society for Dermatological Research (ESDR), Wien, 09.09.-11.09.04).
  • Schöpf E, Grosber M, Wiesend C, Mockenhaupt M: Toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema exsudativum multiforme majus: What ist the role of infection? J Invest Dermatol, 2004; 122: 375 (65th Annual Meeting of the Society for Investigative Dermatology, Providence, Rhode Island, 28.04.-01.05.04).
  • Schöpf E.: Schwere Arzneimittelreaktionen an der Haut. 2002 (113. Tagung der Sächsischen Dermatologischen Gesellschaft, Leipzig, 23.02.02.).
  • Schöpf E.: Schwere Formen von Arzneimittelreaktionen. (Conference Book of abstracts). 2002 (Allergica Kongreß, Frankfurt, 25.05.02).
  • Schöpf E., Mockenhaupt M.: Toxic epidermal necrolysis and Stevens-Johnson syndrome:Clinical classification, epidemiology and etiology. 2002 (Annual Scientific Sessions of Sri Lanka Association of Dermatologists Year 2002 and Joint Meeting with German Dermatological Society, Kandy, Sri Lanka, 14.02.-16.02.2002).
  • Schöpf E., Mockenhaupt M.: Severe Cutaneous adverse reactions (SCAR): Clinical, epidemiological and etiological aspects. (Conference Book of abstracts). 2002 (26th Annual Meeting of the Israel Society of Dermatology an Venereology. Dead Sea, Israel, 05.06.-06.06.02.).
  • Schöpf E., Mockenhaupt M.: Severe cutaneous adverse reactions (SCAR): Clinical, epidemiological and etiological aspects. 2002 (6th Meeting of the German-Japanese Society of Dermatology, Nama, Japan, 4./05.11.02.).
  • Schumann H: Ein prätibiales Ulcus bei komplexer thrombophiler Diathese ohne Zeichen einer durchgemachten tiefen Venenthrombose: Die Rolle der Thrombophilie bei der Entstehung des Ulcus cruris 2006 (48. Jahrestagung der Deutschen Gesellschaft für Phlebologie, Rostock, 7.9.).
  • Schumann H, Burow A,, Bruckner-Tuderman L: The differential diagnostic spectrum of lower limb ulceration: The exact diagnosis is essential for causative therapies 2005 (European Wound Management Association 15.-17.09.2005 Stuttgart).
  • Schumann H, Höping D, Bruckner-Tuderman L: Application of Soft Silicone Foam Dressings in Acquired or Hereditary Fragile Skin Conditions 2005 (Deutsche Gesellschaft für Wundheilung 15.-17.09.2005 Stuttgart).
  • Technau K, Nashan D, Petres J: Das follikuläre basaloide Hamartom - ein Imitator des Basalzellkarzinoms. JDDG, 2005; 3: 838 (15. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie, Magdeburg, 26.09.-01.10.2005).
  • Technau K, Ständer S, Bruckner-Tuderman L, Nashan D: Keratoacanthoma - a reactive malignant epithelial neoplasm. 2005 (World Congress of Cancer, Mai 2005, Wien).
  • Väisänen L, Hurskainen T, Autio-Harmainen H, Hofmann S, Räsänen J, Franzke CW, Bruckner-Tuderman L, Tasanen K: Transmembrane collagen XVII is expressed by amnion epithelial cells and cytotrophoblast cells of human placenta J Invest Dermatol, 2005; 125: A101 (European Society of Dermatological Research 2005, Tübingen).
  • Valerie-Allanore L, Poulhalion N, Fagot JP, Hellmer A, Davidovici B, Sidoroff A, Roujeau JC, Mockenhaupt M: Amifostine, a new drug with high risk of inducing Stevens-Johnson syndrome and toxic epidermal necrolysis J Invest Dermatol, 2006; 126: 107 (Meeting on cutaneous adverse drug reactions and ESDR, in Paris, Frankreich, 7.-9.9.).
  • Volz A, Höping D, Schumann H, Technau K, Nashan D, Bruckner-Tuderman L: Plattenepithelkarzinome als schwerwiegende Komplikation bei Epidermolysis bullosa dystrophica Hallopeau-Siemens Journal der Deutschen Dermatologischen Gesellschaft, 2006; 9 (804) (16. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie, 28.09.-30.09., Bochum).
  • Volz A, Technau K, Radny P, Maier K, Bruckner-Tuderman L: Papulopustulöse Hautveränderungen unter Therapie mit dem monoklonalen Antikörper Cetuximab (Erbitux) JDDG, 2005; 3: 858 (15. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie).
  • Wiesend C, Grosber M, Schlingmann J, Blaschke S, Vetter R, Hinrichts R, Weiss JM, Mockenhaupt M: Multiforme-like adverse skin reactions in asociation with the use of Bextra R (valdecoxib) J Invest Dermatol, 2004; 123: 84 (6th International Congress on Cutaneous Adverse Drug Reactions (ADR); Satellite Congress of the 34th European Society for Dermatological Research (ESDR), Wien, 09.09.-11.09.04).
  • Wiesend C, Schlingmann J, Blaschke S, Vetter R, Hinrichs R, Weiss JM, Mockenhaupt M: Bextra R (valdecoxib) - a suspected cause of multiforme-like adverse drug reactions? Allergologie, 2004; 27: 181 (Drug Hypersensitivity Meeting, Bern, 04.05.-08.05.04).
  • Zimina EP, Bruckner-Tuderman L, Franzke CW: Plasma membrane organization regulates collagen XVII shedding J Invest Dermatol, 2005; 124: A32.
  • Zschocke, I, Cummerow R, Hartmann A, Augustin M: Nutzen und Wirtschaftlichkeit eines 5-FU-/Salicylsäure-haltigen Präparates in der Therapie vulgärer und plantarer Warzen - Metaanalyse und ökonomische Modellierung. Journal der Deutschen Dermatologischen Gesellschaft, 2003; 1: 151.
  • Zschocke I, Braun V, Vielhaber K, Cummerow R, Augustin M: Krankheitskosten der atopischen Dermatitis unter Praxisbedingungen - eine naturalistische Langzeitstudie. Journal der Deutschen Dermatologischen Gesellschaft, 2003: 153.
Sonstige Publikationen:
  • Augustin M.: Malignant Melanoma. Dermatology and Psychosomatics, 2002; 3: 42-44.
  • Braun-Falco M: Interview: Rheinmaintv „Das Thema: Die Gesundmacher der Zukunft – welche Möglichkeiten bieten Stammzellen? 6.12.2006 2006.
  • Brockow K, Traidl-Hoffmann C, Ollert M, Jakob T: Ehre wem Ehre gebührt. Allergo Journal, 2013; 22: 535.
  • Bruckner-Tuderman L: Secondary modifiers and the phenotypic variability of junctional epidermolysis bullosa. Invited editorial. Acta Derm-venereol, 2008; 88: 436.
  • Bruckner-Tuderman L: Systemic Therapy for a Genetic Skin Disease. New Engl J Med, 2010; 363: 680-682.
  • Bruckner-Tuderman L: Small Molecule Therapies for Genetic Skin Fragility? Mol Ther, 2014; 22: 1724-1725.
  • Bruckner-Tuderman L: Dealing with rare diseases in medicine and dermatology - new developments. J Dtsch Dermatol Ges, 2014; 12: 103-104.
  • Duda GN, Grainger DW, Frisk ML, Bruckner-Tuderman L, Carr A, Dirnagl U, Einhäupl KM, Goldman M, Gottschalk S, Gruskin E, Huber C, June CH, Mooney DJ, Rietschel E, Schütte G, Seeger W, Stevens M, Urban R, Veldman A, Wess G, Volk HD: Changing the mindset in life sciences toward translation: a consensus. Sci Transl Med, 2014; 6: 264cm12. : http://doi: 10.1126/scitranslmed.aaa0599
  • Dumit VI, Dengjel J: The cup of youth. Cell Cycle, 2014; 13: 2021.
  • Happle R: Superimposed segmental dermatomyositis: an emerging new paradigm. Eur J Dermatol, 2010; 20: 551. : http://www.john-libbey-eurotext.fr/en/revues/medecine/ejd/e-docs/00/04/5C/B0/article.phtml
  • Happle R: Superimposed segmental hemangioma of infancy. Dermatology, 2010; 220: 180-182. : http://dx.doi.org/10.1159/000259316
  • Happle R: Didymosis cesioanemica: an unusual counterpart of phacomatosis cesioflammea. Eur J Dermatol, 2011; 21: 471.
  • Happle R: Superimposed segmental vitiligo should not be categorized as "type 2 mosaicism" J Am Acad Dermatol, 2012; 66: 852.
  • Happle R: Unilateral nevoid telangiectasias with anemic halos: why aren't they twin spots? J Dtsch Dermatol Ges, 2012; 10: 140.
  • Happle R: Rud syndrome does not exist. Eur J Dermatol, 2012; 22: 7.
  • Happle R: Porokeratosis palmaris, plantaris et disseminata vs. porokeratosis of Mibelli. Brit J Dermatol, 2012; 166: 681-682.
  • Jakob T: Molecular allergology update 2012: Benefits and limitations of molecular allergy diagnostics. Allergologie, 2012; 35: 176-178.
  • Jakob T, Merk H: Jedem Anfang wohnt ein neuer Zauber inne. Allergo J, 2010; 19 (1) .
  • Jakob T, Merk H: „Gute und schlechte Zeiten“ Allergo J, 2010; 19 (285) .
  • Jakob T, Merk H: Start in molekulare Welten der Allergologie. Allergo J, 2010; 19 (361) .
  • Jakob T, Merk H: Das allergologische Zukunftspendel schwingt... Allergo J, 2010; 19 (499) .
  • Jakob T, Merk H: Zum neuen Jahr im neuen Gewand. Editorial Allergo J, 2012; 21: 1.
  • Jakob T, Merk H: Höhen und Tiefen zum Jahresanfang. Allergo Journal, 2013; 22: 3.
  • Jakob T, Merk H: Chance Präventionsgesetz nutzen. Allergo Journal, 2013; 22: 155.
  • Jakob T, Merk H: Paralyse oder Analyse? Allergo Journal, 2013; 22: 296.
  • Jakob T, Merk H: Allergo Journal International. Editorial. Allergo Journal, 2014; 23 (1) : 3.
  • Jakob T, Merk H: Achtung neue Anaphylaxie-Leitlinie. Editorial. Allergo Journal, 2014; 23 (3) : 3.
  • Jakob T, Merk H: Allergologie- Zurück zur alten Stärke. Editorial. Allergo Journal, 2014; 23 (7) : 3.
  • Jakob T, Merk H: Vertrauen durch Transparenz. Editorial Allergo Journal, 2015; 24 (1) : 3.
  • Jakob T, Merk H: Allergo Journal International goes PubMed Central. Editorial Allergo Journal, 2015; 24 (5) : 3.
  • Jakob T, Merk H: Buttermilch ist nicht gleich Muttermilch. Editorial Allergo Journal, 2015; 24 (7) : 3.
  • Jakob T, Merk H, Werfel T: Die Geister die ich rief… Ghostwriting ist kein Kavaliersdelikt. Editorial Allergo J, 2012; 21: 281.
  • Klimek L, Merk H, Jakob T: Intrakutantest for dem Aus? Editorial Allergo Journal, 2015; 24 (2) : 3.
  • Merk H, Jakob T: Allergendiagnostik – ein Krimi unserer Zeit. Allergo J, 2010; 19 (433) .
  • Merk H, Jakob T: In vitro Allergiediagnostik im Fokus. Allergo J, 2010; 19 (81) .
  • Merk H, Jakob T: Sequenzieren, interpretieren, personalisieren. Editorial Allergo J, 2012; 21: 83.
  • Merk H, Jakob T: Gefahr gebannt, Epikutantest gerettet. Editorial Allergo J, 2012; 21: 281-333.
  • Merk H, Jakob T: Vorsicht falsche Versprechungen. Allergo Journal, 2013; 22: 89.
  • Merk H, Jakob T: Heiße allergologische Eisen. Allergo Journal, 2013; 22: 231.
  • Merk H, Jakob T: Therapiemöglichkeiten gut, Versorgungssituation schlecht! Allergo Journal, 2013; 22: 351.
  • Merk H, Jakob T: Urticaria: Spannende Neuzulassung. Editorial. Allergo Journal, 2014; 23 (2) : 3.
  • Merk H, Jakob T: Im Zeichen des Ekzems. Editorial Allergo Journal, 2015; 24 (4) : 3.
  • Merk H, Jung K, Renz H, Werfel T, Jakob T: Grobes Foul an Allergologen. Editorial Allergo J, 2012; 21: 229.
  • Merk H, Klimek L, Jakob T: Hürden bei der spezifischen Immuntherapie. Editorial Allergo Journal, 2015; 24 (6) : 3.
  • Padovan E, Martin SF: Editorial: Innate immune cell determinants of T cell immunity: from basic mechanisms to clinical implications. Specialty section: Immunological memory. Frontiers Immunol, 2016; 6: 664. : http://doi: 10.3389/fimmu.2015.00664
  • Rietschel ET, Bruckner-Tuderman L, Schütte G, Wess G: Moving medicine forward faster. Sci Transl Med, 2015; 4 (7) : 277.
  • Ring J, Akdis C, Behrendt H, Lauener RP, Schäppi G, Akdis M, Ammann W, de Beaumont O, Bieber T, Bienenstock J, Blaser K, Bochner B, Bousquet J, Crameri R, Custovic A, Czerkinsky C, Darsow U, Denburg J, Drazen J, de Villiers EM, Fire A, Galli S, Haahtela T, zur Hausen H, Hildemann S, Holgate S, Holt P, Jakob T, Jung A, Kemeny M, Koren H, Leung D, Lockey R, Marone G, Mempel M, Menné B, Menz G, Mueller U, von Mutius E, Ollert M, O'Mahony L, Pawankar R, Renz H, Platts-Mills T, Roduit C, Schmidt-Weber C, Traidl-Hoffmann C, Wahn U, Rietschel E: Davos Declaration: Allergy – as a gloal problem. Allergy, 2012; 67: 141-143. : http://dx.doi.org/10.1111/j.1398-9995.2011.02770.x
  • Utikal J, Eigentler TK, Huber MA, Meiss F, Weichenthal M, Schneider LA: Zweites Netzwerktreffen der zertifizierten Hauttumorzentren. J Dtsch Dermatol Ges, 2016; 14 (10) : 1051-1052. : http://dx.doi.org/10.1111/ddg.13149
  • Werfel T, Jakob T, Merk H: Die Geister die ich rief… Editorial Allergologie, 2012; 35: 389-390.

Besondere wissenschaftliche Aktivitäten

Abschlussarbeiten